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Summary  
The work in this thesis examines genome-wide and local changes in the patterns of 
nucleosome positioning throughout the human genome. Nucleosomes are the fundamental 
repeating unit of chromatin. Their properties and positioning in the genome dictate whether 
and how proteins involved in gene regulation can access DNA. Nucleosomes are dynamic; their 
positions can vary considerably at some loci from one cell type to another. Chromatin 
remodelling complexes can change the structure and the positions of nucleosomes. Their mis-
regulation leads to congenital defects affecting pre-natal and early childhood development 
and is associated with neuro-psychiatric disorders. As mutations in genes that encode 
chromatin remodelling proteins are associated with human mental health disorders, the work 
in this thesis focusses on changes that occur in chromatin structure during early neural 
development. 
I have used MNase-seq data to construct genome-wide, high-resolution chromatin particle 
positioning maps from undifferentiated human induced pluripotent stem cells (hiPSC) and 
following differentiation to the neuro-progenitor cell (NPC) stage. These maps reveal that a 
small proportion of the pluripotent genome possesses well-positioned nucleosomes, the 
number of which increases approximately 8-fold during neural cell development. This is 
accompanied by changes in the distribution and localisation of nucleosomes between iPS and 
NPC cells.  
Differences in nucleosome positioning during neural cell differentiation were investigated at 
regulatory regions. Loss and gain of positioned nucleosomes at TSS of pluripotent and neural-
specific genes was detected and correlated with gene expression. In addition I investigated the 
chromatin structure at the binding motifs of two important genome regulators REST and CTCF 
in detail. Nucleosome positioning is maintained at REST binding motifs during neural cell 
development. In contrast, at CTCF sites nucleosome repositioning occurs during neural cell 
development. This work provides insight into the role of chromatin structure in the regulation 
of human neural cell differentiation. 
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Chapter 1 : Introduction 
 
  
2 
 
1.1 Overview 
Eukaryotic DNA is packaged into the relatively small nucleus of the cell by coiling the DNA 
around core histone proteins to form nucleosomes. These coils are packaged into higher order 
3D structures that ultimately form condensed chromosomes. This complex of nuclear nucleic 
acids and proteins is known as chromatin. We know that the genome is regulated and that 
timing of events is important, so how can the genes in this packaged DNA be accessible for the 
cellular machinery to utilise them and does the organisation of the genome affect the 
regulation of events in a cell? 
It is well known that chromatin structure is dynamic at both a local and a global level. The 
action of ATP-dependent chromatin remodelling complexes can bring about local changes to 
nucleosome structure by post-translational modifications of histones or by the exchange of 
histone variants. Chromatin remodellers also can slide nucleosomes, leading to changes in 
their positions. It is thought that nucleosome properties and positioning in the genome can 
dictate accessibility to DNA; hence changes in the structure and positions of nucleosomes can 
affect gene regulation. Higher-order chromatin structure is also important in the regulation of 
the genome. It has been shown that chromatin is organised into dynamic functional domains 
and that this organisation is mediated by architectural proteins such as CTCF. Post-
translational modifications of nucleosomes have been studied widely, but the regulation of 
nucleosome positioning and chromatin structure is less understood. Recent studies have 
shown that chromatin structure is both organism and cell-type specific. In addition, clinical 
genetic observations implicate mutations in chromatin remodelling genes in childhood neuro-
developmental syndromes and mental health disorders. 
Deciphering developmentally associated changes in chromatin structure will provide insight 
into how chromatin regulation interfaces with human neuro-development and disease. 
Therefore, the work in this thesis focusses on the changes that occur in chromatin structure 
during early neural development. In order to do this, the genome- wide positions of 
nucleosomes in the human genome were mapped at high resolution using MNase-seq. I have 
constructed and characterised high-resolution chromatin particle positioning maps from 
human induced pluripotent stem cells (hiPSC) in their undifferentiated state and following 
differentiation to the neuro-progenitor cell (NPC) stage. Initially I investigated the global 
patterning of nucleosome positioning in both iPS and NPC. The differences in the distribution 
and localisation of nucleosomes between iPS and NPC cells was determined, to a) to identify 
the locations of organised chromatin across entire human genomes and b) to determine the 
regions in which changes in chromatin structure occur during human neural cell 
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differentiation. Subsequently, changes in nucleosome positioning during early neural cell 
differentiation were investigated at regulatory regions relevant to transcription regulation, for 
example at transcriptional start sites and at the binding motifs of a selection of transcription 
factors relevant to neural cell development. A detailed analysis is presented for REST which is a 
transcriptional repressor of neural genes in non-neuronal cells. Finally, in order to investigate 
whether or not architectural proteins, that affect higher-order chromatin structure, have a role 
in the regulation of neural cell development, changes in nucleosome positioning were 
investigated at CTCF binding motifs. 
1.2 The human genome 
The human genome is large, comprising approximately 3x 109 bp of DNA (Lander, Linton et al. 
2001). The human genome is organised into 24 pairs of chromosomes, 22 autosomes and two 
sex chromosomes. Current estimates are that the total number of genes is 60,483, of which 
19,814 are protein coding genes, 15,900 are long non-coding RNAs and 9894 are small non-
coding RNAs (GENCODE Release (version 22) www.gencodegenes.org). Human protein coding 
genes  vary greatly in size, from several kilobases to several megabases, for example  the 
dystrophin gene is 2.4 Mb (Koenig, Monaco et al. 1988) and they are therefore, along with 
their regulatory units, dispersed over long distances in the genome. Approximately 50-60%  
percent of the human genome comprises tandem repeats (de Koning, Gu et al. 2011), known 
as satellite DNA which is associated with functional centromeres (Verdaasdonk and Bloom 
2011) and telomeres  (Rosenberg, Hui et al. 1997) and with inactive chromatin . 
The major recent important discovery in the work on the human genome is that although only 
1% of the human genome possesses protein coding genes, most of the genome is transcribed. 
Hence much of this transcription generates non-coding RNA. These non-coding RNAs are 
variable in size, may be sense or antisense transcripts and may overlap. Their functions are a 
current active area of research.  
1.2.1 The non-coding human genome 
Recent work has shown the importance of non-coding RNAs in genome regulation (Geisler and 
Coller 2013), therefore the analysis of chromatin structure in both the coding and non-coding 
genomes is important. Micro RNAs (miRNAs) are 20-24 nucleotide RNAs that bind to target 
motifs in messenger RNAs, silencing them (Lim, Lau et al. 2005). They are involved in 
neurogenesis (Stappert, Borghese et al. 2013), specifically, miR-9 is up-regulated in neural 
differentiation and is thought to down-regulate REST (Conaco, Otto et al. 2006) (Packer, Xing 
et al. 2008; Laneve, Gioia et al. 2010). 
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Long non-coding RNAs (lncRNAs) are involved in the regulation of the epigenome by 
association with chromatin modifying complexes (Khalil, Guttman et al. 2009). For example, 
the xist gene encodes a lncRNA that is involved in mammalian X chromosome inactivation 
(Chow, Yen et al. 2005). In addition and relevant here is that lncRNAs are important in the 
maintenance of pluripotency (Sheik Mohamed, Gaughwin et al. 2010), (Guttman, Donaghey et 
al. 2011) and that they can affect gene expression through association with chromatin-
modifying complexes (Tsai, Manor et al. 2010).  
1.3 Primary chromatin structure 
Chromatin was discovered by Walter Fleming in 1878 (Flemming 1965; Paweletz 2001) who 
observed that thread-like structures in the cell nucleus absorbed aniline dyes (Fig 1.1).  In 1963 
Luzzati et al  showed that chromatin had a repeating pattern, with intervals of 100 angstroms, 
that differed from that of the structure of DNA (Luzzati and Nicolauieff 1963) and images of 
repeating units in chromatin fibres were shown by electron microscopy by Olins et al (Olins 
and Olins 1974). Further evidence for repeating units in chromatin was shown by digestion of 
chromatin by micrococcal nuclease (Burgoyne, Hewish et al. 1974; Noll 1974). These repeating 
units in chromatin were named ‘nucleosomes’ and shown to  flow from lysed nuclei as 10nm 
fibre structures that resemble beads on a string  (Olins and Olins 1974; Oudet, Gross-Bellard et 
al. 1975; Olins, Carlson et al. 1976).  The protein component of a nucleosome comprises 
histone proteins.  Kornberg et al  isolated histone proteins and studied them in combination 
with DNA by X ray diffraction and demonstrated that histone H3 and H4 exist as a 
heterotetramer (Thomas and Kornberg 1975). Later it was demonstrated that  histones 
H2A,H2B, H3 and H4 exist in equal amounts (Olins, Carlson et al. 1976) and that these proteins 
form an octomer (Thomas and Kornberg 1975; Thomas and Butler 1977)  Hence nucleosomes 
were described as a bead-like structure of 12.5nm diameter that encompass 200 bp of DNA in 
approximately one negative super-helical turn per bead  (Oudet, Germond et al. 1978). 
  
5 
 
 
 
Figure 1.1 Early illustrations of chromatin. 
Detection of chromatin by Walter Flemming from ‘Zellsubstanz, Kern und Zelltheilung’ (Cell substance, 
nucleus and cell division) (Flemming 1882), reproduced by Paweletz (Paweletz 2001) showing staining of 
cells with aniline dyes, detecting chromatin structure during different phases of the cell cycle. Reprinted 
by permission from Macmillan Publishers Ltd: Nature reviews. Molecular cell biology 2(1): 72-
75.Copyright (2001). 
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More recently the high resolution crystal structure of the nucleosome particle demonstrated 
that the histone octamer comprises four dimers, two H3-H4 and two H2A-H2B. The H3-H4 
dimers form a heterotetramer with which the H2A-H2B dimers interact on opposite sides (fig 
1.2). This histone octomer forms the nucleosome core and is wrapped by 146 bp of DNA, 
comprising 1.65 turns of a left-handed super-helix (Luger, Mader et al. 1997). The centre of the 
nucleosome where there is an overall pseudo two-fold symmetry is defined as the nucleosome 
dyad. 
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Figure 1.2 Crystal structure of the nucleosome core particle. 
The nucleosome core particle comprises an octamer of histone proteins. The histone octamer comprises 
four dimers, two H3-H4 and two H2A-H2B. The H3-H4 dimers form a heterotetramer with which the 
H2A-H2B dimers interact on opposite sides. This histone octomer forms the nucleosome core and is 
wrapped by 146 bp of DNA, comprising 1.65 turns of a left-handed super-helix. Reprinted by permission 
from Macmillan Publishers Ltd: [Nature] (Luger, Mader et al. 1997) copyright (1997).  
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Core nucleosomes are joined together by stretches of DNA which are approximately 20-80 bp 
long, defined as non-nucleosomal DNA and known as linker DNA, to form the 10nm fibre or 
‘beads on a string’ primary chromatin structure. In higher eukaryotes linker DNA may be 
bound by linker histones, for example histones H1 or H5 (in avian species). It has been shown 
that linker DNA can vary in length both in different organisms, between cell types from the 
same organism and at different stages of differentiation. 
The nucleosome repeat length (NRL) is given by the distance from the dyad of one nucleosome 
to the next. Since core canonical nucleosomes in higher eukaryotes are similar in structure, 
protecting 147 bp of DNA, variation in nucleosome repeat length is attributed to changes in 
linker length. The NRL can vary from one organism to another; the S. cerevisiae genome has a 
nucleosome repeat length (NRL) of 165 bp (Yuan, Liu et al. 2005), whereas  in  C. elegans  it is  
175 bp (Valouev, Ichikawa et al. 2008) and early work in human HeLa cells suggested that it is 
approximately 200 bp (Whitlock and Simpson 1976). There is a wide variation in linker length 
between different  cell types in higher eukaryotes  (Compton, Bellard et al. 1976) and recent 
work has shown that the human nucleosome repeat length is variable from one cell type to 
another;  193 bp in granulocytes, 203 bp in CD4+ cells (Valouev, Johnson et al. 2011) and 187 
bp in lymphoblastoid cells (Gaffney, McVicker et al. 2012). This led to the idea that changes in 
linker length, resulting in changes in chromatin accessibility may have a role cell 
differentiation.  
In higher eukaryotes, the addition of the linker histone, H1 to the nucleosome core forms 
‘chromatosomes’ (Simpson 1978). H1 is positioned at the dyad axis of the nucleosome core 
and protects DNA both on entry and exit to the nucleosome core, stabilising core nucleosomes 
(Allan, Hartman et al. 1980). Linker histones are many and varied. In humans there are eleven 
H1 variants :the somatic variants H1.1 to H1.5 that are expressed in most cells and six tissue-
specific H1 variants, these  are encoded by two classes of H1 genes (Happel and Doenecke 
2009).  
Histone H1 binding to chromatin is dynamic, (Lever, Th'ng et al. 2000) (Misteli, Gunjan et al. 
2000). Linker histones are thought to increase chromatin compaction, leading to 
transcriptional repression, hence H1 is depleted in active chromatin (Fan, Nikitina et al. 2005). 
Linker histones can act to block the access of chromatin remodelling complexes and affect 
nucleosome mobility (Hill and Imbalzano 2000) (Ramachandran, Omar et al. 2003) Linker 
histones can be post-translationally modified, for example by phosphorylation (Garcia, Busby 
et al. 2004), reversing chromatin compaction and allowing the access of chromatin remodelling 
complexes  (Horn, Carruthers et al. 2002). 
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In addition, linker histones are involved in the regulation of developmental genes (Nguyen, 
Gokhan et al. 2014). Recently it has been shown that post-translational modification of H1 by 
citrullination affects its binding to DNA and that this is important in pluripotency 
(Christophorou, Castelo-Branco et al. 2014). 
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Figure 1.3 Nucleosome Repeat length (NRL). 
The nucleosome repeat length is given by the distance from the dyad of one nucleosome to the next. 
Linker DNA is the length of DNA between nucleosomes. Core canonical nucleosomes in higher 
eukaryotes protect 147 bp of DNA therefore variation in nucleosome repeat length is attributed to 
changes in linker length. 
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1.4 Higher-order chromatin structure 
The formation of nucleosomes is thought to be the first step in packaging DNA into the nucleus 
of a cell in an ordered manner.  How the higher order packaging of eukaryotic genomes occurs 
has been the subject of some controversy and is not completely understood. 
1.4.1 The 30nm fibre 
The early models of how  nucleosomes might be packaged  into higher order structures  were  
the solenoid model  (Finch and Klug 1976) and the zig-zag model (Woodcock, Frado et al. 1984; 
Burgoyne 1985) which were derived from in vitro studies of chromatin.  In the solenoid model, 
the nucleosomes assemble face-to-face with their nearest neighbour and the linker region is 
bent, packaging six nucleosomes per turn of the 30nm fibre.  Thoma et al show evidence for 
these structures and that H1 is required for this higher order packaging of nucleosomes. 
(Thoma and Koller 1977; Thoma, Koller et al. 1979).  
The zig-zag model proposes that nucleosomes associate with their opposite neighbour and the 
linker is not bent, hence the characteristics of the structure depends on the linker length and 
would be more flexible. This model is supported by work from Rydberg et al (Rydberg, Holley 
et al. 1998). 
The early in vitro work and models of the 30nm fibre led to the idea that chromatin was 
generally ‘packaged’ into this higher order structure when it was inactive. However, more 
recent work has challenged this idea and suggested that the 30nm fibre can exist, but it is by 
no means the only way in which primary chromatin is packaged. There is evidence that the 
10nm fibre can fold into many forms (Engelhardt 2007), generating many different types of 
secondary chromatin structure. Cryo-eM, which allows studies on native chromatin in  living 
cells in a hydrated state (Dubochet, Adrian et al. 1988), have shown  conflicting results for 
detection and characterization of  the 30nm fibre (Dubochet, Adrian et al. 1988; Maeshima, 
Hihara et al. 2010; Scheffer, Eltsov et al. 2011) and its existence has been challenged. Eltsov et 
al concluded that there was no evidence for the 30nm fibre in mitotic chromosomes (Eltsov, 
Maclellan et al. 2008). However, recent Cryo-EM studies have shown that its structure is 
consistent with a zigzag two-start helix, but the structure differs from that in the original 
model. (Song, Chen et al. 2014). Taken together, it seems that the 30nm fibre can exist in vivo, 
but it may not exist all the time, or in all of the nucleus. Hence it is not, as previously thought, 
the dominant form of secondary chromatin structure. 
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1.4.2 The polymer-melt structure 
It has been suggested that that the 10nm fibre exists as a dynamic polymer-melt like structure 
(Nishino, Eltsov et al. 2012), whereby the 10nm fibres are arranged in a loose, irregular 
association, rather than coiled into rigid secondary structures.  Evidence for this fluid 
chromatin fibre structure in living cells has been shown recently along with evidence that 
nucleosomes can move locally, suggesting that  chromatin is packaged more loosely than 
proposed in the original 30nm fibre models (Nozaki, Kaizu et al. 2013). 
In this case, in vivo, where the relative concentration of nucleosomes is high, localised 
structures may form through inter-nucleosome fibre interactions. This model would allow the 
access of large protein complexes necessary for cellular processes to occur, by constant 
movement and rearrangement of the structure locally (Hihara, Pack et al. 2012). 
1.4.3 Fractal globules  
Fractal globules are the result of the condensation of a polymer that has topological 
constraints.  The idea that chromatin could form fractal globules (Mirny 2011) is consistent 
with results from work using chromatin conformation capture techniques (de Wit and de Laat 
2012; Sajan and Hawkins 2012; Dekker, Marti-Renom et al. 2013) to study long-range 
chromatin interactions. These techniques use crosslinking of chromatin, followed by digestion 
and re-ligation and sequencing to determine which regions of chromatin are in close proximity 
to one another in the cell.  One such technique, Hi-C (Lieberman-Aiden, van Berkum et al. 
2009), can be used to look at genome-wide chromatin interactions and the variability in cell to 
cell chromatin structure is averaged across many cells. More recently,  single-cell Hi-C (Nagano, 
Lubling et al. 2013) has been used to construct  a 3D picture of how chromosomes are 
arranged in single cell. 
1.4.4 Chromatin domains 
The fractal model of chromatin would mean that the 10nm fibres would not cross one another, 
could form loops that span large chromosomal domains and have a territorial organisation. 
This structure could easily unfold, which would be important in allowing access for gene 
activation.  The chromatin loops may be anchored by crosslinking proteins to keep them in 
place.  Territories could extend as far as whole chromosomes, which would occupy a particular 
space, but could still interact with other chromosomal domains. 
Evidence that some of these conditions may be met in this model has come from a large body 
of recent research in to the 3D structure of chromatin. Interphase chromosomes have been 
shown occupy distinct territories within the nucleus using  spectral karyotyping (SKY) 
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techniques (Bolzer, Kreth et al. 2005) (Cremer and Cremer 2010) . Within chromosome 
territories, there are two types of compartments that exist along the chromosome; one of 
transcriptionally active chromatin (heterochromatin), and one of inactive chromatin 
(euchromatin). The compartments can interact and they are tissue-specific (Lieberman-Aiden, 
van Berkum et al. 2009). These compartments are up to 10Mb in size and correlate with the 
size of a fractal globule, although the relationship between the fractal globule and these 
chromatin compartments is not yet clear. 
Within chromatin compartments, chromatin forms smaller, approximately 500kb loops which 
may be active or inactive. These loops are known as topologically active domains (TADs) and 
they were characterised using chromatin conformation capture techniques. Single cell Hi C 
experiments have shown that these chromatin domains are not randomly placed (Nagano, 
Lubling et al. 2013). Active chromatin domains tend to be located at the periphery of a 
chromosome and to associate with other active domains, which may be on other 
chromosomes. These topological domains are conserved across species, stable across cell 
types and they can be functionally organised, so that groups of genes are clustered together to 
perform a particular task and their boundaries are enriched in CTCF (Dixon, Selvaraj et al. 
2012). For example, clusters of replication origins that are in the same place tend to fire at the 
same time, hence these clusters are known as ‘replication domains’ (Hiratani, Ryba et al. 
2008).  
Within TADS, there is evidence for the existence of sub-TADs. These comprise a gene and its 
regulatory elements, brought together by the formation sub-megabase topological domains. 
These interactions may be anchored by cohesin, separated by boundary elements which are 
genetically encoded and which tend to be bound by the insulator protein CTCF and may be 
bound by mediator. Boundary sites are sometimes, but not always co-occupied by the Med12 
subunit of the mediator complex, CTCF and Smc, a subunit of the cohesin complex. The 
combination of proteins found at the boundary elements appear to correlate with the size of 
the sub-TAD. The overlap of all three of these proteins occurs at boundary sites in ES cells at a 
high level, suggesting their involvement in cell-type-specific looping. 
It has been shown that these sub-TADs bring together tissue-specific enhancers and promoters 
and may therefore be involved in the regulation of tissue-specific gene expression.  (Phillips-
Cremins and Corces 2013). Another aspect of global spatial and structural organisation of the 
genome that may impact on genome regulation is the existence of lamina associated domains 
(LADs). The nuclear lamina associates with LADs which are transcriptionally repressed. Recent 
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work has shown that this demarcation of the genome is important in the regulation of 
replication timing (Pope, Ryba et al. 2014).  
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Figure 1.4 Current models of primary and higher-order chromatin structure. 
A. The canonical core nucleosome comprises an octamer of histone proteins around which 147 bp of 
DNA is wrapped (diagram courtesy of Dr. N. Kent). B. The top panel shows an electron micrograph of 
nucleosomes existing as a ‘beads on a string’ structure which measures approximately 10nm in diameter 
(courtesy of Victoria Foe). The bottom panel is a cartoon representation of the 10nm fibre. C. The 
polymer melt model for higher order folding of nucleosome fibres. Reprinted from Current opinion in 
cell biology, 22(3): 291-297, Maeshima, K., S. Hihara, et al. "Chromatin structure: does the 30-nm fibre 
exist in vivo?” Copyright (2010), with permission from Elsevier. D. Chromatin exists in topologically 
active domains (TADs) and sub-TADS. E. Interphase chromosomes form ’territories’ in the nucleus that 
can interact. D. and E. Reprinted from"Chromatin meets its organizers."  Bodnar, M. S. and D. L. Spector  
Cell 153(6): 1187-1189 (2013) with permission from Elsevier. F. Cartoon of a metaphase chromosome in 
which chromatin is condensed.   
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1.5 Chromatin remodelling 
The regulated alteration of chromatin structure is known as ‘chromatin remodelling’, this 
occurs in two major ways; by alteration of the structure of the core histone proteins or by 
repositioning nucleosomes. Alteration of the structure of the nucleosome core occurs through 
post translational modification of the core histone proteins (Strahl and Allis 2000)  or by 
exchange of histone variants (Kamakaka and Biggins 2005). Nucleosome repositioning is 
brought about by the action of ATP-dependent chromatin remodelling complexes (Clapier and 
Cairns 2009). Chromatin remodellers are nuclear enzymes that are part of a larger complex 
and use the energy derived from  ATP hydrolysis to slide, evict, eject, or restructure 
nucleosomes by loosening the DNA around the histone core (Havas, Whitehouse et al. 2001). 
1.6 Covalent histone modifications 
Histone proteins are basic proteins that have an N-terminal or C-terminal tail. They have a 
common three dimensional structural motif, known as the histone fold that is found in all 
eukaryotic histone proteins and is involved in the formation of histone dimers.(Arents and 
Moudrianakis 1995). The N-terminal tails of histone proteins  can protrude from a nucleosome 
and can contact neighbouring nucleosomes (Luger, Mader et al. 1997). Histone tails are rich in 
lysine and arginine and the resulting positive charge facilitates their association with negatively 
charged DNA in forming chromatin.  Histone proteins can be post-translationally modified.  
There are many different types of histone modification, but some of the more characterised 
ones are methylation (Lachner and Jenuwein 2002), acetylation (Kimura, Matsubara et al. 
2005), phosphorylation, ubiquitination sumoylation.  
1.6.1 Histone acetylation 
Histone acetylases (HATs) modify lysine residues by acetylation and this process is reversible 
through the action of histone deacetylases (HDACs). Histone acetylation can have a role in 
transcriptional activation (Allfrey, Faulkner et al. 1964). Histone acetyl transferases (HATs) 
catalyse the acetylation of conserved lysine amino acids on histone proteins resulting in the 
activatory H3K9ac and H3K27ac chromatin marks (Berndsen and Denu 2008). Conversely, 
through the action of the HDACs brings about histone deacetylation, generating repressive 
histone marks. 
More recently it has been shown that that histone acetylation has a role in the regulation of 
DNA replication (Unnikrishnan, Gafken et al. 2010) and in the repair of double strand breaks 
(Chen, Carson et al. 2008) in yeast. In addition, histone acetylation may have a direct effect on 
chromatin structure. Acetylation of histone lysine residues neutralises the charge of the 
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histone, weakening its interaction with DNA. In vitro, this can result in a looser chromatin 
structure (Hong, Schroth et al. 1993) (Tse, Sera et al. 1998) and may be a mechanism that 
allows greater access of protein complexes, such as transcription factors, involved in cellular 
processes,  to DNA (Lee, Hayes et al. 1993).  It has been shown that acetylated lysine residues 
are recognised by the bromo-domains in chromatin re-modelling complexes (Kasten, Szerlong 
et al. 2004), perhaps using these histone marks as a ‘docking station’.  In addition, it has been 
shown that co-activator complexes necessary for the activation of transcription can have 
histone acetylation activity (Kuo, Zhou et al. 1998). Recently it has been shown that 
modification of lysines that are inside the nucleosome core can destabilise nucleosomes (Di 
Cerbo, Mohn et al. 2014), providing another level at which chromatin structure alteration can 
occur.  
1.6.2 Histone methylation 
There are two types of histone methyl-transferases; those that catalyse the transfer of methyl 
groups to lysine residues and those that transfer methyl groups to arginine residues on histone 
H3 and H4 proteins. Mono, di or tri methylation can occur on one lysine side chain, generating 
a large number of permutations of histone modification. Histone lysines can be mono, di or tri-
methylated through the action of histone methyl transferases. These modifications can be 
reversed through the action of histone demethylases. Certain methylated histone 
modifications have been correlated with transcriptional activation e.g. H3K4me and H3K36me 
and others with transcriptional repression e.g. H3K9me and H3K27me. Recently it has been 
shown that H3K4me3 is associated with enhancers (Pekowska, Benoukraf et al. 2011).  In 
addition, some methylated histone residues are involved recruiting chromatin remodelling 
complexes, for example in yeast, H3K36me3 is involved in recruiting the chromatin re-
modelling complex Isw1b. (Maltby, Martin et al. 2012).  
However, the current picture of the role of methylation in genome regulation is not simple, 
methylated histone marks are dynamic and they can change during cell differentiation in 
human cells (Pan, Tian et al. 2007) It may be that combinations of histone modifications act in 
concert with the proteins recruited to regulatory regions to regulate the genome. 
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1.7 Histone Variants 
Histone variants differ in their amino acid sequence from the major histone proteins (H1, H2A, 
H2B, H3 and H4). They can replace the major histone proteins normally found in canonical 
nucleosomes by incorporation into chromatin in a replication-dependent or replication-
independent manner. Replication-independent incorporation of histone variants is brought 
about by ATP-dependent chromatin remodelling complexes (Mizuguchi, Shen et al. 2004) 
(Papamichos-Chronakis, Watanabe et al. 2011) or chaperone proteins (Obri, Ouararhni et al. 
2014) 
Some histone variants are thought to alter the structural properties of nucleosomes and 
others have been shown to occur in specific places in the genome (Kamakaka and Biggins 
2005; Shaytan, Landsman et al. 2015). H2AZ is a histone variant that was first described as a 
component of pericentric heterochromatin (Rangasamy et al., 2003), but more recently has 
been shown to be enriched at yeast promoters (Guillemette, Bataille et al. 2005). It is highly 
conserved, expressed throughout the cell cycle and its incorporation into nucleosomes is 
replication-independent. The crystal structure of H2AZ-containing nucleosomes is similar to 
that of canonical nucleosomes (Suto, Clarkson et al. 2000), but  recently H2AZ2.2, a splice 
variant of H2AZ that is found in human cells lines and highly expressed in the brain, has been 
shown to destabilise nucleosomes (Bonisch, Schneider et al. 2012).Recent genome-wide 
studies have shown that H2AZ is important in the maintenance of pluripotency. It is enriched 
at active enhancers and promoters in ES cells, correlates strongly with H3K4 methylation and it 
is localised at bivalent TSS. Its presence may make chromatin more accessible, allowing the 
recruitment of protein complexes that mediate gene activation or repression to promoters and 
enhancers, (Ku, Jaffe et al. 2012; Hu, Cui et al. 2013). In addition, H2AZ is necessary for lineage 
commitment in ES cells (Creyghton, Markoulaki et al. 2008). 
Histone H3.3 is incorporated into nucleosomes in a replication-independent manner (Ahmad 
and Henikoff 2002). It has been associated with histone replacement in areas of the genome 
that are undergoing active transcription (Mito, Henikoff et al. 2005; Schwartz and Ahmad 
2005) and  recently it has been found to be in pericentric chromatin (Goldberg, Banaszynski et 
al. 2010). The chromo-domain-helicase-DNA-binding protein CHD1 is responsible for in the 
incorporation of H3.3 into nucleosomes in Drosophila (Konev, Tribus et al. 2007) and recently it 
has been shown that the incorporation of histone H3.3 is reduced when CHD2 is depleted in 
human cells (Siggens, Cordeddu et al. 2015). In addition, mutations in H3.3 are associated with  
paediatric brain tumours (Liu, McEachron et al. 2014). 
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1.8 Chromatin marks 
Chemical modifications of the genome that can be made without any alteration of the DNA 
sequence are known as ‘chromatin marks’. These modifications include a) post translational 
modification of histone proteins b) the exchange of histone variants and c) DNA methylation. 
These modifications affect nucleosome structure by affecting the strength of the interactions 
between the nucleosome core and the DNA wrapped around it. In addition, these 
modifications can affect the accessibility of other proteins, such as transcription factors, to 
DNA. Hence, these modifications can regulate gene activity determining how and when genes 
are switched on and off.  
Correlation of the presence of post translational modification of histone proteins with the 
occurrence of a particular biological event led to the idea of the ‘histone code’ , whereby 
certain histone modifications or combinations thereof are associated with the of occurrence 
particular cellular processes (Strahl and Allis 2000). More recently, chromatin marks have been 
classified into those that may be involved in gene activation and those that may be involved in 
repression (Table 1.2). However, recent work has shown that the picture is not as simple as it 
seemed. Chromatin marks may act individually, in concert, in different regions of the genome 
and at different times during cell development. It has been shown that post-translational 
histone modifications may be cell and type specific (Heintzman, Hon et al. 2009), their levels 
change during the cell cycle (Schulze, Jackson et al. 2009), during cell differentiation (Hawkins, 
Hon et al. 2010) and in response to environmental factors (Feil and Fraga 2011). In addition 
they may act in concert with exchange of histone variants, but the exact role and mechanisms 
of histone modifications in gene regulation is not completely clear.  As the number known of 
chromatin marks has increased, together with data from genome-wide studies which generate 
detailed information about the locations of these marks, it is becoming clear that the 
relationship between chromatin marks and genome regulation is complex. 
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Mark Location Effect on transcription 
Methylated cytosine CpG residues repressive 
H3K9me1 5’end genes, introns  
H3K9me3 Heterochromatin and 
repetitive elements 
repressive 
H3K9ac Promoters, regulatory 
elements 
active 
H3K20me1 Introns, 5’end of genes  
H3K36me3 Introns,   
H3K79me2 Introns, 5’end of genes  
H3K4me1 Enhancers, introns, 
downstream of TSS 
 
H3K4me2 promoters and enhancers  
H3K4me3 Promoters and TSS repressive 
H3K27ac promoters and enhancers active 
H3K27me3 promoters repressive 
   
H2AZ Regulatory elements  
 
Table 1.1 Summary of chromatin marks, their locations and their effects on transcription. 
Chromatin marks have been classified according into those that may be involved in gene activation and 
those that may be involved in repression. (Dunham 2012; Trynka and Raychaudhuri 2013) 
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1.8.1 Bivalent promoters 
Covalent histone modifications appear to be important development. In embryonic stem cells, 
the promoters of transcription factor genes that are involved in development possess both an 
activatory (H3K4me3) and a repressive chromatin mark (H3K27me3) in mouse (Bernstein, 
Mikkelsen et al. 2006) and in humans (Zhao, Han et al. 2007) , such promoters are known as 
‘bivalent’.  Bivalent promoters have been described as being ‘poised ‘ to express 
developmental genes, but at the same time differentiation is repressed, thus maintaining 
pluripotency (Voigt, Tee et al. 2013) and it has been shown that  bivalency is important in early 
neuronal development (Burney, Johnston et al. 2013). 
1.8.2 Chromatin states. 
Recently, the idea was proposed that rather than particular histone modifications being 
responsible for gene regulation, that combinations of chromatin marks in particular genomic 
locations may determine modes of genome regulation. These regions of particular 
combinations of chromatin marks in the genome  are known as ’chromatin states’ (Ernst and 
Kellis 2012). They are dynamic and reversible and can comprise any combination of chromatin 
marks, covalent histone modifications, methylated DNA, or histone variants which may confer 
active or repressive chromatin. 
Fifteen chromatin states have been defined in human cells (Ernst, Kheradpour et al. 2011) , 
defining states associated with regulatory regions such as promoters, enhancers, insulators, 
transcribed regions and large-scale repressed and inactive domains. These types of analyses 
have led to systematic genome-wide characterisation of regulatory elements and their cell-
type specificity (Ernst and Kellis 2013). Computational modelling of these chromatin states 
using Hidden Markov Modelling (HMM) and tools such as chromHMM, coupled with 
correlation of these states with gene expression data is leading to linking distinct chromatin 
signatures and patterns of gene expression during differentiation (Shah, Oldenburg et al. 
2014). 
1.9 DNA methylation 
DNA may be modified by through the action of DNA methylases that methylate cytosine or 
adenine nucleotides in DNA (Zhang, Huang et al. 2015) (Greer, Blanco et al. 2015). DNA 
methylation is associated with gene repression, it is associated with X chromosome 
inactivation (Hellman and Chess 2007).  In addition, DNA methylation  may be involved in 
altering the structure of chromatin directly by affecting nucleosome stability and positioning, 
having a role in the formation of  hetero-chromatin and in gene silencing (Razin 1998). 
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Alternatively, DNA methylation may affect chromatin structure by acting as a docking station 
for proteins; recruiting for example chromo and bromo-domain containing ATP-dependent 
chromatin remodelling complexes.  
The human genome is 70-80% methylated. Methylation occurs within genes, but promoters 
tend to be under-methylated (Tazi and Bird 1990). Regions of the genome that are hypo-
methylated are known as CpG islands. DNA methylation is mediated by the conserved family of 
DNA methyl-transferases (DNMTs). In mammals there are three DNMTs; DNMT1, DNMT3a and 
DNMT3b. De novo methylation occurs during embryogenesis, mediated by DNMT3a and 
DNMT3b (Okano, Bell et al. 1999). DNMT1 is responsible for maintaining the methylation state 
by binding to hemi-methylated DNA at CpG sites after DNA replication. DNMT1 is essential for 
viability in human ESC cells and loss of DNMT1 results in a global loss of DNA methylation (Liao, 
Karnik et al. 2015) suggesting an important role for methylation in human genome regulation.  
Much of the work on the role of methylation during cell development been done in mouse 
models. This has shown that global changes in methylation occur during embryogenesis but 
methylation patterns change during differentiation and remain stable in differentiated cells. 
(Smith, Chan et al. 2012) Investigations on the role of methylation in the human genome have 
shown that only  a few of the CpG dinucleotides in the human genome change their 
methylation state and that these are in regulatory elements, suggesting that this may be a 
mechanism used to regulate particular sets of genes in differentiation (Ziller, Gu et al. 2013). 
For example binding of the vertebrate insulator protein CTCF can be cell type-specific and can 
be regulated by differential DNA methylation (Wang, Maurano et al. 2012) (Ong and Corces 
2014). 
Recently it has been shown that DNA methylation can affect  nucleosome stability and 
positioning  (Collings, Waddell et al. 2013) (Jimenez-Useche, Ke et al. 2013). In addition there is 
a correlation between DNA methylation and histone methylation patterns. (Smith and 
Meissner 2013) (Meissner, Mikkelsen et al. 2008). Methylated CpG residues are recognised by 
methyl-CpG-binding domain proteins (MBD) which are thought to block access to transcription 
factors by recruiting co-repressor complexes.  For example, MeCP2 is an MBD protein that 
recognises methylated DNA and co-purifies with the SIN3-histone deacetylase (HDAC) complex 
which deacetylates nucleosomes bringing about a repressed chromatin structure, thus 
influencing gene expression (Jones, Veenstra et al. 1998).   
Hence, the relationship between methylated DNA and chromatin is important since DNA 
methylation may lead to the recruitment of enzymes that are involved in post-translational 
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modifications of histone proteins and these changes in chromatin structure ultimately affect 
gene expression.  
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Figure 1.5 Modifications that affect the structure of nucleosomes. 
A. Core histone proteins can be post translationally modified, for example by acetylation (orange) and 
methylation (blue). B  DNA methylation (green) may be involved in altering the structure of chromatin 
directly by affecting nucleosome stability and positioning. 
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1.10 Nucleosome positioning 
Nucleosome positioning refers to the location of the nucleosome core relative to the DNA 
sequence. This is referred to in two ways; translational positioning refers to the linear position 
of the DNA wrapped around the histone octamer whereas rotational positioning refers to the 
orientation of the DNA that is wrapped around the nucleosome (Struhl and Segal 2013). A 
single turn of  DNA is approximately 10.5 bp (Wang 1979), therefore a 10 bp change in the 
translational position of a nucleosome would not affect its rotational position.  
The positions of nucleosomes are often considered across a population of cells. They are 
considered to be ‘positioned’ when, in a population of cells, the centre of a nucleosome is in 
the same location in the genome from one cell to the next. Nucleosomes that are not 
positioned vary in their location from one cell to the next and are termed ‘fuzzy’ (Fig 1.6) 
(Mavrich, Ioshikhes et al. 2008). 
Recent work has shown that broadly, nucleosome positioning is affected by the action of 
chromatin remodelling complexes 2) the underlying DNA sequence and 3) the action of 
transcription factors. However, there is evidence that the positions of adjacent nucleosomes 
are dictated by the positions others. This is known as ‘statistical’ positioning and it is thought 
that a large amount of nucleosome positioning across a genome may be ‘statistical’. The next 
sections will discuss the factors that influence nucleosome positioning. 
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Figure 1.6 Nucleosome positioning. 
A. In a population of cells, nucleosomes that are in the same place in the genome from one cell to the 
next are ‘positioned’. B. Nucleosomes that are not in the same place in the genome from one cell to the 
next are not positioned or ‘fuzzy’.  
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1.11 ATP-dependent chromatin remodelling. 
Nucleosomes can be placed by the action of ATP-dependent chromatin remodelling enzymes, 
independently of DNA replication. This was first shown in S. cerevisiae in a cell-free system by 
reconstituting nucleosomes at the Pho5 promoter using yeast extracts and adding histone 
proteins (Korber and Horz 2004). Recently, further work has shown that ATP-dependent 
nucleosome sliding and eviction are necessary to achieve in vivo patterns of nucleosome 
positions (Padinhateeri and Marko 2011). 
ATP-dependent chromatin re-modelling complexes  can change linker length by sliding or 
disrupting  nucleosomes (Havas, Whitehouse et al. 2001), or exchange histone variants 
(Kamakaka and Biggins 2005) for example H2AZ (Ausio and Abbott 2002), into nucleosomes. 
All of these complexes contain a Snf2-type ATPase subunit and variable numbers of other 
subunits. ATP-dependent chromatin re-modelling complexes have been divided into four 
broad groups  according to the structure of the ATPase subunit and their remodelling  
functions (Clapier and Cairns 2009). 
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Figure 1.7 ATP dependent re-modelling complexes can alter the position, spacing and structure of 
nucleosomes. 
A. An array of positioned nucleosomes with equal linker lengths. B. nucleosomes are repositioned 
without affecting their structure. C. DNA wrapped around the nucleosome core is loosened by altering 
histone-DNA contacts and nucleosomes are re-positioned. D. Nucleosomes are moved and evicted. E. 
Components of the nucleosome core are exchanged for histone variants, destabilising nucleosomes 
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1.11.1 The SWI/SNF remodellers   
Components of the SWI/SNF complex were first identified in S. cerevisiae by two groups. The 
SWI (SWItch) genes were identified as positive regulators of the mating type switching 
enzyme, HO (Stern, Jensen et al. 1984) and the SNF genes  (Sucrose NonFermentable) as  a 
regulator of sucrose metabolism (Neigeborn and Carlson 1984). Later, it was shown that SNF2 
had ATPase activity (Laurent, Treich et al. 1993) and that these proteins are members of a 
multi-subunit complex (Cairns, Kim et al. 1994). In yeast, the RSC remodelling complex 
(Remodelling the Structure of Chromatin) has similar properties to the SWI/SNF complex, but 
different biological functions, but is considered to be a member of this family of remodellers 
(Cairns, Lorch et al. 1996). The SWI/SNF family of re-modellers can both re-position and 
change the structure of nucleosomes by changing the histone-DNA interactions (Whitehouse, 
Flaus et al. 1999). These proteins are characterised by having a bromo-domain that recognises 
acetylated lysines in the N-terminal tails of histones (Hassan, Prochasson et al. 2002). In 
addition, Kruger et al showed that point mutations in histones suppress mutations in SWI/SNF 
genes (Kruger, Peterson et al. 1995). 
The BAF (Brg1 Associated Factors) (Wang, Cote et al. 1996) and PBAF (Polybromo-associated 
BAF) (Xue, Canman et al. 2000) complexes are human chromatin remodelling complexes from 
the SWI/SNF family of remodellers. Either of two ATPase subunits, hBRM (human Brahma), the 
human homologue of SNF2, or BRG1 (Brahma-related Gene 1) can exist in the BAF complex 
whereas PBAF contains only BRG1. BRG1 is involved in the recruitment REST, the 
transcriptional repressor of neural genes in non-neuronal cells, to the RE1 binding sites, 
through recognising H4K8 (Ooi, Belyaev et al. 2006). 
1.11.2 The CHD re-modellers  
The chromo-domain-helicase-DNA-binding proteins (CHD) are chromatin re-modellers that 
have been shown to move and evict nucleosomes in S. cerevisiae (Stockdale, Flaus et al. 2006) . 
CHD1 was first characterised in the mouse and shown to have two N-terminal chromo-
domains in addition to a DNA binding domain (Delmas, Stokes et al. 1993). CHD remodellers 
can bind to the methylated H3K4 histone mark in S. cerevisiae (Pray-Grant, Daniel et al. 2005) 
and in humans Flanagan (Flanagan, Mi et al. 2005) through their chromo-domains. 
CHD1 is the most characterised of this family of proteins. In the fission yeast S.pombe it has 
been shown to have a role in the regulation of nucleosome spacing (Pointner, Persson et al. 
2012). In higher eukaryotes it has been shown to have a role in regulating transcription,  
associating with HDAC and the transcriptional repressor NcoR in mouse (Tai, Geisterfer et al. 
2003) In humans it is recruited to active areas of transcription (Siggens, Cordeddu et al. 2015) 
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and it can bind to methylated histone H3 (Sims, Chen et al. 2005). CHD1 is important in the 
maintenance of pluripotency in mouse ES cells (Gaspar-Maia, Alajem et al. 2009) and in the 
development of D. discoideum (Platt, Rogers et al. 2013). These experiments suggest a role for 
CHD1 in regulating the transcription of genes involved in cell development  through chromatin 
remodelling, whereby the CHD proteins may act as ‘readers’ of the post translational histone 
modifications through their chromo-domains.  
1.11.3 The INO80 and SWR remodellers 
INO80 (Inositol-requiring protein 80) and SWR remodellers are multi-subunit complexes that 
share protein subunits. Both of them have an HSA (SANT-associated domain) domain and a 
Snf2-ATPase domain with a long insertion. In humans, the HSA domain recruits IES (Ino Eighty 
Subunit), actin-related (Arp) proteins  (Chen, Conaway et al. 2013) and YY1 (Cai, Jin et al. 2007) 
and further  IES proteins and Arp5 are recruited to the long insertion in the ATPase domain. 
The INO80 complex was first characterised in S. cerevisiae and shown to slide histone octamers 
along DNA (Shen, Mizuguchi et al. 2000). Later it was shown that this family of remodellers 
exchange histone H2A with the histone variant H2AZ. In S. cerevisiae, SWR-1 incorporates 
H2AZ into nucleosomes (Mizuguchi, Shen et al. 2004) and INO80 removes H2AZ (Papamichos-
Chronakis, Watanabe et al. 2011).  When H2AZ is incorporated into +1 nucleosomes, this 
destabilises the +1 nucleosome leading to gene activation (Yen, Vinayachandran et al. 2013). In 
addition, INO80 is involved in altering nucleosome spacing (Udugama, Sabri et al. 2011) and it 
is in DNA repair and replication (Morrison and Shen 2009). Recently the structure of the yeast 
INO80 complex has been characterised yielding further insight into mechanisms of its function. 
(Tosi, Haas et al. 2013)  
The human IN080 complex has been characterised (Chen, Cai et al. 2011), but there are two 
complexes which are candidates for being human orthologues of SWR; SRCAP (Ruhl, Jin et al. 
2006) and p400/TIP60 (NuA4). As the subunits of the human tip60 (NuR4) complex are 
homologous to the components of the yeast SWR1 or NuA4 complex, it is thought that this 
complex corresponds to a hybrid of the two yeast complexes (Auger, Galarneau et al. 2008). 
Recently a human H2AZ chaperone protein was characterised (Obri, Ouararhni et al. 2014). 
ANP32E is an H2AZ specific chaperone that is part of the p400/TIP60 complex, able to remove 
H2AZ from nucleosomes in vitro that regulates H2AZ at promoters. 
1.11.4 The ISWI remodellers. 
The ISWI re-modellers  (imitation switch) (Deindl, Hwang et al. 2013) re-position nucleosomes 
without altering their structure (Tsukiyama, Palmer et al. 1999). Examples of this group of 
protein are ISW1 and 2 in S. cerevisiae and their mammalian orthologues SNF2H and SNF2L. 
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These proteins have a SANT domain (Boyer, Latek et al. 2004) which can bind histone proteins , 
a HAND domain and a SLIDE domain which are involved binding  in DNA. (Grune, Brzeski et al. 
2003). 
1.12 The effects of DNA sequence on nucleosome positioning.  
Many studies have been carried out in the S. cerevisiae genome to determine the factors that 
influence nucleosome positioning. Studies have shown that although there is no canonical 
nucleosome positioning sequence in yeast, particular sequences do influence nucleosome 
positioning. DNA sequence affects the ability of the nucleosome core histones to bind to DNA; 
certain DNA sequences are more favourable for DNA bending and DNA has to bend around the 
core histone octomer to form a nucleosome. Drew and Travers et al  (Drew and Travers 1985) 
showed that repeating 10 bp patterns of the nucleotides AA/TT creates DNA bending , thus 
nucleosomes are more likely to form in regions of DNA with these sequences. Conversely, DNA 
comprising poly dA : dT tracts or poly dC : dG tracts is rigid and does not favour nucleosome 
formation. In yeast, poly dA : dT  tracts of DNA tend to be found at core promoters, where 
nucleosomes are excluded (Iyer and Struhl 1995; Ioshikhes, Albert et al. 2006; Lee, Tillo et al. 
2007). In addition, in yeast,  AA and TT dinucleotides are  enriched at the 5’ and 3’ ends of 
positioned nucleosomes and AT/TA sequences are located  at the nucleosome borders near 
the TSS (Mavrich, Ioshikhes et al. 2008). 
 
In the human genome, the role of DNA sequence in nucleosome positioning has not yet been 
widely investigated but there is evidence that nucleosomes are depleted at CpG islands (Tazi 
and Bird 1990)  and recently it has been shown that GAA repeats in the human genome lead to 
nucleosome depletion (Zhao, Xing et al. 2015). 
1.13 Statistical positioning of nucleosomes. 
It has been proposed that the positions of nucleosomes are affected by the positions of others, 
i.e. if one nucleosome is in a particular location in the genome, then the positions of adjacent 
nucleosomes would be dictated by the positions of the first (Kornberg and Stryer 1988) . This 
idea assumes that there are ‘barrier’ regions in the genome, that prevent nucleosomes binding 
and that nucleosomes can move freely outside of barrier regions. In S. cerevisiae, it has been 
suggested that +1 nucleosomes may be positioned according to the underlying DNA sequence. 
Then +1 nucleosomes may act as barriers against which nucleosomes are positioned in arrays, 
their packing and organization decaying with distance from the +1 nucleosome (Mavrich, 
Ioshikhes et al. 2008). Barriers also could be formed by the action of chromatin remodelling 
complexes, removing or displacing nucleosomes (Cairns 2009) or by DNA sequences that 
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exclude nucleosomes (Segal and Widom 2009). Further evidence  for the fact that some 
nucleosomes are strongly positioned, forming barriers,  and others are not, was shown in 
experiments by Gossett et al. Global depletion of histone proteins tends to lead to the 
occurrence of fewer well-positioned nucleosomes; it was shown that nucleosomes that were 
retained after histone H3 depletion were associated with stabilizing histone marks, chromatin 
remodelling activity or DNA sequences that favour nucleosome positioning (Gossett and Lieb 
2012). 
 
In humans, it has been suggested that Pol  may act as a barrier, since positioned 
nucleosomes are located downstream of stalled Pol  at the promoter of genes (Valouev, 
Johnson et al. 2011) and nucleosomes tend to be depleted upstream of the TSS in a pol 
dependent manner (Schones, Cui et al. 2008) . Until recently, the mechanism by which this 
barrier could be removed was not known, but recent work suggests that CHD1 may be 
responsible for removing nucleosomes (Skene, Hernandez et al. 2014). In addition, CTCF and 
tRNA genes can act as barriers or insulators (See section 1.15). 
1.14 Patterns of nucleosome positioning in eukaryotic genomes. 
Studies of the positions of nucleosomes in eukaryotic genomes have shown that there are 
areas of the genome that possess arrays of nucleosomes and areas where nucleosomes are 
depleted. Much of the most detailed analysis of the patterns of nucleosome positions has been 
undertaken in the S. cerevisiae genome (Jiang and Pugh 2009; Park 2009) (Kent, Adams et al. 
2011). The yeast genome contains 6,000 small (less than 1kb), tightly packed genes (Goffeau, 
Barrell et al. 1996) over which nucleosomes are densely packed and tend be uniformly spaced. 
There are approximately 70,000 positioned nucleosomes  which occupy about 81% of the S. 
cerevisiae genome (Lee, Tillo et al. 2007). In S. cerevisiae, gene promoters and the 3’ ends of 
genes tend to be nucleosome depleted, whereas gene bodies tend to possess nucleosome 
arrays (Lee, Tillo et al. 2007). Areas of nucleosome depletion are known as nucleosome free 
regions (NFR) and strongly positioned nucleosomes have been found to occur near the 
transcriptional start site (TSS) (Mavrich, Ioshikhes et al. 2008; Jiang and Pugh 2009). 
Nucleosomes positioned just upstream of the transcriptional start site are known as the -1 
nucleosome and the first nucleosome that is positioned downstream of the TSS is known as 
the +1 nucleosome. These strongly positioned nucleosomes in gene promoters are thought to 
be important in the regulation of gene expression. Early in vitro work showed that enzymes 
can traverse chromatin displacing nucleosomes during elongation but not during the initiation 
of transcription suggesting that nucleosomes might limit the access of polymerases to genes. 
(Lorch, LaPointe et al. 1987; Boeger, Griesenbeck et al. 2003; Henikoff 2008). 
33 
 
Also in S. cerevisiae, it has been shown that nucleosomes can restrict the access of activatory 
transcription factors to their binding sites (Segal, Fondufe-Mittendorf et al. 2006) (Lee, Tillo et 
al. 2007), thus affecting transcriptional activity and nucleosome loss through histone 
depletion, resulting  in an increase in transcription in many yeast genes (Han and Grunstein 
1988). However, there may be more than one type of organisation of chromatin at gene 
promoters with variation in the mobility and groupings of nucleosomes at and surrounding the 
transcriptional start site, affecting both expression levels and transcriptional plasticity- the 
ability to alter gene expression. Tirosh and Barkai et al showed that in S. cerevisiae, 
nucleosome occupancy can be high upstream of the TSS in some promoters and that this 
correlates with lower transcriptional plasticity. In contrast, gene promoters where nucleosome 
occupancy was high in the distal region of the promoter and not at the TSS, tend to have more 
mobile nucleosomes and higher transcriptional plasticity, the gene expression change can be 
up or down, thus higher levels of nucleosome occupancy correlates with more regulation. 
(Tirosh and Barkai 2008). 
 
In recent  years, genome-wide patterns of nucleosome positioning at transcriptional start sites 
have been well characterised in a wide range of other eukaryotic model organisms; in S. 
pombe (Lantermann, Straub et al. 2010) D. melanogaster (Mavrich, Jiang et al. 2008), the 
cellular slime mould  D. discoideum (Platt 2013) (Chang, Noegel et al. 2012) and in C. elegans 
(Valouev, Ichikawa et al. 2008). These studies have shown that broadly, there is a pattern of 
nucleosome positioning at TSS. The TSS itself tends to be devoid of strongly positioned 
nucleosomes but it is flanked by well positioned nucleosomes on either side; the -1 and +1 
nucleosomes.  Further by phased arrays of well positioned nucleosomes occur on either side of 
the -1 and +1 nucleosomes. In these arrays, the strength nucleosome positioning diminishes 
with the distance from the TSS. 
Genome-wide nucleosome maps also have been constructed from higher eukaryotes; from the  
smaller of the plant genomes; A. thaliana and  O. sativa , (Chodavarapu, Feng et al. 2010; Li, 
Liu et al. 2014; Wu, Zhang et al. 2014; Singh, Bag et al. 2015; Zhang, Zhang et al. 2015), from 
the mouse  (Li, Schug et al. 2011) (Teif, Vainshtein et al. 2012) and from human cells (Ozsolak, 
Song et al. 2007; Schones, Cui et al. 2008; Tillo, Kaplan et al. 2010; Gaffney, McVicker et al. 
2012; Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012). These studies have shown that 
broadly, phased arrays of well positioned nucleosomes flank the NFR at the TSSs, with low 
numbers of nucleosomes in gene promoters  and higher levels in exons (Tilgner, Nikolaou et al. 
2009). In the human genome positioned nucleosomes are located at gene promoters (Schones, 
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Cui et al. 2008) and in regulatory regions such as at CTCF sites (Fu, Sinha et al. 2008) and at 
enhancers (West, Cook et al. 2014) 
Although these organisms appear to have similar patterns of chromatin structure at TSS, they 
have widely differing genome sizes (Table1.1) and the percentage of the genome that 
possesses well positioned nucleosomes appears to be inversely proportional to genome size. 
For example in S. cerevisiae approximately 85% of the genome possesses well-positioned 
whereas In the plant genomes,  A. thaliana and  O. sativa, the figure is  12% and 16% of the 
genome respectively  (Zhang, Zhang et al. 2015). This suggests that although there appear to 
be some common patterns of nucleosome positioning across eukaryotic genomes, there might 
be variation in the mechanisms by which chromatin regulates the genome. 
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Organism Genome 
size 
(M bp) 
No. of protein 
coding  genes 
Reference 
S. cerevisiae 
 
12 6,000 (Goffeau, Barrell et al. 1996) 
S. pombe 
 
12.5 5,124 http://www.pombase.org 
D. discoideum 
 
34 12,257 http://dictybase.org 
C. elegans 100 19,735 (Hillier, Coulson et al. 2005) 
http://www.ensembl.org 
A. thaliana 135 27,416 (AGI 2000) 
https://www.arabidopsis.org 
D. melanogaster 
 
143 13,918 http://www.ensembl.org 
M. musculus 2500 22,528 (Waterston, Lindblad-Toh et al. 2002) 
http://www.ensembl.org 
H. sapiens 3000 19,814 (Lander, Linton et al. 2001), 
http://www.gencodegenes.org 
 
Table 1.2 The genome sizes of a selection of model eukaryotic organisms. 
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1.15 Insulators  
1.15.1 Insulator proteins. 
Insulator proteins were first characterised in the Drosophila genome (Kellum and Schedl 1991). 
They seem to have a dual role in genome regulation, acting at a local level as enhancer 
blockers, preventing the interaction of enhancers and promoters (Cai and Levine 1995). In 
addition they are present at the boundaries of sub-topologically associated domains (TADs), 
where genes and their regulatory regions are brought together over long distances, forming 
loops (Maeda and Karch 2007). Their role seems to be in organising the genome into domains, 
organising chromatin in a cell type specific manner, resulting in cell type specific gene 
expression.  
CTCF is a DNA binding protein that was first identified as a transcriptional repressor of the 
chicken c-myc gene (Lobanenkov and Gudvin 1989). Identification and characterisation of the 
chicken CTCF  binding motif showed that CTCF acts by binding to three repeats of the DNA 
sequence CCCTC, hence the name CCCTC-binding factor (Lobanenkov, Nicolas et al. 1990). 
CTCF is a highly conserved, well characterised 11- zinc-finger DNA binding protein whose 
isoforms are differentially expressed in the chicken (Klenova, Nicolas et al. 1993). CTCF is the 
major insulator so far characterised in human cells (Filippova, Fagerlie et al. 1996) and appears 
to have many roles (Phillips and Corces 2009). It is both a transcriptional activator and 
repressor and acts as an insulator protein, blocking the interaction between enhancers and 
promoters, thus demarcating active and inactive chromatin domains (Handoko, Xu et al. 2011). 
In addition, CTCF appears to have dominant role in determining chromatin structure on a 
global level, defining different chromatin compartments (Cuddapah, Jothi et al. 2009) by  
playing a role in the formation of chromatin loops (Splinter, Heath et al. 2006; Handoko, Xu et 
al. 2011; Rao, Huntley et al. 2014) facilitating long-range chromosome interactions 
(MacPherson and Sadowski 2010; Phillips-Cremins and Corces 2013)  
A large body of work has shown the association of CTCF at specific DNA binding sites at the 
stem of chromatin loops, forming topological domains (Dixon, Selvaraj et al. 2012) .Recent 
work has shown that CTCF binding sites have directionality specified through the differential 
binding of its zinc fingers. This determines the direction in which chromatin loops are formed, 
with CTCF sites at the bases of loops having the opposite orientation from each other (Guo, 
Monahan et al. 2012; Guo, Xu et al. 2015; Vietri Rudan, Barrington et al. 2015). However, the 
relationship between the transcriptional regulation of genes that determine cell lineage and 
TAD structures is still not well understood. Recent studies in the mouse genome during 
differentiation from ESC to NPC, using 5C technology have been carried out. This has shown 
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that particular combinations of architectural proteins are utilised in organising higher order 
chromatin structure during lineage commitment. (Phillips-Cremins, Sauria et al. 2013). This 
demonstrates the importance of architectural proteins such as CTCF in chromatin organisation 
and cell development.  
The importance of CTCF has been shown though the demonstration of its role in human 
disease. Alterations in CTCF-associated boundary regions resulting in the disruption of TADs 
can result in drastic effects. This has been shown in mouse models of human genetic disorders 
resulting in limb malformation syndromes caused by deletions, inversions, or duplications of 
the TAD that spans the region of chromosome 2 containing the genes WNT6/IHH/EPHA4/PAX3 
(Lupianez, Kraft et al. 2015).  In addition, several de novo point mutations in CTCF have been 
shown to be responsible for causing intellectual disability, microcephaly and  growth 
retardation, suggesting a role for CTCF in neuro-development (Gregor, Oti et al. 2013). In 
addition, recent work has shown that CTCF is important in the early development of the mouse 
brain. Watson et al have shown that CTCF is important  for NPC survival and  the loss of CTCF 
can lead to the premature differentiation of NPC cells and therefore depletion of the NPC  pool 
of cells (Watson, Wang et al. 2014). 
Human CTCF was characterised by Filipova et al whose early work on defining the binding 
sequences of CTCF  showed that CTCF could bind to divergent sequences in the promoter of c-
myc by utilising different combinations of its zinc fingers, hence it was termed a ‘multivalent 
protein’ (Filippova, Fagerlie et al. 1996). Several CTCF binding motifs have been derived from 
different human cell types (Kim, Abdullaev et al. 2007; Xie, Mikkelsen et al. 2007; Bao, Zhou et 
al. 2008; Jothi, Cuddapah et al. 2008) and recent genome-wide studies have revealed a high 
level of complexity in the binding of CTCF to DNA. Nakahashi et al (Nakahashi, Kwon et al. 
2013) studied the sequence diversity, genome-wide, of a similar number of CTCF binding 
motifs across primary lymphocytes and defined groups of zinc fingers that bind specifically to 
different  components of the binding motif; the conserved core and the non-conserved 
flanking sequences. More detailed studies of CTCF binding motifs  has shown that there are, on 
average  55,000 binding motifs across a wide variety of human cell types, but that binding site 
utilisation is cell type specific  (Wang, Maurano et al. 2012). These recent genome-wide studies 
support the early work suggesting that CTCF binding is complex; through variation in the DNA 
sequences bound and via the differential use of its zinc fingers. In addition, there is evidence 
that CTCF binding sites might have different binding affinities suggesting the occurrence of  
stronger binding at ubiquitous CTCF sites  and that weaker binding occurs at cell type specific 
sites  (Chen, Tian et al. 2012; Plasschaert, Vigneau et al. 2014). 
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Taken together, the complexity of CTCF binding would allow maximum flexibility in its putative 
binding locations in the genome, perhaps providing mechanisms of cell type specificity in 
binding, dictating lineage specification. 
1.15.2 tRNA genes  
Classically tRNA genes (tDNAs) are known for their role in translation in protein synthesis. They 
are transcribed by RNA polymerase III generating transfer RNA molecules that assemble amino 
acids during protein synthesis. However, in S. cerevisiae it has been known for some time that 
these tRNA genes have another role; they can act as insulators, for example silencing the HMR 
locus (Donze and Kamakaka 2001). This function of tDNAs depends on the binding of RNA 
polymerase III (RNAP) (Donze and Kamakaka 2001)  the transcription factors TFIIIB and TFIIIC 
(Simms, Dugas et al. 2008). It was shown in S. cerevisiae that TFIIIC binds to the B-box in tRNA 
genes or to sites elsewhere known as ETC sites (extra TFIIIC sites), these are TFIIIC binding sites 
that are transcription independent (Moqtaderi and Struhl 2004).  In addition, TFIIIC-mediated 
barriers require chromatin remodellers such as the RSC complex (Valenzuela, Dhillon et al. 
2009). 
Recently tRNA genes have been shown to act as enhancer blocking insulators in mouse cells 
(Ebersole, Kim et al. 2011) and both enhancer blockers and barrier insulators in human cells 
(Raab, Chiu et al. 2012). Similarly the presence of ETC’s has been shown in humans and these 
sites, enriched in TFIIIC, have associated CTCF binding (Oler, Alla et al. 2010) (Moqtaderi, Wang 
et al. 2010). Whether cohesin is recruited at this type of insulator in a similar manner to how it 
is recruited at CTCF binding sites, is not yet clear. However, this conserved role of tRNA genes 
as insulators may be an important mechanism for genome organisation and therefore cell 
type-specific gene regulation in human cells.  (Van Bortle and Corces 2012) 
1.16 Cell differentiation 
1.16.1 Embryonic stem cells ESCs.  
Embryonic stem (ESCs) exist in the inner cell mass of a pre-implantation embryo. They have 
the capacity to differentiate into any of the three germ layers; endoderm, mesoderm or 
ectoderm, this property is known as ‘pluripotency’. Pluripotent cells are characterised by 
having globally reduced DNA methylation, depletion of the post-translational histone 
modification H3K27me3 at the promoters of developmental genes and female cells retain two 
activated X-chromosomes. In addition, early work showed that particular transcription factors 
are expressed in pluripotent cells, defining their ‘stemness’. For example, Nanog (Mitsui, 
Tokuzawa et al. 2003), Oct4  (Niwa, Miyazaki et al. 2000) and Sox2 which co-occupy a number  
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of their target genes that encode developmentally important transcription factors (Boyer, Lee 
et al. 2005), in addition, they co-occupy the promoters of microRNAs that are involved in the 
maintenance of pluripotency (Marson, Levine et al. 2008). 
1.16.2 Mouse embryonic stem cells (mESCs). 
Embryonic stem cells were first established in cell culture in the mouse, using mitotically 
inactive fibroblasts or ‘feeder cells’ (Evans and Kaufman 1981; Martin 1981). This opened the 
gateway to looking for the mechanisms involved in the control of both pluripotency and 
differentiation. Subsequently, several key signalling factors were found to be important in the 
maintenance of the undifferentiated state in mouse ESCs; Leukaemia inhibitory factor (LIF) 
(Kurisaki, Hamazaki et al. 2005) and bone morphogenetic protein 4 (BMP4) (Ying, Nichols et al. 
2003) . Hence it was possible to culture mouse ESCs in culture using LIF and without the need 
for feeder cells (Smith, Heath et al. 1988). More recent work established the production of 
mESC by stimulating cells with LIF and by inhibition of ERK1/ERK2 and GSK3β signalling. These 
cell culture conditions are known as 2i/LIF (Ying, Wray et al. 2008) and generate cultured 
mouse ESC cells in the ‘naïve’ state, similar to primary cells derived from the inner cell mass.  
Another category of pluripotent cells known as epiblast stem cells (mEpiSCs) has been derived 
and characterised. (Tesar, Chenoweth et al. 2007). These cells are derived from the post-
implantation epiblast and represent a pluripotent state that is distinct from that in ESC cells, 
the X chromosome is inactivated and these cells are poised to differentiate into progenitor 
cells. This state is known as the ‘primed’ pluripotent state (Nichols and Smith 2009).  
1.16.3 Human (hESCs). 
Human ESCs were established initially using irradiated mouse embryonic fibroblasts as ‘feeder 
’cells (Reubinoff, Pera et al. 2000)  (Thomson, Itskovitz-Eldor et al. 1998) However, it was 
difficult to establish clonal populations from these cells.  Later, clonal populations of ES cells 
were derived by using serum-free medium and the addition of recombinant basic fibroblast 
growth factor (bFGF) (Amit, Carpenter et al. 2000) and later feeder-free cultures were 
established (Xu, Inokuma et al. 2001).  More recently, studies of the growth and maintenance 
of human ESCs in culture have shown that human ESCs differ from mouse ESCs; self-renewal in 
human cells is dependent on different signalling pathways than in mouse. The maintenance of 
pluripotency in human cells is dependent on the inhibition of the TGF/Activin/nodal and the 
FGF signalling pathways (Vallier, Alexander et al. 2005). In addition, the human pluripotent 
state has been described as ‘primed’, whereas that in mouse is described as ‘naive’ (Ying, Wray 
et al. 2008) therefore human ESCs differ from mouse ESCs and are thought to be most similar 
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to mouse EpiESCs. (Hanna, Cheng et al. 2010). Recently, Gafni et al (Gafni, Weinberger et al. 
2013) have shown that it is possible to derive human ‘naïve’ cells using defined culture 
conditions (NHSM medium)  which include LIF/2i,  TGF beta, FGF2, JNKi, p38i and ROCKi 
(Y27632). Manipulation of growth factor signalling in defined culture conditions has led to the 
ability to define pluripotent states in human cells and study the mechanisms involved in their 
maintenance. 
1.16.4 Induced pluripotent stem cells.  
Induced pluripotent cells (iPSC) are pluripotent cells derived from somatic cells. These cells 
provide a convenient source of pluripotent cells without using embryos, facilitating research 
into the mechanisms involved in both the maintenance of pluripotency and in bringing about 
differentiation. These cells can be produced for example, from fibroblasts, by expressing 
transcription factors that are involved in the maintenance of pluripotency such as KLF4, SOX2 
and OCT4 and c-Myc;  iPSC have been generated in both mouse (Takahashi and Yamanaka 
2006)  and human cells (Takahashi, Tanabe et al. 2007; Yu, Vodyanik et al. 2007). More 
recently, cell culture methods have been refined to generate naïve hiPSC cells with 
characteristics close to those of mouse iPS cells. (Hanna, Cheng et al. 2010). 
1.16.5 Neural Cell Differentiation. 
Neural progenitor cells are multipotent cells in the nervous system that can differentiate into 
neurons, astrocytes and oligodendrocytes and have a limited capacity to self-renew 
(Carpenter, Cui et al. 1999). It is possible to generate mammalian NPCs in vitro from embryonic 
stem cells, this has been done in human embryonic stem cells and from induced pluripotent 
cells (Chambers, Fasano et al. 2009). In the embryo, neural cells are produced from the 
ectoderm. Generation of NPCs in vitro is undertaken by culturing pluripotent cells in medium 
containing two factors that inhibit SMAD signalling, generating early neural ectoderm cells. 
Dual SMAD inhibition utilises the small molecule inhibitor SB431542 to inhibit the ALK4, ALK5, 
and ALK7 receptors (Inman, Nicolas et al. 2002) and block the TGFpathway which act via 
SMAD 2 and 3, which controls cell proliferation and differentiation to mesoderm, and inducing 
neural differentiation (Smith, Vallier et al. 2008). A second small molecule inhibitor LDN-
193189 inhibits the transcription of the BMP type I receptors ALK2 and ALK3 which act via 
SMADs 1, 5 and 8 in the Bone morphogenetic protein (BMP) pathway. This pathway is involved 
in regulation of cell fate decisions during embryogenesis. 
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Figure 1.8 Generation of induced pluripotent cells and derived neural progenitor cells from somatic 
cells. 
iPS cells are generated by expression of transcription factors responsible for maintaining pluripotency; 
cMyc, KLF4, Oct4 and Sox2. NPC cells are generated from iPS cells after the formation of embryoid 
bodies, by dual SMAD inhibition (Chambers, Fasano et al. 2009) using the inhibitors SB431542 and 
LDN19389 that inhibit the TGFand BMP pathways respectively. 
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1.17 Chromatin structure during cell differentiation 
Observations of chromatin structure in ES cells showed that chromatin tends to be globally 
decondensed (Ahmed, Dehghani et al. 2010). Some chromatin structural proteins, for example 
HP1 (Cheutin, McNairn et al. 2003) are less tightly bound to chromatin than in differentiated 
cells (Meshorer, Yellajoshula et al. 2006)  In contrast, in mouse neural progenitor cells (NPC) 
derived from embryonic stem cells (ESC), the chromatin structure becomes more compact 
(Meshorer, Yellajoshula et al. 2006). In addition, there is a higher expression of chromatin 
remodellers in ES cells (Kurisaki, Hamazaki et al. 2005) and chromatin remodellers are 
necessary for differentiation (Kaji, Caballero et al. 2006). These observations suggested  that 
the chromatin architecture in pluripotent cells is both accessible and dynamic leading to the 
idea that pluripotent cell chromatin architecture is ‘plastic’ allowing the access of cell 
machinery to key regions of the genome involved in the  regulation of pathways involved in 
specifying differentiation. 
Gross chromatin structure at the level of chromatin domains changes during differentiation of 
ES cells, these changes occur between chromatin domains, not within them (Dixon, Jung et al. 
2015). Recent genome wide studies of replication timing, in both pluripotent cells and cells 
differentiated from them, have shown that replication timing can alter during differentiation. 
In addition, replication domains with similar timing are located in close proximity. Thus, 
replication domains are co-ordinated both in time and space and form both structural and 
functional units of regulation (Dixon, Jung et al. 2015). 
In addition to gross changes in chromatin compaction, ‘chromatin marks’ have been shown to 
change during cell differentiation. For example, ES cells have been shown to have fewer 
histone modifications associated with heterochromatin than differentiating cells.(Meshorer 
and Misteli 2006). A large body of work has shown that enzymes involved in bringing about 
post-translational chromatin modifications are important in neural development (Lilja, 
Heldring et al. 2013).  
Recent studies of changes in nucleosome positions in mouse and human cells have shown that  
changes in positions of single nucleosomes tend to occur at regulatory regions; at the binding 
sites of transcription factors that are involved in the maintenance of pluripotency and that 
there is a depletion of nucleosomes  at enhancers in pluripotent cells (West, Cook et al. 2014). 
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1.18 Transcription factors involved in neural development. 
Activatory transcription factors are often DNA binding proteins which act by binding to 
enhancers or promoter proximal elements. They usually bind to a specific binding site that is 
adjacent to the promoter of a gene and they recruit the transcription machinery. Repressive 
transcription factors act by blocking the binding of RNA polymerase to the promoter and they 
may recruit co-repressors to do so. Some transcription factors have specific roles in neural 
development and/or have associated chromatin remodelling activity. These are discussed in 
the next section. The chromatin structure at and surrounding the binding motifs of a selection 
of these transcription factors has been undertaken in the work of this thesis, these were ATF2, 
YY1 and PAX6 and REST. 
1.18.1 ATF2 (activating transcription factor 2). 
ATF2 is a global transcription factor that binds to the cyclic AMP response element (CRE). It is 
involved in DNA damage repair and has histone deacetylase activity (Kawasaki, Taira et al. 
2000). It is ubiquitously expressed, most highly in the brain. In mice it has been shown to be 
involved in neuronal development and migration. (Reimold, Grusby et al. 1996) In humans it is 
expressed in neurons and has been found to be down-regulated in the hippocampus of 
Alzheimer’s, Parkinson’s and Huntington’s patients (Pearson, Curtis et al. 2005) 
1.18.2 YY1 (yin-yang) transcription factor. 
YY1 is a GLI -Kruppel zinc finger protein that has roles in development and differentiation 
(Beketaev, Zhang et al. 2015) and can act as a transcriptional activator or repressor . It is a 
DNA-binding protein that can recruit the polycomb repressive complex PRC2 (Basu, Wilkinson 
et al. 2014) and it is also involved in transcriptional activation by recruiting  the chromatin -
remodelling complex INO80 (Cai, Jin et al. 2007).  It has been shown that its activity is 
regulated through histone acetylation and deacetylation through the action of HDACs and 
HATs. (Yao, Yang et al. 2001) and recently it has been shown that YY1 is involved in targeting 
chromatin to the nuclear periphery (Harr, Luperchio et al. 2015). Thus, it might be expected 
that changes in chromatin structure might be detected at YY1 binding sites during neural 
development and differentiation.  
1.18.3 PAX6 (paired box 6). 
The transcription factor PAX6 is a DNA binding protein that is expressed in developing eye 
(Hanson and Van Heyningen 1995), telencephalon (Stoykova, Treichel et al. 2000), thalamus, 
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spinal cord and pancreas  and mutations in PAX6 cause aniridia in humans. (Glaser, Walton et 
al. 1992). In addition, PAX6 is important in embryonic development, specifically in the 
development of the central nervous system. It has been shown that knockdown of PAX6 in 
human embryonic stem cells affects neuro-endoderm development. (Zhang, Huang et al. 
2010). 
1.18.4 EGR1/Zif268/Knox-24/NGIF-A  
Is a nuclear transcription factor is encoded by  an immediate  early  gene which may be 
involved  in neuronal plasticity (Knapska and Kaczmarek 2004). It is expressed in both adult 
and embryonic brain and in  (Wells, Rough et al. 2011). EGR-1 activates the CACNA1H gene 
that encodes the Cav3.2, a component of the voltage-dependent calcium channel complex, 
though the EGR1 sites in the promoters of the CACNA1H gene. This activation is counteracted 
by REST (Van loo et al).  Mutations in the CACNA1H gene have been linked to epilepsy (Chen, 
Lu et al. 2003)  
1.18.5 The REST complex 
REST (repressor element 1 silencing transcription factor/neuron-restrictive silencing factor) is a 
zinc-finger protein that binds to the neuron-restrictive silencer element (NRSE) (Mori, 
Schoenherr et al. 1992) also known as RE1 element (Kraner, Chong et al. 1992). The 21 bp 
NRSE element was first characterised as a selective repressor of the rat superior cervical 
ganglion 10 (SCG10) gene in non-neuronal cells and this element was shown to have homology 
to the silencer in the voltage-gated type II sodium channel (NaV1.2) gene.  It was shown that a 
sequence-specific protein (NRSBF) binds to the NRSE/RE1 element and that this factor is 
present in nuclear extracts from non-neuronal, but not neuronal cells. This suggested that the 
neuron-specific expression of the SCG10 gene might be regulated by the activity of NRSBF 
(Mori, Schoenherr et al. 1992). At the same time Kraner et al  (Kraner, Chong et al. 1992) 
identified a 28 bp element,  named RE1, as a repressor element in the 5’ flanking region of the 
type II gene by using transient expression assays. Later studies characterised the sequence, 
genome-wide locations and conservation of its binding motif in both human, mouse and rat 
cells (Bruce, Donaldson et al. 2004; Johnson, Gamblin et al. 2006; Zhang, Xuan et al. 2006; 
Jorgensen, Terry et al. 2009). 
 
Using in situ hybridisation techniques in mouse cells, Schoenherr et al showed that REST is 
expressed in undifferentiated neuronal progenitors but not in differentiated neurons in vivo 
(Schoenherr and Anderson 1995). This and more recent research has shown that REST is 
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involved in the regulation of neurogenesis by repressing neuronal gene expression in non-
neuronal cells (Wu and Xie 2006; Johnson, Teh et al. 2008; Jorgensen, Terry et al. 2009). 
REST binds to the RE1 motif and recruits co-repressors (Ballas, Grunseich et al. 2005).The co-
repressors of REST mediate histone modifications and chromatin remodelling bringing about 
repressive changes in chromatin. REST has three domains through which it recruits co-
repressors, the N-terminal domain (NTD), through which it recruits the SIN3 histone 
deacetylase (HDAC) complex (Huang, Myers et al. 1999), the C-terminal domain where the 
coREST complex, that contains BRG1, HDAC1 and HDAC2, LSD1 and G9a, binds (Andres, Burger 
et al. 1999; Hakimi, Bochar et al. 2002), and the DNA-binding domain which is involved in the 
recruitment of a further complex comprising Mediator in combination with G9a (Ding, 
Tomomori-Sato et al. 2009). During gene repression REST is recruited to RE1 sites. BRG1 (Ooi, 
Belyaev et al. 2006), an ATP-dependent chromatin remodeller, recognises acetylated H4K8, 
leading to an increase in REST recruitment to RE1 sites. REST recruits the co-repressor 
complexes CoREST and SIN3 complexes, both of which contain the histone deacetylases 
HDAC1 and HDAC2 (Ballas, Battaglioli et al. 2001). The C-terminal domain of REST binds the 
H3K9 methytransferase G9a (Roopra, Qazi et al. 2004).  After H3K9 deacetylation, G9a 
methylates H3K9. LSD1, a histone demethylase (Tachibana, Sugimoto et al. 2001; Shi, Lan et al. 
2004), removes the mono and di-methylation chromatin marks that are associated with gene 
activation from H3K4 (Shi, Lan et al. 2004). 
Studies of REST target genes have shown that many of their functions are neuronal; they are 
genes involved in for example, ion channels, ion conductance, axon guidance and synaptic 
transmission (Paquette, Perez et al. 2000; Ballas and Mandel 2005; Johnson, Gamblin et al. 
2006). However, REST also has been shown to be involved in the regulation of other more 
diverse cellular processes, such as heart development (Kuwahara, Saito et al. 2003) , 
hematopoietic development (Scholl, Stevens et al. 1996), and the cytoskeleton (Schoenherr, 
Paquette et al. 1996).  
 
Changes in the levels of expression of REST can have catastrophic effects, causing disease. 
REST may function as an tumour suppressor in human epithelial cells, (Westbrook, Martin et 
al. 2005)  high levels of are REST found in epilepsy (McClelland, Flynn et al. 2011), (Roopra, 
Dingledine et al. 2012) and recently REST has been shown to be involved in Alzheimer’s disease 
(Lu, Aron et al. 2014). REST appears to have a role as a ‘master regulator’ role in neural cell 
development. The key to how REST regulates neural genes appears to lie in the associated 
chromatin remodelling and modification activities of its co-repressors that resulting in 
repressive changes in chromatin. 
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1.19 Chromatin re-modelling and human health.  
Mutations in many of the genes that encode chromatin re-modelling proteins are involved in 
human disease, for example in cancer (Wang, Allis et al. 2007; Wang, Allis et al. 2007; 
Vogelstein, Papadopoulos et al. 2013). Mutations in genes encoding proteins in the H3.3-ATRX-
DAXX chromatin remodelling pathway are responsible for Glioblastoma multiforme (GBM) 
which is a lethal brain tumour in adults and children  (Schwartzentruber, Korshunov et al. 
2012) and CHD5 is strong candidate a tumour suppressor gene that is deleted in 
neuroblastoma (Fujita, Igarashi et al. 2008). 
Strikingly, a significant number of the genes that encode chromatin re-modelling proteins are 
implicated in genetic risk for human neuro-psychiatric disease. In particular, the CHD re-
modellers, that can move and evict nucleosomes, have neuro-psychiatric disease associations 
in humans. 
1.19.1 Neuro-psychiatric disorders 
Neuro-psychiatric disorders span the clinical disciplines of neurology and psychiatry. These 
disorders include Autism Spectrum Disorder (ASD) and Attention deficit hyperactivity disorder 
(ADHD), which are prevalent in children. Also they include schizophrenia and bipolar disorder 
that often begin in adolescence and early adulthood. They overlap with epilepsy and the 
dementias arising in the ageing brain. There is also a wide-range of rarer syndromes, such as 
Rett’s and Kleefstra’s syndromes, which carry a high risk for one or more of the more common 
disorders.  Taken together, these disorders are estimated to account for 14% of the global 
burden of disease, greater than that borne by cancer and cardiovascular disease. 
1.19.2 Genetics and Neuro-psychiatric disorders 
Recent advances in genetics has identified over 100 genes in which mutation confers elevated 
risk for neuro-psychiatric disorders such as Autism Spectrum Disorder (ASD), epilepsy and 
schizophrenia (De Rubeis, He et al. 2014). This has been done through large genome-wide 
association studies (GWAS) of copy number variant (CNV) data, duplications or large deletions 
of sections of chromosomes, and small nucleotide polymorphism data (SNP) data in many 
human cases to look for a common trait. These studies have generated lists of candidate 
disease genes and information about the types and nature of the mutations involved in these 
neuro-psychiatric disorders. Candidate disease genes include the  voltage-gated calcium 
channel subunits, CACNA1C and CACNB2  (PGC 2013) and  N-methyl-D-aspartate receptor 
(NMDAR) complexes (Fromer, Pocklington et al. 2014) and proteins that interact with, or are 
subunits of chromatin remodelling complexes. 
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1.19.3 Epigenetics and Neuro-psychiatric disorders. 
GWAS has been useful in identifying the genes responsible for disease where simple inherited 
mutations of a single gene are responsible, for example fragile X syndrome (Willemsen, 
Levenga et al. 2011). However, most of these neuro-psychiatric disorders occur through more 
than one genetic change, which may occur as de novo mutations, making the task of finding 
candidate disease genes difficult. A further complication is that many disorders cannot be 
explained purely by genetic risk. The relationship between common genetic variation and 
human disease is complex. It is becoming clear that genome regulation is important in many 
human diseases. Mis-regulation of the epi-genome can lead to congenital defects affecting 
pre-natal and early childhood development and is associated with neuro-psychiatric and 
disorders. Mis-regulation of epigenetic regulators occurs in rare neurodevelopmental disorders 
such as Rett’s, Kleefstra’s and CHARGE syndromes. These may be due to mutations in genes 
encoding proteins that recognise modified DNA. For example, Rett’s syndrome is caused by a 
mutation in the MECP2 gene (Amir, Van den Veyver et al. 1999).  MECP2 encodes methyl CpG 
binding protein 2 which is essential in mature nerve cells and regulates gene expression by 
binding to methylated CpG in DNA. Alternatively, mutations can occur in genes encoding 
proteins that covalently modify histone proteins; Kleefstra’s syndrome is caused by mutation 
or deletion of the histone methyl transferase, Histone-lysine N-methyltransferase (EHMT1) 
which modifies histone H3 by methylating lysine 9 (Kleefstra, van Zelst-Stams et al. 2009). 
1.19.4 CHD proteins and human neuro-psychiatric disorders. 
Recent research has shown that approximately half of the members of the CHD group of 
proteins (CHD2, 5, 7 and 8) have neuro-psychiatric disease associations in humans.  CHD2 has 
been shown to modify chromatin structure by catalysing the assembly of nucleosomes into 
arrays (Liu, Ferreira et al. 2015). It is a strong candidate gene for ASD (O'Roak, Stessman et al. 
2014) and it is also associated with epilepsy (Chenier, Yoon et al. 2014). CHD8 is a DNA helicase 
that is involved in chromatin remodelling at chromatin boundaries by enhancer-blocking 
(Thompson, Tremblay et al. 2008) and mutations in CHD8 have been implicated in ASD (Neale, 
Kou et al. 2012) . CHD5 is associated with neuroblastoma (Fujita, Igarashi et al. 2008) and 
CHD7 is associated with the neuro-developmental disorder CHARGE syndrome (Vissers, van 
Ravenswaaij et al. 2004). CHARGE syndrome is a congenital pleiotropic disease and 50% of 
CHARGE syndrome patients have mutations in the CHD7 gene.  
1.20 Methods for determining the positions of nucleosomes. 
Micrococcal nuclease (MNase) is both an endo and an exonuclease that was isolated from the 
bacterium Staphylococcus aureus. It digests single-stranded, double-stranded DNA and RNA 
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(Tucker, Hazen et al. 1978). Early work using MNase to digest rat liver chromatin showed that 
limiting digestion generated 185 bp DNA fragments and further digestion generated 150-160 
bp fragments (Axel 1975). This suggested that limiting MNase digestion of chromatin cleaves 
DNA in the linker region between nucleosomes and that further digestion is at the boundary of 
protection of the DNA protected by the core nucleosome. In addition it showed that it is 
possible to detect positioned nucleosomes in higher eukaryotic cells.  
Mapping the positions of nucleosomes by indirect end-labelling was developed by Nedospasov 
et al (Nedospasov and Georgiev 1980) using MNase in SV40.  In this method, MNase and a 
restriction enzyme are used to digest chromatin. The ladder of DNA fragments that are 
protected by the nucleosome core are separated from the histone proteins that form the 
nucleosome core and then size fractionated by electrophoresis. The region of interest in the 
genome is detected using a radio-labelled probe. When the cleavage patterns of chromatin are 
compared with that of naked DNA, the regions where proteins are bound to DNA can be 
mapped. The region of DNA protected by the nucleosome generates a nucleosome ‘footprint’. 
Thus genomic foot-printing allows the one-dimensional analysis of a complex three-
dimensional structure by mapping nuclease cleavages in DNA.  This method has been further 
developed in studies of S. cerevisiae chromatin to map nucleosomes at individual genes (Kent 
and Mellor 1995).  
There are several methods available for mapping the genomic position of chromatin protein 
complexes. ChIP-seq (Chromatin immuno-precipitation followed by sequencing) is a method 
whereby DNA-binding proteins are crosslinked to DNA in vivo, the DNA is sheared by 
sonication and then the DNA fragments of interest are purified by immuno-precipitation and 
the purified DNA fragments are sequenced (Jiang and Pugh 2009; Park 2009). 
Recent developments in DNA sequencing technology have made it possible to study the 
chromatin structure of entire genomes. Now it is possible to sequence all of the fragments of 
DNA in the genome that are protected by binding chromatin proteins using MNase-seq (Fig 
1.9). After sequencing these fragments using high throughput sequencing techniques, the 
sequencing reads of the DNA fragments protected by chromatin particles can be aligned back 
to the positions in the genome from whence they came. This generates genome-wide 
information about the distribution and localization of chromatin species.  Next-generation 
nucleosome-sequencing methods have been developed using either cleavage  of chromatin 
with micrococcal nuclease (Floer, Wang et al. 2010; Kent, Adams et al. 2011; Zhang and Pugh 
2011), or by using  hydroxyl  radicals (Brogaard, Xi et al. 2012) followed by next-generation 
sequencing, either by single or paired-end sequencing (Lieleg, Krietenstein et al. 2015). 
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When the DNA fragments generated by limiting MNase digestion of chromatin are separated 
by electrophoresis, a ‘nucleosome ladder’ is visible; each band represents a multiple of 147 bp, 
the amount of DNA protected by a core nucleosome. Hence, when chromatin is digested using 
MNase in vivo, it is possible to create a DNA ladder that contains all of the DNA fragments in 
the genome that are protected by binding chromatin proteins. By separating the data into size 
categories of DNA fragments, it is possible to construct several maps of the locations of 
chromatin species of different sizes. For example, DNA fragments in the 50-100 bp size range 
might represent fragments protected by transcription factors and DNA fragments in the 150-
200 bp size range might represent fragments protected by mono-nucleosomes (Henikoff, 
Belsky et al. 2011; Kent, Adams et al. 2011). Thus, high resolution genome-wide maps of the 
positions of nucleosomes can be constructed. 
Much of the information from these large scale studies is available in central repositories such 
as the UCSC genome browser (genome.ucsc.edu), ENCODE (The Encyclopaedia of DNA 
Elements) and mouse ENCODE (www.mouseencode.org) and GENCODE (Encyclopaedia of 
genes and gene variants www.gencodegenes.org).  As more data is being generated, 
experimental protocols are being standardised and more sophisticated methods of data 
analysis are being developed. The epigenome roadmap project 
(www.roadmapepigenomics.org) is a catalogue of human epigenomic data with the aim of 
aiding biology and disease-oriented research. 
  
51 
 
Figure 1.9 MNase-seq methodology 
Chromatin is digested using micrococcal nuclease (MNase). The resulting DNA fragments that were 
protected by chromatin particles are purified and sequenced using an Illumina paired-end HiSeq 
protocol. Reads are aligned to the genome and histograms of the read frequency distributions are 
constructed. The peaks obtained in the histogram represent positioned nucleosomes. 
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1.21 Aims of this thesis 
To date, genome-wide changes in chromatin structure that occur during development in 
human cells have not been investigated widely. The advent of high throughput genome-wide 
sequencing has greatly enhanced the study of both genetics and of gene regulation.  Now it 
has become possible to use next generation sequencing to map nucleosome positions at high 
resolution on a genome wide scale using MNase-seq in the higher eukaryotic genomes from 
any cell type. Therefore it is possible to construct and compare genome-wide chromatin maps 
from stem cells and differentiated cells derived from them. Deciphering the relationship 
between changes in chromatin structure and functional changes in genome regulation will 
reveal mechanisms of regulation during development. This will lead to developing a greater 
understanding of how mis-regulation of chromatin organisation causes human disease. 
 
MNase-seq defines both the genomic position and the size of nuclease-resistant chromatin 
species, to map chromatin structure (Kent, Adams et al. 2011). This methodology has been 
used in the work of this thesis to construct nucleosome maps from human cells. The aim of this 
thesis was to construct and analyse genome-wide chromatin maps from both undifferentiated 
human iPS cells (hiPS) and iPS cells differentiated to neural progenitor cells (NPC).  By 
comparing the nucleosome maps from pluripotent cells and cells developed to the early stage 
of neuronal differentiation, those areas of chromatin structure that might be involved in the 
regulation of neurodevelopment would be identified. This may identify the regulatory regions 
of the genome that are targeted by chromatin remodelling proteins during neurodevelopment. 
 
The work from this thesis will answer the following questions: 
1. Are nucleosomes randomly distributed or strategically placed in the human genome? 
2. Does chromatin structure change during neural development? 
3. Does chromatin structure change at regulatory sites during neural development? 
4. Can I identify genes that are targeted for regulation during neural development? 
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Chapter 2 : Materials and Methods 
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2.1 Biological sample preparation 
Cell cultures were prepared by Shona Joy and Prof. Nick Allen. 
2.1.1 Cell culture 
The 34D6, male, human iPS cell line (a gift from Prof Chandran, Edinburgh) was cultured in 
mTeSR1 (Stem Cell Technologies) following the manufacturer’s instructions. Briefly, tissue 
culture plates (Nunclon, Invitrogen) were coated for at least 2 hours with MatrigelTM (BD 
Biosciences) diluted 1:75 with DMEM (Invitrogen). 34D6  iPS cells were plated at a density of 
~106 cells/10cm plate in complete mTeSR1TM medium containing 10µM Y27632 (Tocris) and 
incubated at 37oC in a standard 5% CO2, humidified incubator (Binder). To passage iPS cells, 
cells were first treated with 10µM Y27632 for 2hrs, cells were then washed with Ca2+/Mg2+-
free PBS  and cell colonies lifted from the plate by incubation with Dispase (Stem cell 
technologies) containing 10µM Y27632 (Tocris). Colonies were then fragmented by gentle 
trituration, collected by centrifugation (180 x g) and resuspended in medium for re-plating. 
2.1.2 Dual SMAD inhibition 
For neural differentiation a dual SMAD inhibition protocol was used (Chambers, Fasano et al. 
2009). 34D6 iPS cells were harvested as described above for iPS cell passaging. 34D6 iPS cell 
colony fragments were plated in non-adherent bacteriological grade culture dishes in ADF 
differentiation medium to allow for embryoid body formation. ADF differentiation medium 
comprised advanced DMEM/ F12™ media (Invitrogen) supplemented with 
penicillin/streptomycin (5µg/l, Invitrogen), L-glutamine (200mM, Invitrogen), 1x Lipid 
concentrate (Invitrogen), 7.5µg/ml holo-transferrin (Sigma), 14µg/ml Insulin (Roche), 10µM β-
mercaptoethanol (Sigma). Medium was supplemented with 10µM Y27632 (Tocris) for the first 
2 days, with 10µM SB-431542 (Tocris) until day 4 of differentiation and 0.5µM LDN193189 
(Miltenyi) until day 8 of differentiation.  Medium was changed every 2 days. At day8, 
neuralised embryoid bodies were washed with Ca2+/Mg2+-free PBS and then dissociated by 
incubation at 37oC with accutase (PAA laboratories). A single cell suspension was obtained by 
gentle trituration and cells washed with ADF medium and harvested by centrifugation at 
1000rpm. Neural progenitors were then plated onto tissue culture plates coated with 0.1µg/ml 
Poly-L-Lysine (Sigma) and 10µg/ml Laminin (Sigma) in ADF medium + 5ng/ml FGF2. 34D6-
derived neural progenitors were grown to sub-confluency and passaged once by dissociated 
with accutase and re-plating. The 34D6 iPS cells derived neural progenitors were harvested for 
nucleosome preparation on day 16 of differentiation. 
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The NPC cell population was validated using immunocytochemistry by checking for the 
presence of the NPC-specific markers, such as Nestin and the loss of pluripotency markers, for 
example Oct-4. Greater than 90% of the differentiated population contained neural 
progenitors.  
2.2 DNA extraction and sequencing 
2.2.1 In vivo MNase digestion of chromatin 
Chromatin was prepared from human iPS cells and NPC cells as described previously for the S. 
cerevisiae genome (Kent, Adams et al. 2011). In vivo MNase digestion of chromatin and 
subsequent DNA extraction from human iPS cells and the same cells differentiated to NPC cells 
was undertaken by Dr. Nicholas Kent. Three bio-replicates for each cell type, induced 
pluripotent (iPS) and derived neural progenitor (NPC) cells were utilised for MNase-seq. The 
samples of cultured cells, grown independently under the same conditions were also treated 
independently with MNase. The cell membranes and nuclei were made permeable to MNase 
using the detergent NP-40 (Stewart, Reik et al. 1991) (Kent and Mellor 1995) and treated by in 
vivo digestion with 300U/ml MNase at room temperature for 4 minutes. DNA fragments were 
purified from the MNase treated samples and then the samples for each cell type were pooled 
in equimolar amounts.  DNA extracted from chromatin samples was size-fractionated on 
agarose gels. 25-35ug of DNA less than 300 bp was size-selected for each cell type (Fig 3.1). 
2.2.2 Illumina HiSeq 2000 platform (HiSeq) paired end mode sequencing.  
Paired-end mode sequencing was undertaken by Source BioScience 
(http://www.sourcebioscience.com/). Paired end mode sequencing of size-fractionated DNA 
was performed on a Illumina HiSeq 2000 platform (HiSeq) using a read-length of 50 bp. Eight 
flow cells were used for each cell type to obtain a sufficient depth of coverage of the human 
genome. A standard Illumina paired-end mode sequencing protocol was used, apart from the 
omission of the nebulisation step and the addition of a further gel purification step to 
eliminate any excess concatenated linkers after the ligation of linker DNA to the sample. Base 
calling and quality control of the sequencing data was performed using Real Time Analysis 
(RTA) 1.09, CASAVA 1.8 software. 
2.3 Analysis of paired-end DNA sequence data 
2.3.1 Alignment of paired-end reads to the genome 
A total of 3.4 and 3.0 billion paired-end reads were obtained in fastq format from iPS and NPC 
cells respectively. The reads from individual flow cell lanes were aligned to human genome 
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assembly hg19 using Bowtie version 0.12.8 (Langmead, Trapnell et al. 2009). The command 
line options for bowtie were as follows: bowtie -v 3 --trim3 14 --maxins 5000 --fr -k 1 --best -p 
12. The maximum insert size was set at 5000 to obtain the maximum range of available 
particle sizes in the chromatin sample and the read length was clipped to 36 bp to remove any 
adaptor sequences. The bowtie –fr command ensures that alignments are only called when 
mate pairs have a relative orientation of FR ("forward stand, reverse strand") and the insert 
size condition specified is met. A total of 2.5 x 109 aligned paired-end reads were obtained for 
the pluripotent genome and 2.25 x 109 aligned paired-end reads for NPC. 
In this method, all of the DNA fragments less than 300 bp in size, generated after MNase 
digestion, were utilised for sequencing. As these data contain a variety of lengths of DNA 
fragments, generated by the protection from MNase digestion by chromatin species, rather 
than fragments generated by strict size-selection, the selection of insert sizes for further 
analysis was undertaken computationally. This meant that other published software packages, 
for example Danpos (Chen, Xi et al. 2013) were not suitable for nucleosome mapping. Hence, a 
bespoke data processing pipeline was developed. Subsequent data processing was undertaken 
in a similar manner to the method previously described for the S. cerevisiae genome (Kent, 
Adams et al. 2011). This method was adapted and automated using high performance 
computing to process the human genome data which is a much larger data-set than that 
generated from the S. cerevisiae genome. Data was processed according to the flowchart (Fig 
2.1). In house Shell scripts were used to create chromosome and particle-specific directories 
and to move files into them as required. All the scripts used in this analysis are available on a 
DVD.  
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2.3.2 Data validation and normalisation.  
The number of reads obtained for each human chromosome in each cell type was determined 
using the scripts: count_reads_5 and count_reads_6.  These scripts count the number of lines 
in the chromosome specific .sam files, hence generating the number of aligned paired-end 
reads for each chromosome. The results are shown in the Appendix. Fig A.2. As the ratio of 
reads obtained between iPS and NPC cells in the Y chromosome was 0.6, indicating a 
substantial difference in read counts obtained from the Y chromosome between the two cell 
types, the data from the autosomal genome was utilised for further analysis.  
To compensate for the slight genome-wide difference in total read counts between the two 
cell types, the read counts for the NPC autosomal genome were multiplied by the ratio of the 
total aligned reads in the autosomal genomes of iPS v NPC cells, which was 1.117. (See 
Appendix table A.1) 
2.3.3 Analysis of the number and distribution of chromatin particle sizes. 
The distribution of paired-end read insert sizes binned at single base pair resolution was 
determined by concatenating the chromosome-specific sam files and processing the data using 
the scripts: pair_read_histogram_ARCCA_scratch_multi,  add_pair_histo_iPS4_autosomes and 
add_pair_histo_NPC2_autosomes. 
Normalised data from the autosomal genome was used to construct the frequency distribution 
presented in (Fig 3.2). 
2.3.4 Division of the paired-end read data into chromatin particle size classes 
Paired-end reads obtained from Bowtie alignments in .sam format were sorted into separate 
chromosome-specific files using the UNIX ‘grep’ command in the shell script: 
human_NIPS_chr_grepv2.sh. Edited versions of this script were used for iPS cell data 
processing. The resulting chromosome-specific .sam format files were processed using the 
script SAM_parserJH.pl. This script calculates the mid-point of each insert and separates the 
reads according the insert size (ISIZE). The reads were filtered according to the insert size plus 
or minus a window value ($pwind). The pwind value was set as shown in Table 2.1. The pwind 
values that were set resulted in three non-overlapping ranges of putative chromatin particle 
sizes. Hence, nucleosomes are represented by the 138-161 bp chromatin particle size class. 
Other user-defined parameters that were set in this script were the $SAM_ID_flag variable 
which was specific to each .sam file and the chromosomes, specified in the array 
@chromosome. All of the .sam files in chromosome-specific directories were processed and 
the resulting particle-specific sam files were output into new chromosome-specific directories.  
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The script cat_part was used to concatenate the replicate chromosome-specific files for each 
particle size, and then the script part_sort_pwind.pl was used to move the concatenated files 
for each chromosome into whole genome, particle-specific directories.  
 
Particle size class Lower limit Upper limit pwind 
Sub-nucleosomal 112.5 137.5 0.1 
nucleosomal 138.75 161.25 0.075 
Super-nucleosomal 161.875 188.125 0.075 
 
Table 2.1  Summary of the pwind values and the resulting non-overlapping chromatin particle size 
classes 
The value of pwind in the script SAM_parserJH.pl  results in three non-overlapping chromatin particle 
size classes of approximately 112-137 bp, 138-161 bp and 161-188 bp herein referred to as sub-
nucleosomal, nucleosomal and super-nucleosomal chromatin particles respectively. 
2.3.5 Construction of normalised read mid-point frequency distributions. 
To represent a unique chromatin particle position for each paired-read, the convention of 
marking the genomic position of the mid-point of the insert DNA was followed. This 
convention is designed to represent a position equivalent to the nucleosomal dyad (Luger et 
al., 1997). The script humanhistogramXY_2.pl was used to calculate the frequency distribution 
for the mid-point position of the paired read insert size values counting reads at 10 bp 
resolution (defined in the variable $bin_width). To reduce random variation, the data was 
smoothed using a 3bin moving average. 
Frequency distributions were output as chromosome-specific files in .sgr format. Sgr files are 
tab-delimited graph files in the format: chromosome identification: chromosomal location of 
the start of each 10 bp bin: frequency of the paired-read midpoint values that fall within that 
10 bp bin. These chromosome-specific  files can be  can be loaded into the Integrated Genome 
Browser (IGB) (Nicol, Helt et al. 2009), so that the frequency distribution of the paired-read 
midpoint values can be visualised as a histogram aligned with the genome. This provides 
information about the location and distribution of the user-selected particle sizes in the 
genome. The frequency distributions for all of the autosomal .sgr files for all three chromatin 
particle size classes in NPC cells were normalised for read depth as described in section 2.3.2 
using the series of scripts: NPC_pwind_scale_factor. 
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2.4 Processing data from published human nucleosome maps 
Maps derived by Kunjale et al (Kundaje et al. 2012) from the K562 chronic myelogenous 
leukaemia (Cml) cell line  (Lozzio and Lozzio 1979) and from the B-lymphoblastoid cell line 
GM12878  ( Corriell biorepository) were made by sequencing DNA purified from chromatin in 
the mono-nucleosome size range after MNase digestion.  These published data-sets were 
converted from bigwig to bedgraph format using the script: bigWigToBedGraph (downloaded 
from the UCSC genome browser). Chromosome-specific bedgraph files were constructed using 
the shell scripts: human_chr_grep_word_boundary_stanford_Gm12878.sh and 
human_chr_grep_word_boundary_stanford_K562.sh. The chromosome-specific bedgraph files 
were then converted to .sgr files (Scripts Gm12878_bedgraph_to_sgr_v5 and   
K562_bedgraph_to_sgr_v5). These scripts bin the data into 10 bp bins and calculate a 3 bin 
moving average exactly as described for the iPS and NPC data above. 
To validate and determine the quality of the final re-processed maps, the final chromosome-
specific .sgr files were analysed using the scripts sgr_analyser_K562 and 
sgr_analyser_Gm12878. This generated the total numbers of aligned paired -end reads 
obtained for each chromosome and hence for each genome.  
The positions of all of the peaks in the K562 and GM12878 genomes were determined using 
the peak algorithm (PeakFinder), script: peak_finder43. 
2.5 Construction of genomic feature lists  
2.5.1 TSS  
The positions of transcriptional start sites for all of the full length transcripts for human 
genome build Feb 2009 GRCH37/hg19 were derived as follows. Track = Gencode Genes v17, 
table =basic, was downloaded from the UCSC genome browser generating the file: 
Gencode_basic_TSS_v2.txt (contains 94,151 TSS). Two files were generated from the UCSC 
data download: a) The file gencode_TSS_genes.txt which contains annotation information for 
all of the genes extracted from the UCSC browser was generated using the script 
extract_GENCODE_TX_start and b) a non-redundant file of strand-specific TSS 
(Gencode_unique_TSS_v5.txt, no of non-redundant TSS = 83,142) was generated using the 
script Gencode_TSS_Duplicates_extract_v5.pl. The output from this script was split into 
chromosome-specific files.   
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2.5.2 Transcription factor binding motifs. 
The genome-wide binding positions for a select group of transcription factors were obtained. 
The sequence of the consensus binding motif used in this study for each transcription factor is 
shown in Table 2.2. The genomic positions of the consensus binding sequence for each 
transcription factor were extracted from fasta files from the hg19 genome assembly using in 
house perl scripts. Fasta files were downloaded from 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/chromosomes/ 
This directory contains the Feb. 2009 assembly of the human genome (hg19, 
GRCh37 Genome Reference Consortium Human Reference 37 (GCA_000001405.1)) 
Since the ATF2 consensus binding sequence is a palindrome, only forward strand motif 
positions were obtained. For the other motifs, forward and reverse strand positions were 
obtained and combined to generate a single file of binding positions for each transcription 
factor. All perl scripts used to extract the transcription factor binding positions are in the folder 
TF_BINDING_SITE on the DVD. 
The consensus binding motif for YY1 was derived from ChIP-seq data derived from H1ESC cells 
in factorbook (http://www.factorbook.org) (Wang, Zhuang et al. 2013) which were derived by 
taking the sequences of the top 500 TF ChIP-seq peaks. In this study, the motif M1 was used 
from factorbook. The ATF2 CRE binding motif was taken from Hai et al (Hai, Liu et al. 1989). 
The PAX6 consensus binding sequence was derived using (ChIP) in ES-derived neuroectodermal 
cells (NECs) (Bhinge, Poschmann et al. 2014). CTCF binding positions were derived by matching 
the H1ESC ChIP region data from the Broad institute downloaded from the UCSC genome 
browser, file wgEncodeAwgTfbsBroadH1hescCtcfUniPk.narrowPeak (UCSC accession 
wgEncode EH000085) with the consensus binding motif derived by Ong et al (Ong and Corces 
2014). 
RE1 sites were derived by matching the consensus binding motif derived by Bruce et al (Bruce, 
Donaldson et al. 2004) with ChiP data that was derived from  the ENCODE database (Gerstein, 
Kundaje et al. 2012) and downloaded using the UCSC genome browser from human genome 
assembly Feb 2009 GRCH37/hg19 Group=regulation, Track name = TXnFactorChiP, Table= wg 
EncodeRegTfbsCLusteredv2  from uniform processing of data from the Jan. 2011 ENCODE data 
freeze ( Fig 2.1). 
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Table 2.2 Generation of genome-wide positions of transcription factor motifs 
The genome-wide binding motifs for a select group of transcription factors were determined. The 
binding motifs of ATF2 (Hai, Liu et al. 1989) and YY1 binding sequences from H1ESC cells in factorbook 
(Wang, Zhuang et al. 2013) and the PAX6 consensus binding sequence derived using (ChIP) in ES-derived 
NECs (Bhinge, Poschmann et al. 2014) were extracted from the hg19 genome using in house perl scripts. 
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Figure 2.1 Derivation of REST genomic binding positions. 
Alignment of REST consensus binding motifs were aligned with ChIP data from the ENCODE project. 
 
2.6 Development of a peak-finding algorithm 
In order to locate and quantify the number of positioned chromatin particles in each size class, 
a peak-finding algorithm was developed. In order to set the parameters for the peak-finding 
algorithm, the quality of the final chromosome-specific .sgr files was assessed using the script: 
sgr_analyser_iPS_v3. The output from this script is two files; the first contains the sum of the 
paired-read midpoint values per 10 bp bin for each chromosome and the second contains the 
sum of the paired-read midpoint values per 10 bp bin for each chromosome below user-
defined thresholds. In this way, the average number of paired-read midpoint values per 10 bp 
bin for the autosomal genome was determined for the nucleosomal chromatin particle size 
class (138-161 bp) in both iPS and NPC cells. The average number of reads per 10 bp bin for the 
iPS and NPC nucleosome maps was determined as 1.56 for the iPS map and 2.1 for the NPC 
map nucleosomal size class (138-161 bp). Therefore, a value of two was chosen to define the 
‘noise’ threshold for subsequent peak searches. This analysis showed that there was a minority 
of 10 bp bins in which the frequency of the paired-read midpoint values was >1000 (632 bins in 
iPS and 806 bins in NPC) and most of the frequency distribution comprised 10 bp bins in which 
the frequency of the paired-read midpoint values was <50. These regions of the genome with 
high frequencies of paired-read midpoint values were, for example at the ends of 
chromosomes and at runs of repeats and at centromeres. As I could not rule out the fact that 
these high frequencies were an artefact of the repetitive nature of the underlying sequence, 
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these regions were excluded by setting the upper threshold for the centre of the peak in the 
peak-finding algorithm to 1000. Peaks were defined as three consecutive 10 bp bins where the 
value of the paired-read midpoint frequency in the central 10 bp bin was between 30 and less 
than 1000, given as A. The lower threshold for the paired-read midpoint frequency values for 
the bins either side of the central bin was set at two. The upper threshold for each of the 
paired-read midpoint frequency values for the bins either side of the central bin given as B, 
was less than the paired-read midpoint frequency in the central bin (A). The series of scripts 
called peak finder peak_finder43_iPS_150_pWIND2_hive and 
peak_finder43_NPC_150_scaled_hive were used to obtain the number and location of peaks 
representing positioned chromatin particles for all three classes of chromatin particle in this 
analysis.  
 
 
Figure 2.2 Defining a peak representing a positioned chromatin particle. 
Numbering on the 10 bp bins represent the upper and lower paired-end read frequency thresholds used 
for each bin. The central bin has a low threshold of 30 reads and an upper threshold of <1000, defined 
as A. Each of the 10 bp bins either side have a low threshold of 2 and an upper threshold value defined 
as B, where B must be less than the value of A.   
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2.7 Locating and comparing patterns of positioned chromatin particles 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read 
mid-points, were given explicit genome positions using the heuristic peak-finding algorithm 
(peak-finder) as described in section 2.6. This was carried out for all of the chromatin particle 
size classes in iPS and NPC cells and the published human chromatin particle maps derived 
from K562 and GM12878 cells (Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012). The 
scripts used for comparison of the locations of positioned chromatin particles are in the folder: 
PEAK_COMPARE on the DVD. 
2.7.1 SiteWriter 
The perl script SiteWriterJH_CFD_10bin_2.pl, (Kent, Adams et al. 2011) was used to construct 
normalised average cumulative frequency distributions of the paired-read midpoint values at 
and in the bins surrounding  genomic feature loci within a user-defined window, for example 
at TSS and transcription factor binding sites. The chromosome-specific, chromatin-particle-
specific .sgr files generated as described above were concatenated to form whole-genome-
particle.sgr files to use in SiteWriter. The file containing the locations of the genomic features 
were generated as described in section 2.5.  
The output from the SiteWriter script comprises two files: the first is a CFD.txt file of the 
normalised average cumulative frequency values that are output in tab-delimited text format. 
The values are normalised by dividing the cumulative frequency value in each bin by the 
number of bins specified in the user-defined window. The graphs derived from the CFD.txt file 
were plotted in excel or in R version 3.2.1 using the ggplot2 package. The second output file 
from SiteWriter, a C3.txt file, contains a matrix of locally-normalized dyad frequency values for 
every bin position. These data can be used in cluster analysis. See section 2.8.  
2.7.2 Comparison of positioned chromatin particles from different size classes. 
To compare the overlap in the locations of positioned chromatin particles within +/- 10 bp 
between all three chromatin particle size classes in the same cell type, the following scripts 
were used:  
iPS_peak5_part_compare_v5_sitewriter_window_v6 
NPC_peak5_part_compare_v5_sitewriter_window_v6_ARCCA.  
The results of this analysis are shown in the Venn diagrams in Fig 3.9 
The script ‘ diff_cell_peak5_part_compare_v5_sitewriter_window_v6_ARCCA’ was used to 
compare the overlap in the locations of positioned nucleosomal chromatin particles within +/- 
10 bp in NPC, K562 and GM12878 cells. The results are shown in Fig A3 (Appendix). 
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2.7.3 Comparison of positioned chromatin particles in the same size class during 
differentiation from iPS to NPC. 
To compare the overlap in the locations of positioned chromatin particles within +/- 10 bp in 
the same size class during differentiation from iPS to NPC the following scripts were used:  
iPS150_v_NPC150_peak5_part_compare_v5_sitewriter_window_v6. 
iPS175_v_NPC175_peak5_part_compare_v5_sitewriter_window_v6 
2.7.4 Comparing positioned chromatin particles at TSS  
The number and location of TSS with positioned chromatin particles within 300 bp of a TSS was 
determined using series of scripts called peak_TSS (e.g. iPS_peak5_TSS-UP or iPS_peak5_TSS-
DOWN) for all three chromatin size classes. The scripts 
iPS_v_NPC_peak5_TSS_down_compare_v5 and iPS_v_NPC_peak5_TSS_up_compare_v5_new 
were used to determine, for the genes that possessed nucleosomes near the TSS, which genes 
were exclusive to one cell type and which were in common between iPS and NPC cells. In 
addition, the annotation information for these subclasses of TSS was obtained. These scripts 
are in the folder: TSS on the DVD. 
2.8 Cluster analysis.  
In order to determine whether there were common patterns of chromatin particle positioning 
frequency in a user-defined window, surrounding a genomic feature, cluster analysis was 
undertaken using data generated from the ‘C3’ files generated from SiteWriter. Cluster 
analysis was undertaken in R, using the Canberra method to generate a distance matrix from 
the ‘C3’ files generated as described in section 2.7.1. Several different methods for generating 
the distance matrix were utilised on test data: for example maximum, Euclidean and 
Manhattan. The Canberra method is similar to the Manhattan method, which sums the 
absolute differences between variables, but in the Canberra method the absolute difference 
between the variables of the two objects is divided by the sum of the absolute variable values 
prior to summing. The Canberra method generated the best data separation. Dendrograms 
generated by hierarchical agglomerative clustering were used to determine the number of 
groups to use in k-means clustering. Heat maps were generated from the log2 transformed 
data from the cluster groups using the heatmap2 function from the gplots package in R. All R 
scripts used for clustering and heat map generation are in the folder CLUSTER on the DVD.  
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2.8.1 Clustering chromatin particle positions.  
As there were too many peak positions derived to use all of them in cluster analysis, randomly 
selected peak positions (n=20,000) were derived from the ‘C3’ files using the shell script 
‘shuf.sh’ for each chromatin particle size class in both iPS and NPC  cells. The UNIX function 
‘shuf’, used in the script shuf.sh’, extracts lines of text from a file at random. The output files 
from this are located in the folder called ‘PEAK5_20K_Random_site_files’ on the DVD.  The 
peak positions for each chromatin particle size class and for both iPS and NPC were clustered 
using the ‘R’ scripts in the folder: Peak5_cluster_R_scripts on the DVD. 
2.8.2 Clustering chromatin particle size class data at RE1 sites. 
The iPS 150 .sgr data was processed using the script SiteWriter_Full_CFD_C3.plx and the list of 
RE1 sites generated in section 2.5.2 (filename: 
autosome_RE1_site_match_encode_chip_FR.txt). The data from the output C3.txt file was 
clustered using the script cluster_R_v3_RE1_iPS_150k_final.R. 
411 of the RE1 sites (those in clusters C2, 5 and 7) in the iPS genome that possessed positioned 
nucleosomal (138-161 bp) chromatin particles surrounding them were grouped together to 
form a subset of the total number of RE1 sites named C257, filename: RE1_iPS-150_C257.txt. 
The remaining 460 sites, which in the iPS genome had less well-positioned chromatin particles 
surrounding them, were grouped together and named C12368, filename: RE1_iPS-
150bp_C12368.txt.  
Using the R script ‘re-cluster_R_RE1_NPC_150_v2.R’. The data for the C257 subset of RE1 sites 
in NPC cells was extracted from the NPC nucleosomal size class (138-161 bp) ‘C3’ file. These 
data were clustered into four groups, generating the files: 
RE1_iPS150_C257_NPC_C1_sitewriter.txt 
RE1_iPS150_C257_NPC_C2_sitewriter.txt 
RE1_iPS150_C257_NPC_C3_sitewriter.txt 
RE1_iPS150_C257_NPC_C4_sitewriter.txt 
 
These cluster site files were re-grouped according to the chromatin structure in each cluster: 
C1, 3 and 4 had well-positioned chromatin particles surrounding the RE1 site in the 
nucleosomal chromatin particle size class (138-161 bp) from NPC cells and were grouped 
together in the file: RE1_iPS150_C257_NPC_C134_sitewriter.txt 
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2.8.2 Clustering chromatin particle size class data at CTCF sites. 
The sub-nucleosomal (112-137 bp) size class data from iPS cells was processed using SiteWriter 
and the file of CTCF sites derived in section 2.5.2: filename: 
autosome_CTCF_ONG_site_match_H1ESC_chip_sitewriter.txt (n=9516). Data from the ‘C3’ file 
generated was clustered using the R script: R_v3_iPS_125_CTCF_H1ESC_ARCCA_v2.  The 
resulting output files were used to generate average cumulative frequency distributions in the 
sub-nucleosomal particle size class, for each cluster, using SiteWriter. 
The cluster site files were concatenated in order of the strength of the signal in each cluster 
follows: Cluster5: Cluster4: Cluster1: Cluster2: Cluster6: Cluster3 to form the file: 
iPS_125_CTCF_clus_ordered_sites.txt. This file of ordered CTCF binding sites was used to 
extract the data from the C3 files in the same order for the nucleosomal and super-
nucleosomal particle size classes in iPS cells and for the sub-nucleosomal, nucleosomal and 
super-nucleosomal particle size classes in NPC cells, using the perl script: 
CTCF_cluster_order.pl.  The output files from this are in the folder: “ORDERED 
_CTCF_C3_data”. These ordered data sets were used to create heat maps for each of the 
chromatin particle size classes using the R script: 
CTCF_ONG_cluster_ordered_big_heatmaps_v3.R. 
2.9 Extraction of REST target gene annotation. 
Annotation information for RE1 sites was extracted from the annotation file 
‘gencode.v18.annotation.gtf’ downloaded from GENCODE: www.gencodegenes.org using the 
series of scripts in the folder: RE1_ANNOTATION on the DVD. 
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Chapter 3 : Generation and analysis of chromatin maps   
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3.1 Introduction 
The aim of this chapter was  to construct and characterise genome-wide nucleosome maps 
using  MNase-seq (Kent, Adams et al. 2011), from human induced pluripotent cells (iPS) in 
their undifferentiated state (Takahashi, Tanabe et al. 2007; Yu, Vodyanik et al. 2007) and iPS 
cells developed to the neural progenitor stage (NPC) (Chambers, Fasano et al. 2009). The 
analysis and comparison of these maps would reveal the genome-wide changes in patterns of 
chromatin structure that occur during the earliest stages of neural cell development. 
Other genome-wide chromatin maps have been constructed from various human cell types 
(Schones, Cui et al. 2008; Gaffney, McVicker et al. 2012; Kundaje, Kyriazopoulou-
Panagiotopoulou et al. 2012), but this the first study of high-resolution chromatin maps from 
human cells at different stages of neural cell differentiation. The work in this chapter details 
the construction, validation and comparison of these maps. This work shows that only a small 
proportion of the human genome contains highly positioned nucleosomes and that the 
frequency of positioned nucleosomes in the genome increases during neuro-development. 
This suggests that there is a high degree of genome regulation during neural differentiation. 
3.2 Generation of size-selected DNA samples 
Undifferentiated human iPS cells, herein referred to as iPS cells and the same cells developed 
to NPC were used to construct genome-wide MNase-resistant chromatin particle maps. The 
cells were cultured and differentiated by Shona Joy and Prof. Nick Allen. Subsequent 
processing of the cells in order to obtain DNA samples for sequencing was undertaken by Dr. 
Nick Kent. In brief, three bio-replicates for each cell type were treated by partial in vivo 
digestion with MNase and DNA fragments were purified from them and pooled in equimolar 
amounts. The DNA fragments were separated according to size by gel electrophoresis. Figure 
3.1A shows that a ‘nucleosome ladder’ is visible in the samples from both cell types. The 
nucleosome repeat length for bulk chromatin for both iPS and NPC was calculated by plotting 
calibration curves of the log of the molecular size of the DNA in base pairs as a function of the 
migration distance of the DNA in the gel (Appendix Fig A.1). In order to determine the average 
nucleosome repeat length, the size of the furthest dominant migrating band in the MNase 
ladder, representing the DNA protected by nucleosomes, was determined.  A nucleosome 
repeat length of 200 bp was obtained in both cell types. This is similar to the human 
nucleosome repeat lengths obtained previously in other cell types, for example in HeLa cells, 
190-200 bp (Whitlock and Simpson 1976), 193 bp in granulocytes, 203 bp in CD4+ cells 
(Valouev, Johnson et al. 2011) and 187 bp in lymphoblastoid cells (Gaffney, McVicker et al. 
2012).  
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Since the human genome is large (approximately 3x109 base pairs), MNase-resistant DNA 
fragments of less than 300 bp were size-selected from each cell type from the complete 
nucleosome ladders using preparative gel electrophoresis. This size-selection was necessary in 
order to be able to obtain a sufficient read-depth of the human genome (approximately one 
read per base pair of DNA) (Kent, Adams et al. 2011) in the size range of DNA that would be 
protected from MNase by human nucleosomes, within the cost constraints of this project. 
Nevertheless, this necessitated using eight HiSeq flow cell lanes for each cell type. However, by 
sequencing all of the fragments below the approximate size of a di-nucleosome (300 bp), this 
allowed the study of MNase resistant species, represented by DNA fragments, that were both 
smaller and larger than the size of core nucleosome that footprints approximately 150 bp of 
DNA. This strategy was taken so that it might be possible to a) detect the locations in the 
genome protected from MNase digestion through the binding of transcription factors, by 
analysis of the mapped MNase resistant fragments that were smaller than the size of a core 
nucleosome (150 bp) and b) to analyse locations in the genome protected from MNase 
digestion by the presence of chromatin species that were larger than a core nucleosome 
(approximately 150 bp). This strategy would cover the analysis of MNase resistant species in 
the size range of transcription factor complexes, human core-nucleosomes and those in the 
size range of human chromatosomes. 
Fig 3.1A shows the total and size-selected DNA samples after MNase digestion of chromatin in 
both iPS and NPC cells. Size-selected DNA pools from each cell type were sequenced in paired-
end mode using Illumina technology as described in Chapter 2.  In total, the pooled iPS cell 
sample generated 2.5 x 109 aligned paired-end reads and the NPC sample generated 2.25 x 109 
aligned paired-end reads (Fig3.1B). The resulting DNA fragments purified from both iPS and 
NPC represent regions of genomic DNA that are protected from MNase digestion by the 
binding of chromatin proteins and perhaps transcription factors and herein they are referred 
to as chromatin particles. 
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Figure 3.1 MNase digestion of chromatin in iPS cell and NPC cultures yields nuclease protected DNA 
suitable for size selection and analysis by paired-end mode Illumina sequencing. 
DNA was extracted from 3 pooled bio-replicates of iPS cells and iPS cells developed to the neuro-
progenitor stage (NPC) A. Ethidium bromide stained agarose gel showing the size distributions of 
MNase-resistant DNA species before and after size-selection. DNA fragments less than 300 bp in size 
were selected for Illumina paired-end sequencing. B. The total number of sequencing reads obtained 
and the number of aligned paired-end sequencing reads obtained from the Illumina sequencing for both 
cell types cells is indicated in the table.    
  
73 
 
3.3 Construction of MNase-resistant chromatin particle maps. 
3.2.1 Data validation 
The paired-end reads were aligned to the human genome (assembly hg19) using  Bowtie 
0.12.8 (Langmead, Trapnell et al. 2009) and the resulting .sam files of  aligned reads were 
examined to determine the quality and comparability of the data obtained from each cell type. 
The number of aligned reads obtained for each human chromosome in each cell type was 
determined (see Appendix Fig A.2). The number of paired-end reads obtained for each 
chromosome in each cell type is broadly similar in most of the chromosomes. However, the 
ratio of reads obtained between iPS and NPC cells in the Y chromosome is only 0.6, indicating a 
substantial difference in read counts obtained from the Y chromosome between the two cell 
types. For this reason, it was decided to use the data from the autosomal genome for further 
analysis. Although there was only a small difference in total read counts between the two cell 
types, it was decided to normalise the read counts, by multiplying the reads for the NPC 
autosomal genome by the ratio of the total aligned reads in the autosomal genomes of iPS v 
NPC cells. 
To assess the number and size distribution of chromatin particle sizes for the autosomal 
genome as a whole, the frequency distribution of the total number of aligned paired-end reads 
obtained from both cell types with respect to insert size was determined at single base pair 
resolution. These data were plotted as a frequency distribution (Fig 3.2). This generated an 
estimate of the number and distribution of chromatin particle sizes in both cell-types. The 
distributions from both cell types were broadly similar, confirming a comparable level of 
MNase digestion. In particular, the number of DNA fragments in the 140-160 bp range 
matched closely between the two cell types. This is the size range of DNA that would be 
protected from MNase by core nucleosomes (147 bp). However, there was a difference in the 
distribution of chromatin particle sizes at the extreme ends of each distribution. More 
chromatin particles were observed in the lower end of the distribution in NPC than in iPS cells. 
For example, in the 50 bp chromatin particle size class, there were seven-fold more particles in 
NPC than in iPS cells. In contrast, there were more chromatin particles in the upper end of the 
distribution in iPS cells than in NPC. For example, in the 300 bp particle size class, there were 
seventeen fold more particles in iPS cells than in NPC cells. This result might suggest a 
difference in nucleosome structure between the two cell types. If nucleosomes were more 
accessible to MNase in NPC cells, then there would be a greater number of chromatin particles 
in the smaller size range.  
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Hence, it was decided that fragments in the 110 bp - 190 bp range, where the difference in the 
read count frequency between the two cell types is minimal would be used for subsequent 
analysis. 
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Figure 3.2 Sequence reads derived from MNase resistant DNA in iPS cell and NPC cultures show 
broadly similar paired-read insert size distributions. 
The number and size of the aligned paired-end sequencing reads from the genomes of both iPS and NPC 
was determined single base pair resolution. Read counts for the autosomal NPC genome were 
normalised (reads x 1.117.) Data from the autosomal genomes of both cell types was plotted as a 
frequency distribution of the log10 of the number of aligned paired-end reads. Data in the 110-190 bp 
size range was divided into three size classes (112-137 bp, 138-161 bp and 162-188 bp) for use in later 
analysis, shown by the vertical grey lines. 
 
 
 
 
  
77 
 
3.2.2 Division of the chromatin particle data into three size classes. 
Aligned reads with insert sizes in the 110 bp-190 bp range were processed further as described 
in the flow chart (Fig 3.3), using a series of in-house Perl and shell scripts to generate 
chromosome-specific and genome-wide frequency distributions for the paired-end read mid-
point positions of MNase-resistant chromatin particles. To be able to define the positions of 
chromatin particles of different sizes in the human genome precisely, it was decided to divide 
the 110-190 bp chromatin particle size range data obtained into three non-overlapping size 
classes. These were 1) 112-137 bp (125 bp +/- 10%), herein referred to as representing sub-
nucleosomal particles 2) 138-161 bp (150 bp +/- 7.5%) herein referred to as representing core 
nucleosomal particles and 3) 162-188 bp (175 bp +/- 7.5%) herein referred to as representing 
super-nucleosomal particles. This would mean that it would be possible to detect core 
nucleosomal sized (approximately 150 bp) chromatin particles in the 138-161 bp size class. In 
addition, it might be possible to detect chromatin particles that might represent transcription 
factors or transcription factor complexes in the 125-137 bp size class. Finally in the 162-188 bp 
size class, it might be possible to detect chromatin particles that generate a DNA footprint that 
is larger than that of a core nucleosome, for example those generated by modified 
nucleosomes or chromatosomes. 
Chromatin particle maps for each size class were generated by plotting the frequency 
distributions of the mid-point position of the paired-read insert size values on to the genome 
for each DNA fragment. Hence, the output from the processing pipeline was three chromatin 
particle maps corresponding to sub-nucleosomal, 112-137 bp, core nucleosomal, 138-161 bp 
and super-nucleosomal, size 162-188 bp fragments (Table 3.1). 
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Figure 3.3 Flow chart of the data processing pipeline for paired-end sequence read data 
Perl scripts or shell functions used to process the data at each step are in red text. A description of the 
data processing activity is shown in black text. The output from the pipeline is files containing frequency 
distributions of paired-read mid points for various chromatin particle size classes in Affymetrix .sgr 
format. 
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Chromatin particle size class Name 
112-137 bp Sub-nucleosomal 
138-161 bp   Nucleosomal 
162-188 bp Super-nucleosomal 
 
Table 3.1. Division of the chromatin particle data into three size classes. 
Chromatin particle data was divided computationally into three non-overlapping size classes 1) 112-137 
bp: sub-nucleosomal particles 2) 138-161 bp: core nucleosomal particles and 3) 162-188 bp: super-
nucleosomal particles. 
 
 
The number of reads obtained in each of the three chromatin particle size classes in each cell 
type was calculated. This was possible as the total number of paired-end reads obtained from 
both cell types with respect to insert size had been determined at single base pair resolution. 
The frequency of chromatin particles in each of the three size classes is similar in each cell 
type. The ratio of NPC/iPS particles in each size class is shown in Fig 3.5  
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Figure 3.4  Analysis of paired read data obtained from iPS and NPC cells. 
Chromatin particle data was divided into three size classes; i) 122-137 bp (sub- nucleosomal) ii) 138-161 
bp (nucleosomal) iii) 162-188 bp (super-nucleosomal. A. Histogram of the number of aligned paired-end 
reads in each chromatin particle size class determined at single base pair resolution for the autosomal 
genome in each cell type. Read counts for the autosomal NPC genome were normalised (reads x 1.117.) 
B. The ratio of reads (NPC/iPS) obtained in each cell type and each insert size class 
. 
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3.4 Characterisation of the MNase-resistant chromatin particle maps 
The chromatin particle positioning maps from both iPS and NPC cells were visualised using the 
Integrated Genome Browser (IGB) (Nicol, Helt et al. 2009). IGB is a visualization tool for the 
interactive exploration of large, integrated genomic datasets. Using this tool it is possible to 
view chromatin particle maps from each of the human chromosomes, plotted as histograms 
and aligned to the genome. Hence, is possible to scan a human chromosome for regions of 
interest in the genome to gain an overall impression of the patterns in chromatin particle 
positioning in the human genome. 
Fig 3.5 shows histograms of the frequency of paired-read mid points for each of the three 
chromatin particle maps from a section of chromosome 12 for both iPS and NPC cells. The 
frequency distribution of paired-read mid points in each size class resolve into discrete peaks, 
suggesting that individual positioned MNase-protected chromatin species have been mapped 
successfully. 
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Figure 3.5 Histograms of paired-read midpoint positions derived from MNase resistant DNA in iPS cell 
and NPC. 
Histograms were constructed by counting sequencing reads in 10 bp bins for all three chromatin particle 
size classes in both iPS and NPC cells. The histograms were visualised using the Integrated Genome 
Browser (IGB) at an intergenic region of chromosome 12 and plotted in R. Distinct patterns of peaks are 
detected in all three chromatin particle size classes, suggesting that the mapping of MNase-resistant 
chromatin particles of varying sizes in the human genome was successful. 
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Initial viewing of sections of the human chromatin particle maps using the IGB suggested that 
the patterns of chromatin particle positioning in the human genome were different from that 
of the S. cerevisiae genome. 85% of the S. cerevisiae genome possesses positioned 
nucleosomes (Mavrich, Ioshikhes et al. 2008; Kent, Adams et al. 2011) and gene bodies tend to 
possess nucleosome arrays (Lee, Tillo et al. 2007) whereas  gene promoters and the 3’ ends of 
genes tend to be nucleosome depleted. Examination of a section of human chromosome 12 
revealed that nucleosomes do not tend to be strongly positioned at high density across the 
human genome, nor strongly positioned across whole gene bodies. Fig 3.6 shows an example 
of this using a region of chromosome 12 from the iPS chromatin particle map in the super-
nucleosomal size class. An array of positioned nucleosomes is visible that is within an intron of 
the SOX5 gene but it is also just upstream of a splice variant of SOX5.  This illustrates that it is 
possible to detect arrays of strongly positioned nucleosomes in the human genome, but they 
do not always occur across entire gene bodies. In addition, large parts of the human genome 
appeared to possess weakly positioned or ‘fuzzy’ nucleosomes. These observations suggested 
that much of the human genome does not possess strongly positioned nucleosomes and that 
strongly positioned nucleosomes might occur in low numbers at regulatory regions in the 
human genome, rather than across whole gene bodies. 
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Figure 3.6 Comparison of the histograms of paired-read midpoint positions derived from MNase 
resistant DNA in the human and S. cerevisiae genomes 
A. Detection of an array of peaks in the paired-read midpoint positions derived from MNase resistant 
DNA derived from the super- nucleosomal (162-188 bp) chromatin particle size class in iPS cells in a 
section of human chromosome 12. The peaks represent an array of positioned super-nucleosomal 
chromatin particles and the array is located just upstream of a splice variant derived from the SOX5 
gene. Few well-positioned chromatin particles are detected in the rest of the gene body. A map 
representing the structure of the model of the SOX5 gene and the relevant splice variant is shown. B. A 
section of the histograms of paired-read midpoint positions derived from the S. cerevisiae chromosome 
1. The peaks represent arrays of well positioned nucleosomes across all of the gene bodies. 
Nucleosomes are not positioned in the intervening regions, known as nucleosome free regions. 
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3.5 PeakFinder 
PeakFinder is a peak marking algorithm that I derived in order to investigate the number and 
distribution of well-positioned nucleosomal chromatin particles in iPS and NPC cells. This tool 
was designed to locate and report the number of genomic positions of peaks in the chromatin 
particle mid-point frequency distribution that might represent positioned chromatin particles. 
Chromatin particles that are positioned at a particular genomic locus are usually represented 
by a Gaussian distribution of the sequencing reads at that locus. This distribution may occur if 
MNase trims the DNA protected by the chromatin particle imprecisely, or it could occur 
because of variation in the exact nucleosome positioning across a population of cells. In a 
Gaussian distribution, the standard deviation determines the width of the ‘bell’.  In the case of 
chromatin particle positioning data, the shape of the distribution of aligned sequencing reads 
at a given locus in the genome reflects the variation in positioning; a narrow peak represents 
well positioned chromatin particles (See Chapter 1 Fig 1.7). Therefore it was decided to derive 
the algorithm to detect the locations of Gaussian distributions with a narrow bell in the 
frequency distributions of the mid-point position of the paired-read insert size values. 
Hence, PeakFinder was a simple heuristic peak marker that detected Gaussian peaks derived 
from the cumulative read count in each of three consecutive 10 bp bins. The lower, ’noise’ 
threshold of the cumulative read count in the first and third bins was derived from the average 
number of reads in the genome per 10 bp bin in the 138-161 bp chromatin particle size class. 
The upper threshold set for the centre of the three consecutive 10 bp bins was set to eliminate 
any peaks with artificially high values caused by sequencing artefacts. The lower threshold set 
for the centre of the three consecutive 10 bp bins was empirically determined. The final 
parameters used to define this peak were set stringently to detect high numbers of reads in 
the central bin of the peak, so as to detect only very strongly positioned chromatin particles. 
The PeakFinder tool was tested empirically by visualising the results in the IGB.  
3.6 The number of positioned nucleosomes increases during neural cell 
development. 
The PeakFinder tool was used to investigate the number of strongly positioned nucleosomes in 
each chromatin particle size class in both iPS and NPC cells. This would yield information about 
changes in chromatin particle positioning during neural cell differentiation. Using the 
PeakFinder tool, approximately 48,840 positioned nucleosomal chromatin particles were 
identified in iPS cells. Assuming a nucleosome repeat length of 200 bp in iPS cells, this 
corresponds to 0.32% of the genome and suggests that there are few well positioned 
chromatin particles in the nucleosomal chromatin particle size class in iPS cells.  Following 
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differentiation to NPC, the number of peaks representing positioned nucleosomal chromatin 
particles increased to 408,152; an 8.4 increase in peaks in NPC compared with iPS cells. For the 
sub -nucleosomal size class,  6,026 and 39,315 peaks were found in iPS and NPC  cells 
respectively; a  6.5 fold increase in the number of positioned particles during differentiation 
from iPS to NPC cells. In addition, there was only a small increase in the number of positioned 
super-nucleosomal chromatin particles during differentiation from iPS to NPC cells (Fig 3.7A).   
This suggests that chromatin is more organised in NPC cells. The major change in numbers of 
peaks observed during differentiation from iPS to NPC cells occurred in the nucleosomal (138-
161 bp chromatin particle size) class. This suggests that the chromatin particle size 
representing core nucleosomes may be more dynamic in the pluripotent state and then they 
become more strongly positioned during differentiation from pluripotent to neural progenitor 
cells. Fig 3.7 B shows the same graph shown previously in Fig 3.4. When compared with Fig 
3.7A, this shows that although the number of reads obtained in each chromatin particle size 
class is similar, indicating that the total number of chromatin particles in each genome is 
similar, the number of strongly positioned nucleosomes changes during differentiation from 
iPS to NPC. 
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Figure 3.7 See next page for legend. 
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Figure 3.7 Comparison of the total number of positioned chromatin particles in each size class in iPS 
and NPC cells. 
The number and position of peaks representing positioned chromatin particles in the iPS and NPC 
genomes was determined for each chromatin particle size class; i) 122-137 bp (sub- nucleosomal) ii) 
138-161 bp (nucleosomal) iii) 162-188 bp (super-nucleosomal) using the  heuristic peak calling method 
(PeakFinder). A. The frequency distribution of positioned chromatin particles in each insert size class. B. 
The total numbers of positioned chromatin particles in each insert size class for each cell type and the 
fold change in the numbers of positioned chromatin particles between iPS and NPC. C. The frequency of 
chromatin particles in each of the three size classes as shown in previously in Fig 3.4, when compared 
with the number of positioned particles in  A. this illustrates that there is a change in chromatin particle 
positioning during differentiation to NPC, but little change in the total number of chromatin particles in 
each genome.  
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To validate the chromatin particle maps constructed in this study, data from two published 
high-resolution chromatin maps constructed using MNase-seq from two other human cell 
types, K562 and GM12878 by Kundaje et al (Kundaje et al. 2012) were processed so that a 
comparison between the data sets could be made. K562 is a chronic myelogenous leukaemia 
(Cml) cell line  (Lozzio and Lozzio 1979) and GM12878 is a  B-lymphoblastoid cell line GM12878 
(Corriell Biorepository :https://catalog.coriell.org/1/Browse/Biorepositories). These maps were 
constructed by sequencing the DNA fragments that were purified from agarose gels in the 
mono-nucleosome (150 bp) size range after MNase digestion according to the method by 
Valouev et al (Valouev, Johnson et al. 2011)  GEO: GSE35586. In the study presented in this 
thesis, all of the DNA fragments that were less than 300 bp in length were purified for DNA 
sequencing and then fragments were divided into three size classes for further analysis. Hence, 
the fragments, in the work presented here, of 138-161 bp, referred to as nucleosomal 
chromatin particles were used for comparison with the published K562 and GM 12878 maps. 
The 138-161 bp chromatin particles are the most similar in size to those in the K562 and GM 
12878 mono-nucleosome maps. The data from the K562 and GM 12878 nucleosome maps was 
converted into the same format as the iPS and NPC data sets derived in this thesis. The data 
was converted from bedgraph to sgr format, re-binned into 10 bp bins and smoothed using a 
three bin moving average. Hence, the two data sets could be compared directly.  
The number of positioned chromatin particles in each of the K562 and GM12878 re-processed 
nucleosome maps from K562 and GM12878 cells was determined using the PeakFinder tool 
and the results are shown in Table 3.2 along with the previously obtained results for iPS and 
NPC cells. The number of positioned nucleosomal size chromatin particles data obtained from 
NPC cells is most similar to that found in the K562 and GM12878 nucleosome maps. This result 
suggests that the number of positioned nucleosomal chromatin particles is similar in the 
differentiated cell lines, NPC, K562 and GM12878. Interestingly, an analysis of the overlap in 
the locations (within 10bp) of the positioned nucleosomal chromatin particles between these 
three cell types (Fig A3, Appendix), showed that only approximately 1.4% and 0.5% of the 
positioned nucleosomal chromatin particles in NPC cells were in the same location as those in 
K562 and GM12878 cells respectively and very few (682), nucleosomal chromatin particles 
were located in the same position in all three cell types. However, approximately 17% of the 
positioned nucleosomal chromatin particles in K562 cells were located in the same place as 
those in GM12878 cells.  
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Table 3.2 Putative positioned chromatin particles in different cell types. 
The frequency of positioned chromatin particles as determined by a heuristic peak calling method for 
the entire genomes in iPS, NPC, K562 and GM12878 cells. 
  
91 
 
Assuming a nucleosome repeat length of 200 bp in the NPC, K562, GM12878 cell types and 
that the size distribution of the DNA fragments isolated and sequenced in the mono 
nucleosome size range by Kundaje et al is the same as those in the nucleosomal (138-161 bp) 
chromatin particle size class in this study, it is possible to estimate and compare the fraction of 
the genome that possesses positioned nucleosomal chromatin particles in each of these cell 
types.  2.7% of the NPC genome contains chromatin particles in the nucleosomal (138-161 bp) 
size class. In the K562 and GM12878 cells, it was determined here, using PeakFinder on the re-
processed published data, that 2.45% and 1.6% of these genomes contain positioned 
nucleosomes respectively. This analysis suggests that the quality of the chromatin particle 
maps derived in this thesis is similar to that of the published maps generated by Kundaje et al.  
Gaffney et al and Valouev et al generated nucleosome maps from differentiated human cell 
lines using MNase seq and estimated the fraction of the genome that possesses positioned 
nucleosomes. Valouev et al (Valouev, Johnson et al. 2011) used a positioning stringency metric 
to estimate the percentage of the genome that is occupied by positioned nucleosomes in 
granulocytes, CD4+, and CD8+ T-cells. They determined that, at the lowest stringency they 
utilised, a maximum of 20% of the genome possesses positioned nucleosomes. Similarly, 
Gaffney et al (Gaffney, McVicker et al. 2012) analysed a sample of  a million regions of 200 bp 
in length  from their nucleosome maps generated by in vivo MNase digestion  in 
lymphoblastoid cells. They estimated nucleosome positioning by counting the number of 
midpoints of DNA fragments of 142-152 bp in size within 15 bp of a genomic position and 
excluded positions with less than 50 midpoints. In this way they estimated that 81% of the 
human genome has weak nucleosome positioning, 8.4 % has moderately strong positioning 
and only 0.3% has very strong positioning. 
Although there are minor differences between the results obtained in this study and in the 
published studies, these may be accounted for by cell type specific differences in positioning, 
in the methods of DNA fragment isolation or analysis and variation in the algorithms used to 
determine nucleosome positions. Taken together, the results presented here are in general 
agreement with the conclusion reached by Gaffney et al and Valouev et al, that most of the 
human genome does not possess strongly positioned nucleosomes. 
3.7 Investigating the organization of positioned chromatin particles. 
Having determined the number of positioned nucleosomal size chromatin particles in the iPS 
NPC, K562 and GM12878 genomes, the next question was whether the chromatin particles 
might be positioned in functional groups such as phased arrays.  To answer this question, the 
average chromatin structure at each of the peak positions obtained using the peak finding 
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algorithm (PeakFinder) in the genomes of all four cell types was determined in the 
nucleosomal chromatin particle size class. The positions of the peaks were used to construct 
an average cumulative frequency distribution of the sequence read mid-points at and 
surrounding (+/- 300 bp) each nucleosomal (138-161 bp) chromatin particle position for each 
of the cell types. Fig 3.8 shows a comparison of the average cumulative frequency distribution 
of the nucleosomal chromatin particle size class surrounding a peak position in the 
nucleosomal chromatin size class in all four cell types, iPS, NPC, K562 and GM12878 cells. This 
result shows that the pattern of nucleosome positioning in all four cell types is broadly similar. 
Nucleosomal chromatin particles in these cell types do not form phased arrays; rather, they 
are on average flanked by one or two nucleosomes.   Hence, the results presented here 
suggest that the human genome possesses few strongly positioned nucleosomes and that they 
are located in discrete regions of the genome. 
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Figure 3.8 Comparisons of the positions of chromatin particles in the nucleosomal (138-161 bp) 
chromatin particle size range mapped in iPS and NPC cells by MNase-seq with those mapped in K562 
and GM12878 cells. 
The data from the nucleosome maps generated for the K562 and GM12878 cell lines (Kundaje, 
Kyriazopoulou-Panagiotopoulou et al. 2012) was converted from bedgraph to sgr format and the data 
was re-binned into 10 bp bins, calculating a 3bin moving average. The K562 and GM12878 maps were 
constructed by sequencing DNA purified from chromatin in the mono-nucleosome (approx. 150 bp) size 
range after MNase digestion. These data were compared with the iPS and NPC chromatin particle maps 
generated in the 138-161 bp size range since this is most similar to the size range of the chromatin 
particles in the K562 and GM12878 maps. The positions of all of the peaks in the K562, GM12878, iPS 
and NPC genomes were determined using the peak detecting algorithm (PeakFinder). The positions of 
the peaks from each genome were used to construct an average cumulative frequency distribution of 
the chromatin particle distribution at and surrounding (+/- 300 bp) each 150 bp chromatin particle 
position in the respective genomes of each cell type. Comparison of the average cumulative frequency 
distribution of the peak positions  are shown in   A. iPS and K562,  B. iPS and GM12878, C. NPC and K562, 
D. NPC and GM12878. 
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3.8 Chromatin particles from different size classes in the same cell type 
are largely discrete. 
The chromatin particle size data was divided into three non-overlapping size classes; sub-
nucleosomal particles, nucleosomal particles and super-nucleosomal particles. This was in 
order to detect genomic loci that might be protected by chromatin particles with differing 
structure and /or function, for example transcription factors, transcription factor complexes, 
modified nucleosomes or chromatosomes. However, it was possible that the chromatin 
particle size classes created here might have been artificial and rather than represent discrete 
particles, that they were derived from a common binding protein. This could occur through 
variation in the extent of MNase digestion, generating extended footprints and/or variation in 
positioning across the cell population. Alternatively, these chromatin particles might 
interconvert. As nucleosomes can change their structure in situ through the action of 
chromatin remodelling complexes, it was decided to investigate whether there might be any 
relationship between the positions of chromatin particles in the same cell type but in different 
size classes. Nucleosomes can be post-translationally modified, for example by the exchange 
histone variants. In addition, how tightly the DNA wraps around the nucleosome core can vary 
and in the human genome, the presence or absence of histone H1 associating with the 
nucleosome core can vary (See Chapter 1 section 1.7). All of these changes have the potential 
to affect the amount of DNA protected by chromatin proteins when it is digested with MNase. 
A comparison of the locations of positioned of chromatin particles across different size classes 
within each cell type was determined by comparing the location of the peaks, representing 
well-positioned chromatin particles, obtained using PeakFinder. This was undertaken by 
determining how many chromatin particles in one size class were located in the same genomic 
position as a chromatin particle in each of the other two size classes within a window of +/- 10 
bp Fig 3.9A shows the results of this analysis in iPS cells. 20% of the chromatin particles in the 
sub-nucleosomal (112-137 bp) size class overlap in position with those in the nucleosomal 
(138-161 bp) size class in iPS cells. Similarly, in iPS cells, 24% of the chromatin particles in the 
nucleosomal size class (138-161 bp) overlap in position with those in the super nucleosomal 
(162-188 bp) size class.  In NPC cells 6.6% of the sub-nucleosomal chromatin particles (112-137 
bp) overlap in position with those in the nucleosomal (162-188 bp) chromatin particle size 
class. The result is similar (5.4%) for the overlap of the nucleosomal (162-188 bp) and the 
super nucleosomal (162-188 bp) chromatin particle size class in NPC cells. (Fig3.9 B). These 
data show that the chromatin particles in the three different chromatin particle sub-classes are 
mostly discrete.  
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Fig 3.9 See next page for legend 
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Figure 3.9 Chromatin particles mapped by MNase-seq in the same cell type, exhibit largely discrete 
MNase-resistant DNA size classes 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were given explicit genome positions using the heuristic peak-finding algorithm (PeakFinder). 
The Venn diagram shows the number of particle positions determined for each size class of sequence 
read; i) 122-137 bp (sub- nucleosomal) ii) 138-161 bp (nucleosomal) iii) 162-188 bp (super-nucleosomal)  
and the frequency of the overlap of the positions within +/- 10 bp for each size class for A. iPS and B. 
NPC. 
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It was decided to test this further using a different method. Hence, the chromatin particle data 
for 20,000 randomly selected peak positions in iPS cells were clustered into four groups in the 
nucleosomal chromatin particle size class (Fig 3.10). These groups are shown as heat maps on 
the left side of the panel. For each group, the mean chromatin particle frequency values 
centred at and surrounding the nucleosomal chromatin particle size class positions were 
plotted for both the nucleosomal (138-161 bp) and the super-nucleosomal (162-188 bp) size 
class data. The results are shown in the average cumulative frequency distributions on the 
right-hand side of each panel. The peaks in mean chromatin particle mid-point frequency in 
the nucleosomal (138-161 bp) size class data are accompanied by peaks that occur at a much 
lower frequency in the super-nucleosomal (162-188 bp) size class data. This result suggests 
that MNase protected particles in the nucleosomal size class are not frequently observed as 
super-nucleosomal-size MNase protected particles in the same genomic positions. This 
confirms the observation shown in the Venn diagrams in Fig 3.9. 
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Fig 3.10 see next page for legend 
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Figure 3.10 Chromatin particles mapped in iPS cells by MNase-seq exhibit largely discrete MNase-
resistant DNA size classes. 
20,000 randomly selected peak positions in the nucleosomal (138-161 bp) chromatin particle size class 
in iPS cells described above were clustered into four groups as shown in the left-hand panel. For each 
group, the mean chromatin particle frequency values centred on and surrounding the nucleosomal (138-
161 bp) particle positions were plotted for both nucleosomal (138-161 bp) and the super-nucleosomal 
(162-188 bp) size class data. The graphs are shown on the right-hand side. The peaks in mean chromatin 
particle frequency in the nucleosomal (138-161 bp) size class data are accompanied by peaks that occur 
at a much lower frequency in the super-nucleosomal (162-188 bp) size class data, again suggesting that 
nucleosomal (138-161 bp) MNase protected particles in chromatin are not frequently observed as 
super-nucleosomal (162-188 bp) MNase protected particles in the same genomic positions.  
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A similar analysis was carried out for 20,000 randomly selected peak positions in the 
nucleosomal chromatin particle size class in NPC cells (Fig 3.11). These results show that core 
nucleosomal size MNase protected particles in chromatin are not observed frequently as 
super-nucleosomal-size MNase protected particles in the same genomic positions in NPC cells. 
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Fig 3.11.  See next page for legend  
103 
 
Figure 3.11 Chromatin particles mapped in NPC cells by MNase-seq exhibit largely discrete MNase-
resistant DNA size classes. 
20,000 randomly selected peak positions in the nucleosomal (138-161 bp) chromatin particle size class 
in NPC cells described above were clustered into four groups as shown in the left-hand panel. For each 
group, the mean chromatin particle frequency values centred on and surrounding the nucleosomal (138-
161 bp) particle positions were plotted for both nucleosomal (138-161 bp) and the super-nucleosomal 
(162-188 bp) size class data. The graphs are shown on the right-hand side. The peaks in mean chromatin 
particle frequency in the nucleosomal (138-161 bp) size class data are accompanied by peaks that occur 
at a much lower frequency in the super-nucleosomal (162-188 bp) size class data, again suggesting that 
nucleosomal (138-161 bp) MNase protected particles in chromatin are not frequently observed as 
super-nucleosomal (162-188 bp) MNase protected particles in the same genomic positions.  
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3.9 Defining the relationship between chromatin particles during neural 
cell differentiation. 
Next, the relationship between chromatin particles in the same size class was investigated 
during differentiation from iPS to NPC as an indication of developmental change. The location 
of the peaks, representing well-positioned chromatin particles, obtained using PeakFinder was 
quantified in each of the nucleosomal and super-nucleosomal size classes in iPS and NPC. The 
degree of overlap in the positions of particles during neural development is shown in the Venn 
diagrams Fig 3.12 A (nucleosomal particles, 138-161 bp) and Fig 3.13 A (super-nucleosomal 
particles, 162-188 bp). This shows how many positioned chromatin particles of the same size 
class were in the same position, within a window of +/- 10 bp after differentiation of iPS to 
NPC cells. These data show that 32% of the iPS nucleosomal chromatin particles overlap in 
position with the NPC nucleosomal chromatin particles, whereas 17% of the iPS super-
nucleosomal chromatin particles overlap with the NPC super-nucleosomal chromatin particles.  
The four cluster groups generated in iPS cells in both the nucleosomal chromatin particle size 
class (138-161 bp) and the super-nucleosomal chromatin particle size class (162-188 bp) were 
used to generate the average cumulative frequency distributions shown in Fig 3.12B and Fig 
3.13B respectively, for both iPS and NPC cells. These results show that where a nucleosomal 
chromatin particle is positioned in iPS cells, this tends to remain positioned in NPC cells. 
Similarly, where a positioned super- nucleosomal chromatin particle is positioned in iPS cells, 
this tends to remain positioned in NPC cells. Hence, chromatin particles of the same size class 
tend to occur in the same locations during neural cell differentiation, confirming the results in 
the Venn diagrams in each case.  
These analyses, taken together with the fact that the number of positioned chromatin particles 
increases during differentiation, suggest that during differentiation, most of the additional 
nucleosomes are positioned de novo, i.e. generally they do not occur due to the inter-
conversion of existing particles of another size class. These results suggest that the different 
chromatin particles are discrete entities that are positioned independently from each other 
during differentiation. 
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Figure 3.12 Distribution of nucleosomal chromatin particle positions during neural cell development. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were given explicit genome positions using the heuristic peak-finding algorithm (PeakFinder).  A. 
The Venn diagram shows the number of particle positions determined for the nucleosomal (138-161 bp) 
size class of sequence read in iPS and NPC cells and the frequency of the overlap of the positions in each 
cell type within +/- 10 bp for this size class. B. The mean chromatin particle frequency values centred on 
and surrounding the nucleosomal (138-161 bp) size class particle positions were plotted for the 
nucleosomal (138-161 bp) size class data in iPS and NPC cells and they are shown in the graphs. 
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Fig 3.13 See next page for legend. 
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Figure 3.13 Distribution of super-nucleosomal chromatin particle positions during neural cell 
development. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were given explicit genome positions using the heuristic peak-finding algorithm (PeakFinder).  A. 
The Venn diagram shows the number of particle positions determined for the super-nucleosomal (162-
188 bp) size class of sequence read in iPS and NPC cells and the frequency of the overlap of the positions 
in each cell type within +/- 10 bp for this size class. B. The mean chromatin particle frequency values 
centred on and surrounding the super-nucleosomal (162-188 bp) size class particle positions were 
plotted for the super-nucleosomal (162-188 bp) size class data in iPS and NPC cells and they are shown 
in the graphs. 
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3.10 Discussion. 
In this chapter, high-resolution genome-wide chromatin particle maps were constructed from 
both iPS and NPC cells, from which individual positioned chromatin particles were detected. 
The chromatin particles between approximately 110 bp and 190 bp in size were divided into 
three size classes and it was shown that the frequency of positioned chromatin particles is 
greater in NPC cells than in iPS cells in all of the chromatin particle size classes. This suggests 
that the frequency of positioned chromatin particles in the genome increases during 
development from pluripotent to neural progenitor cells. The eight-fold increase in the 
frequency of chromatin particles that occurs in neural progenitor cells compared with 
pluripotent cells in the chromatin particle size class that represents core nucleosomes (138-
161 bp) is the largest and most notable. Although the vast majority of the fragments in the 
138-161 bp size range will be derived from sequences protected by nucleosomes, for any given 
loci the possibility that protected fragments could be derived from the binding of other 
proteins, whose footprints fall into the nucleosomal size range, cannot be excluded. However, 
this result suggests that it is the core nucleosomes that are the most dynamic of the chromatin 
particles analysed here. 
Hence, in pluripotent cells few of the nucleosomes are positioned and then, during 
differentiation to NPC cells, chromatin is re-organised, resulting in positioning of nucleosomes 
(Fig 3.14). This global increase in the number of positioned nucleosomes in differentiated cells 
compared with pluripotent cells is in agreement with West et al  (West, Cook et al. 2014) who 
have shown in both mouse and human cells that nucleosome occupancy increases during 
differentiation from iPS to fibroblast cells. This is also illustrated in this study (Table 3.2) by 
comparison of the number of positioned nucleosomes in iPS cells with the number detected in 
the published  K562 and GM12878 chromatin maps (Kundaje, Kyriazopoulou-Panagiotopoulou 
et al. 2012). Patterns of organised nucleosomes have been implicated in gene regulation both 
in yeast (Jiang and Pugh 2009) and more recently in the  human genome Schones et al 
(Schones, Cui et al. 2008). The high frequency of positioned nucleosomes in NPC cells that we 
detect, indicative of more organised chromatin, suggests a high degree of genome regulation 
in these cells.  
Mapping the locations of changes in patterns of nucleosome positioning to regulatory regions 
of the genome is important in determining the role of nucleosome positioning in the 
mechanisms of regulation of neural cell development. As there is evidence that nucleosomes 
might limit the access of polymerases to genes (Lorch, LaPointe et al. 1987) and deletion of 
histone proteins can affect gene expression (Han and Grunstein 1988), the work in the rest of 
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this thesis focusses on nucleosome positioning at transcriptional regulatory regions in the 
human genome. To date, much of the work to date in many different eukaryotic organisms 
(see Chapter 1, section 1.14) has focussed on nucleosome positioning at transcriptional start 
sites (TSS) and at transcription factor binding sites, therefore the work in the next chapter 
investigated nucleosome positioning at TSS and at the binding sites  of transcription factors 
relevant to neural cell differentiation 
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Figure 3.14 Summary of nucleosome positioning during human neural cell development. 
Discrete chromatin particles of different size classes can be detected in both iPS and NPC, represented 
as sub-nucleosomes (112-137 bp), nucleosomes (138-161 bp) and super-nucleosomes (162-188 bp). 
Chromatin particles that are not strongly positioned exist in all three size classes in both the iPS and NPC 
genomes; they are represented by ‘fuzzy’ nucleosomes in the diagram. During neural cell development, 
the number of positioned chromatin particles increases in all chromatin particle size classes, but most 
notably in the nucleosomal chromatin particle size class. 
 
  
112 
 
 
Chapter 4 : Nucleosome positioning at TSS and selected 
transcription factor binding sites during neural cell 
differentiation. 
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4.1 Introduction 
Patterns of nucleosome positioning at TSS appear to be mainly conserved across the 
eukaryotes. Patterns of nucleosome positioning at transcriptional start sites have been well 
characterised in a variety of eukaryotic organisms from yeast to man. Many of these studies 
have examined the correlation between the patterns of nucleosome positioning at TSS and 
gene expression. This has led to the idea that the positioning of the +1 and +2 nucleosomes in 
gene promoters is important in the regulation of gene expression (Lorch, LaPointe et al. 1987; 
Boeger, Griesenbeck et al. 2003; Henikoff 2008). However, this is not as simple as it first 
appeared. Zaugg et al showed that  patterns of nucleosome positioning at TSS in S. cerevisiae 
can vary and that there is a group of highly expressed S. cerevisiae genes that do not have a 
strongly positioned +1 nucleosome (Zaugg and Luscombe 2012). They suggested that the 
patterns of +1 and -1 nucleosome positioning can be grouped into four categories, reflecting 
different expression states, determining whether a gene is ‘on’ or ‘off’, rather than using the 
expression level of a gene. In S. pombe it has been shown that the presence of a -1 
nucleosome negatively correlates with gene expression (Moyle-Heyrman, Zaichuk et al. 2013). 
Studies of genome-wide patterns of nucleosome positioning in human cells have shown that 
the human genome appears to have a higher density of nucleosomes at regulatory regions. 
This may generate cell-type specific chromatin structure, specifying cellular differentiation 
(Schones, Cui et al. 2008; Tillo, Kaplan et al. 2010). These studies have shown that human 
nucleosomes tend to be positioned around the TSS of expressed genes, whereas unexpressed 
genes have a +1 nucleosome, but no other positioned nucleosomes near the TSS. In addition, 
West et al have shown that changes in the positions of nucleosomes in the human genome 
tend to be single changes, often at transcription factor binding sites and enhancers (West, 
Cook et al. 2014). It has been shown that the average pattern of nucleosome positioning for all 
TSS is not a strong one. This is most likely because the patterns of nucleosome positioning at 
human TSS are variable; there is not a canonical pattern. By clustering the patterns of 
positioned nucleosomes at TSS in human K562 cells, Kundaje et al have shown that variable 
positioning patterns exist. In addition, 20% the TSS had high gene expression levels that 
correlated with a strongly positioned -1 nucleosome, but not a strongly positioned +1 
nucleosome  (Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012). 
 
The aim of this chapter was to determine whether there are patterns of chromatin particle 
positioning at transcription regulatory sites in the genome and whether they change during 
neural cell differentiation. This would indicate which genes might be targeted for regulation 
during early neural development. 
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4.1 Sub-nucleosomal particles are positioned upstream of protein -
coding gene TSS in iPS and NPC 
In order to determine whether there is a canonical pattern of chromatin particle positioning at 
TSS in iPS cells and NPC and whether there is a general change in any pattern at TSS during 
neural cell development, the positions of all known human protein coding TSS (n=67,047) were 
extracted from the Gencode annotation file. Fig 4.1 shows the average cumulative frequency 
distribution of MNase protected DNA species for all three chromatin particle size classes; sub-
nucleosomal, nucleosomal  and  super-nucleosomal at and surrounding the TSS of all known 
human protein coding genes. This result shows that, on average, a canonical chromatin 
particle positioning pattern cannot be detected in the nucleosomal and super-nucleosomal 
chromatin particle size classes in iPS cells or in NPC. However, a peak in the frequency 
distribution of MNase protected DNA species in the sub-nucleosomal chromatin particle size 
class approximately 60 bp upstream of the TSS in both cell types was detected. 
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Average cumulative frequency distributions of chromatin particle size classes A. 112-137 bp (sub-
nucleosomal), B. 138-161 bp (nucleosomal) and C. 162-188 bp (super-nucleosomal) show the chromatin 
structure at and surrounding (+/-600 bp) of known protein coding TSS in both iPS and NPC cells 
(n=67,047). 
 
Figure 4.1 Chromatin structure at known protein coding TSS in iPS and NPC cells 
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4.2 Detection of changes in chromatin structure at transcriptional start 
sites during neural cell differentiation. 
To detect changes in chromatin particle positioning at TSS during neural cell differentiation,  
the number and location of peaks in the frequency distribution of MNase protected DNA 
species representing positioned chromatin particles from all three chromatin particle size 
classes was investigated. In chapter 3 the PeakFinder tool was used to locate the positions of 
all of the strongly positioned chromatin particles in all three chromatin particle size classes; 
sub-nucleosomal, nucleosomal and super-nucleosomal. These data were used together with 
the positions from a non-redundant list of all full length  human TSS (n=84,142) to determine 
the number and location of peaks present within 300 bp upstream or downstream of a 
transcriptional start site (TSS) in one cell type or in common between iPS and NPC cells. The 
results of this analysis are shown in the Venn diagrams in Fig 4.2.  
These results suggest firstly, that in all three chromatin particle size classes, there are more 
positioned chromatin particles at TSS in NPC cells than in iPS cells. This is not particularly 
surprising, as the magnitude of the increase in positioned chromatin particles at TSS is broadly 
in line with the overall increase in number of positioned particles that occurs in the whole 
genome during neural cell differentiation. Secondly, these results show that a) in the sub-
nucleosomal chromatin particle size class 49% of the TSS with peaks in iPS cells overlap with 
those in NPC, b) in the nucleosomal chromatin particle size class 55% of the TSS with peaks in 
the nucleosomal chromatin size class iPS overlap with those in NPC and c) in the super-
nucleosomal chromatin particle size class, 38% of TSS with peaks in iPS overlap with those in 
NPC. 
Taken together, these results suggest that nucleosomes can be positioned both upstream and 
downstream of a TSS in both cell types, but the number of positioned nucleosomes within 300 
bp of a TSS increases during neural cell development. In addition, of the genes with chromatin 
structure within 300 bp of a TSS in pluripotent cells, approximately 50% are specific to these 
cells.  
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Fig 4.2 for legend see next page. 
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Figure 4.2 Nucleosome positioning at transcriptional start sites (TSS) in iPS and NPC cells. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were given explicit genome positions using the heuristic peak-finding algorithm (PeakFinder). 
Venn diagrams show the numbers of TSS that have at least one positioned chromatin particle within + 
300 bp “upstream” (A, C and E) and -300 bp, “downstream” (B, D and F) from a non-redundant list of all 
human TSS (n=84,142) exclusively in one cell type and in common between iPS and NPC cells in all three 
chromatin particle size classes: sub-nucleosomal (112-137 bp), nucleosomal (138-161 bp) and super-
nucleosomal (162-188 bp). At the bottom of each panel the “total” figure represents  the total number 
of positioned chromatin particles (+/-300 bp from a TSS) exclusively in one cell type and in common 
between iPS and NPC cells for each chromatin particle size class. 
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4.3 Detection of changes in chromatin particle positioning at individual 
genes during neural cell differentiation. 
As the results from in earlier work in this chapter suggested that the nucleosomal chromatin 
particle size class is the most dynamic during neural cell development, it was decided to 
examine the patterns of chromatin particle positioning in the nucleosomal chromatin particle 
size class at individual genes. This would validate whether it was possible to detect loss and 
gain of individual nucleosomal chromatin particles at TSS during early neural development.  
The paired-read midpoint position frequency data at and surrounding the TSS of individual 
genes at which loss and gain of nucleosomal chromatin particles nucleosomes was detected 
were visualised using the IGB.  Then data was extracted from the .sgr files containing the 
paired-read midpoint position frequency data in 10 bp bins, at and surrounding representative 
TSS and plotted as histograms for all three chromatin particle size classes in both iPS and NPC 
cells. 
Fig 4.3 and Fig 4.4 shows examples of individual genes where there is a positioned 
nucleosomal chromatin particle at a TSS in iPS cells, but not in NPC cells. Fig 4.3 shows a 
section of NANOG gene, in which there is a peak representing a positioned nucleosomal 
chromatin particle near the TSS that is present only in iPS cells. Interestingly, this peak overlaps 
with a positioned sub-nucleosomal chromatin particle in iPS cells, but it is not seen in the sup-
nucleosomal particles. This suggests that the predominant peak at the NANOG TSS in iPS cells 
is smaller than the size of a human super-nucleosome.  NANOG is a transcriptional regulator 
whose expression is involved in the maintenance of pluripotency (Boyer, Lee et al. 2005) and it 
is expressed in iPS but not in NPC cells. A positioned nucleosome was detected just upstream (-
1) of the NANOG gene in iPS cells that is completely absent in NPC cells. The location of the 
nucleosome detected in iPS cells is in an important regulatory region of the NANOG gene that 
may be involved in expression of alternative NANOG transcripts (Das, Jena et al. 2011).This 
result is consistent with the idea that a nucleosome positioned in the promoter of the NANOG 
gene is necessary for the expression of NANOG in pluripotent cells. 
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Fig 4.3 see next page for legend 
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Figure 4.3 Positioned Chromatin particles are detected upstream of the TSS in the NANOG gene in iPS 
cells. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were detected at and surrounding TSS using the heuristic peak-finding algorithm (PeakFinder). 
Histograms were plotted of counts of paired-read midpoint positions in 10 bp bins from a section of 
chromosome 12 for all three chromatin particle size classes:  sub-nucleosomal (112-137 bp), 
nucleosomal (138-161 bp) and super-nucleosomal (162-188 bp) for both iPS and NPC cells.  A strongly 
positioned chromatin particle is visible just upstream of the NANOG gene TSS exclusively in iPS cells (*), 
in the sub-nucleosomal and nucleosomal chromatin particle size classes. A map of the 6,661  bp NANOG 
gene is depicted at the bottom of the panel. Exons are represented by filled black boxes and the 
direction of transcription by a black arrow head. The position of the TSS is represented by a black 
vertical line. 
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Fig 4.4 shows a section of ELF3 gene, in which there is a peak representing a positioned 
nucleosomal chromatin particle at the TSS that is present only in iPS cells. Interestingly, this 
peak overlaps with both a positioned sub-nucleosomal chromatin particle and a positioned 
super-nucleosomal chromatin particle in iPS cells, but it is not seen in any of the three 
chromatin particle size classes in NPC. ELF3 is a member of the ETS transcription factors that is 
thought to be expressed specifically in epithelial tissues but is also thought to play a role in 
early development (Oliver, Kushwah et al. 2012). This protein seems to have many and various 
roles including repressing androgen receptor activity (Shatnawi, Norris et al. 2014), but no 
specific role in neural development. Hence it would not be expected that this gene would be 
expressed in NPC cells and the lack of chromatin structure near the TSS of this gene in NPC 
cells may reflect this.  
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Fig 4.4 See next page for legend 
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Figure 4.4 Positioned Chromatin particles are detected at the TSS in the ELF3 gene in iPS cells. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were detected at and surrounding TSS using the heuristic peak-finding algorithm (PeakFinder). 
Histograms were plotted of counts of paired-read midpoint positions in 10 bp bins from a section of 
chromosome 1 for all three chromatin particle size classes:  sub-nucleosomal (112-137 bp), nucleosomal 
(138-161 bp) and super-nucleosomal (162-188 bp) for both iPS and NPC cells.  A strongly positioned 
chromatin particle is visible at the TSS of the short form of the ELF3 gene TSS in iPS cells (*), but not in 
NPC cells, in all three chromatin particle size classes. A map of the 6,670  bp ELF3 gene is depicted at the 
bottom of the panel. Exons are represented by filled black boxes and the direction of transcription by a 
black arrow head. The position of the TSS is represented by a black vertical line. 
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A section of the GRIA1 (GluR-1) and NEGR1 genes are shown in Fig 4.5 and Fig 4.6 respectively. 
In both genes there is a nucleosomal chromatin particle positioned downstream of the TSS (+1 
nucleosome), only in NPC cells. In the case of the NEGR1 gene, there is a small peak in the 
super-nucleosomal chromatin particle size class in the same place. However, for both of these 
genes there is a dominant peak in the nucleosomal chromatin particle size class only in NPC. 
The GRIA1 gene encodes an AMPA receptor subunit. These glutamate receptors are receptors 
for neurotransmitters in the brain. NEGR1 (neuronal growth regulator 1) is a neural growth 
promoting factor that is involved in dendrite growth (Pischedda, Szczurkowska et al. 2014). 
The NPC-specific chromatin structure detected here may be important in the neural-specific 
regulation of these genes. 
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Fig 4.5 See next page for legend. 
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Figure  4.5 Positioned Chromatin particles are detected at the TSS in the GRIA1 gene in NPC cells. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were detected at and surrounding TSS using the heuristic peak-finding algorithm (PeakFinder). 
Histograms were plotted of counts of paired-read midpoint positions in 10 bp bins from a section of 
chromosome 5 for all three chromatin particle size classes:  sub-nucleosomal (112-137 bp), nucleosomal 
(138-161 bp) and super-nucleosomal (162-188 bp) for both iPS and NPC cells.  A strongly positioned 
chromatin particle is visible downstream of the TSS of the GRIA1 gene TSS in NPC cells (*), but not in iPS 
cells, in the nucleosomal chromatin particle size class. A map of the 323 kb GRIA1 gene is depicted at the 
bottom of the panel. Exons are represented by filled black boxes and the direction of transcription by a 
black arrow head. The position of the TSS is represented by a black vertical line. 
 
 
 
 
 
 
 
 
 
 
 
 
128 
 
 
 
Fig 4.6 See next page for legend. 
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Figure 4.6 Positioned Chromatin particles are detected at the TSS in the NEGR1 gene in NPC cells. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were detected at and surrounding TSS using the heuristic peak-finding algorithm (PeakFinder). 
Histograms were plotted of counts of paired-read midpoint positions in 10 bp bins from a section of 
chromosome 1 for all three chromatin particle size classes:  sub-nucleosomal (112-137 bp), nucleosomal 
(138-161 bp) and super-nucleosomal (162-188 bp) for both iPS and NPC cells.  A strongly positioned 
chromatin particle is visible upstream of the TSS of the NEGR1 gene TSS in NPC cells (*), but not in iPS 
cells, in the nucleosomal chromatin particle size class. A map of the 879 kb NEGR1 gene is depicted at 
the bottom of the panel. Exons are represented by filled black boxes and the direction of transcription 
by a black arrow head. The position of the TSS is represented by a black vertical line. 
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Fig 4.7 shows a section of the PSMD4 gene. In this case the chromatin particle positioning in all 
three size classes is very similar in both cell types. Peaks in the paired-read midpoint position 
frequency in both the nucleosomal and super-nucleosomal chromatin particle size classes 
occur at the TSS of the PSMD4 gene in both cell types. However, sub-nucleosomal chromatin 
particles are not positioned at the TSS of this gene in either cell type. 
Fig 4.8 shows a section of the PIK3R2 gene. At and surrounding the PIK3R2 TSS, the patterns of 
chromatin particle positioning are similar in each chromatin particle size class in both iPS cells 
and NPC.  
In both cases, the pattern of chromatin particle positioning at and surrounding the TSS in these 
two genes does not change during differentiation from iPS to NPC.  PSMD4 is a 26S 
proteasome regulatory subunit and PIK3R2 (PI3-kinase regulatory subunit beta) is involved 
many cellular functions such as cell growth, proliferation, differentiation, and glucose 
metabolism. Since these two proteins are involved in general cellular function, it might be 
expected that they are expressed in both of the cell types analysed here. 
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Fig 4.7 See next page for legend. 
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Figure 4.7 Chromatin particles positioning patterns are similar in all chromatin particle size classes in 
both cell types at the TSS of the PSMD4 gene 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were detected at and surrounding TSS using the heuristic peak-finding algorithm (PeakFinder). 
Histograms were plotted of counts of paired-read midpoint positions in 10 bp bins from a section of 
chromosome 1 for all three chromatin particle size classes:  sub-nucleosomal (112-137 bp), nucleosomal 
(138-161 bp) and super-nucleosomal (162-188 bp) for both iPS and NPC cells.  Chromatin particle 
positioning is visible at the TSS of the PSMD4 gene TSS in both iPS cells and NPC cells. A map of the 12 kb 
PSMD4 gene is depicted at the bottom of the panel. Exons are represented by filled black boxes and the 
direction of transcription by a black arrow head. The position of the TSS is represented by a black 
vertical line. 
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Fig 4.8 See next page for legend. 
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Figure 4.8 Chromatin particles positioning patterns are similar in all chromatin particle size classes in 
both cell types at the TSS of the PIK3R2 gene. 
Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence read mid-
points, were detected at and surrounding TSS using the heuristic peak-finding algorithm (PeakFinder). 
Histograms were plotted of counts of paired-read midpoint positions in 10 bp bins from a section of 
chromosome 19 for all three chromatin particle size classes:  sub-nucleosomal (112-137 bp), 
nucleosomal (138-161 bp) and super-nucleosomal (162-188 bp) for both iPS and NPC cells. Similar 
patterns of chromatin particle positioning are visible surrounding the TSS of the PIK3R2 gene within 
each chromatin particle size class in both iPS cells and NPC cells. A map of the 17 kb PIK3R2 gene is 
depicted at the bottom of the panel. Exons are represented by filled black boxes and the direction of 
transcription by a black arrow head. The position of the TSS is represented by a black vertical line. 
  
135 
 
4.5 Patterns of chromatin particle positioning at individual loci correlate 
with gene expression. 
Wu et al have examined changes in gene expression during human neural cell development 
using RNA-seq (Wu, Habegger et al. 2010). Wu et al used hESC cells and hESC cells 
differentiated to three stages of differentiation; N1 (early initiation), N2 (neural progenitor), 
and N3 (early glial-like). The data presented in thesis was generated from hiPSC cells and hiPSC 
cells differentiated to NPC. The method of generating NPC cells in both cases was by embryoid 
body formation, therefore the hESC and hESC developed to N2 cells are similar to the cells 
used in the work of this thesis. The expression level of the six genes whose chromatin structure 
at TSS was examined in section 4.3 was determined from the data published by Wu et al and 
the results are shown in Table 4.1. Expression of the NANOG and ELF3 genes is high in hESC 
cells and decreases in hESC-N2 cells. This correlates with the loss of the positioned nucleosome 
at the TSS of these genes during differentiation from iPS to NPC in this study. Similarly, 
expression of the GRIA1 and NEGR1 genes is high in hESC-N2 cells and decreases in hESC cells. 
This correlates with the gain of the positioned nucleosome at the TSS of these genes during 
differentiation from iPS to NPC in this study. In the case of the PSMD4 and PIK3R2 genes, there 
is little change (approximately 2 fold) in gene expression during differentiation from hESC cells 
to hESC-N2, nor any change in chromatin particle positioning during differentiation from iPS to 
NPC. 
These results suggest that in the case of the six genes shown here, patterns of chromatin 
particle positioning may correlate with gene expression in iPS and NPC. This suggests that loss 
and gain of positioned chromatin particles at TSS are important in gene regulation and that 
this regulation may influence the progression from pluripotent iPS cells to neural progenitor 
cells.  
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
Gene 
symbol 
Fold change gene 
expression.  
N2-A/hESC 
 
Direction of 
change in gene 
expression 
hESC to N2-A 
Positioned 
nucleosome 
at TSS in iPS cells 
Positioned 
nucleosome 
at TSS in NPC  
cells 
NANOG 0.0009 down   
ELF3 0.0358 down   
GRIA1 265.2 up   
NEGR1 12.625 up   
PSMD4 0.416 down   
PIK3R2 1.973 up - - 
 
Table 4.1 Correlation of cell type specific chromatin particle positioning in iPS and NPC cells with gene 
expression data derived from hESC and N2-A cells.  
Six representative TSS were visualised using the IGB to determine their chromatin structure in iPS and 
NPC (shown in Figs 4.3-4.8). The presence (tick), absence (cross) of a positioned chromatin particle 
within 300 bp of the TSS is indicated. The absence of any strong chromatin particle positioning within 
300 bp of the TSS is indicated by a dash. Gene expression data was taken from data published by Wu et 
al and it is shown as the ratio of the expression values for hESC and N2-A cells (Wu, Habegger et al. 
2010).  
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4.6 Chromatin structure at transcription factor binding sites. 
In addition to investigating changes in chromatin particle positioning at transcriptional start 
sites, changes in chromatin particle positioning at transcription factor binding sites was 
investigated. The genome-wide binding positions for a select group of transcription factors 
which are involved in either in chromatin remodelling or neural development were 
determined. These were, ATF2, YY1 and PAX6 (See chapter1, section 1.18). Fig 4.9 shows the 
average cumulative frequency distributions for all three chromatin particle size classes at and 
surrounding the ATF2, YY1 and PAX6 binding sites. Positioned chromatin particles were not 
detected at or surrounding any of these transcription factor binding sites. In addition, a change 
in chromatin structure during differentiation from iPS to NPC cells was not detected. It seems 
surprising that there are no changes in chromatin structure surrounding these sites during 
differentiation, since all of these transcription factors are thought to have functions related to 
chromatin remodelling or neural development. In the case of YY1, positioned nucleosomes 
have been shown to exist at YY1 sites in GM12878 at sites located distally to annotated 
transcripts (Wang, Zhuang et al. 2012). It is possible that only a specific subset of these 
transcription factor binding positions are utilised at this stage in differentiation and if the 
nucleosomes  were offset in position, then the results would be masked by averaging the 
chromatin structure across all sites. This could be resolved by clustering the data into subsets 
of sites according to the chromatin structure surrounding the sites. Work by Kundaje et al 
(Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012) showed recently, that in K562 cells at 
EGR1 sites, no particular pattern of chromatin structure was detected in an aggregation plot, 
but when the data was clustered, a specific patterns of nucleosome positioning were detected 
at small subsets of sites. However, in the work presented here, there are no gross global 
changes in chromatin structure occurring at these transcription factor binding positions during 
differentiation from iPS to NPC cells.  
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Figure 4.9 Nucleosomes are not positioned at or surrounding several transcription factor binding sites 
that are involved in remodelling or neural development. 
Average cumulative frequency distributions at and surrounding transcription factor binding sites (+/- 
600 bp) for all three chromatin particle size classes: 112-137 bp (sub-nucleosomal), 138-161 bp 
(nucleosomal) and 162-188 bp (super-nucleosomal) at   A. ATF2 (n=9,881), B.YY1(n=39,945)  and C. PAX6 
(n=1,432) binding sites.  
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Discussion. 
In this chapter, unbiased searching has revealed a spectrum of examples of cell-type-specific 
nucleosome positioning at and surrounding TSS. Nucleosome positioning surrounding TSS at 
the level of individual genes has shown that loss and gain of individual nucleosomes between 
the two cell types, iPS and NPC, can be detected. In addition, specific patterns of chromatin 
structure at the TSS of genes associated with pluripotency (NANOG) and neural-specific genes 
(GRIA1 and NEGR1) have been shown.  This variation in chromatin structure at TSS may be 
important in gene regulation during the progression from pluripotent to neural progenitor 
cells.  
In this chapter it was shown that 1.3% of the positioned nucleosomes in the NPC genome are 
positioned in close proximity to transcriptional start sites, therefore a large proportion of the 
nucleosomes in the human genome are positioned in locations other than at TSS, for example 
at transcription factor binding sites, enhancers and insulator binding sites.  
An initial study of a selected set of transcription factor binding sites that are involved either in 
chromatin remodelling or neural development, where it might be expected that chromatin 
structure would change during neural cell differentiation, showed that there was little change 
in chromatin structure at these regulatory sites during differentiation from iPS to NPC cells. 
This suggested that changes in chromatin structure do not influence the activity of these 
factors during neural cell development. However, it has been shown that positioned 
nucleosomes exist at RE1/NRSF binding sites in the human genome in CD4+ cells (Valouev, 
Johnson et al. 2011). REST is involved in the regulation of neurogenesis by repressing neuronal 
gene expression in non-neuronal cells (Wu and Xie 2006) (Johnson, Teh et al. 2008) (Jorgensen, 
Terry et al. 2009), acting through binding to RE1 elements and then recruiting  co-repressors 
(Ballas, Grunseich et al. 2005). Therefore, the work in the next chapter examines whether 
there are changes in the positions of chromatin particles during differentiation from iPS to NPC 
cells at RE1/NRSF binding sites. 
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Chapter 5 : Chromatin structure at REST binding motifs during 
neural cell differentiation 
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5.1 Introduction  
It has been shown that nucleosomes are positioned at and surrounding RE1 sites, where REST 
binds, in human lymphoblastoid cells (Valouev, Johnson et al. 2011) and recently in K562 and 
GM12858 cells (Nie, Cheng et al. 2014).  However, changes in nucleosome positioning during 
neural cell development in human cells has not been investigated previously. The work in this 
chapter investigated whether it was possible to detect changes in i) MNase-protected species 
at RE1 sites, ii) chromatin structure flanking  RE1 sites and iii) whether it was possible, through 
the analysis of changes in chromatin structure, to identify genes that are targeted by REST 
during neural cell development.  
Putative mammalian targets of REST, initially defined by the presence of a REST binding motif, 
and more recently defined using  ChIP-seq data,  have been tested by using gene targeting and 
RNA interference  experiments to alter the expression of REST and measure any resulting 
changes in the  transcriptional activity of these putative target genes (Sun, Cooper et al. 2008; 
Bruce, Lopez-Contreras et al. 2009 ). REST target genes have been defined from studies in 
mouse, rat and human cells. Much of the early work was done in mouse cells but recently 
studies have been done in human cells (Rockowitz, Lien et al. 2014). A comparison of the REST 
target genes in mouse and human ES cells suggests that there are  twice as many REST targets 
in human than mouse but that there is conservation of REST binding at a core, but not all, REST 
target genes (Rockowitz and Zheng 2015). 
REST was reviewed in Chapter 1 section 1.18.5 and its role as a transcriptional repressor of 
neural genes in non-neuronal cells is summarised in Fig 5.1. 
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Figure 5.1 REST is a transcriptional repressor of neural genes in non-neuronal cells 
REST mediates epigenetic change through the removal of ‘activatory’ chromatin marks and the addition 
of ‘repressive ‘chromatin marks. REST binds to RE1 elements and recruits co-repressors that have 
chromatin remodelling activity.  BRG1, an ATP-dependent chromatin remodeller, recognises acetylated 
H4K8, leading to an increase in REST recruitment to RE1 sites. REST recruits the co-repressor complexes 
CoREST and mSin3, both of which contain the histone deacetylases HDAC1 and HDAC2. After H3K9 
deacetylation, the H3K9 methytransferase EHMT2 (G9a) methylates H3K9, repressing transcription.  
LSD1, also a member of the CoREST complex, removes the mono and di-methylation chromatin marks 
that are associated with gene activation from H3K4. 
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5.2 Derivation of REST binding motifs  
Traditionally the sequences of transcription factor binding motifs have been determined by 
using DNase foot-printing, Electrophoretic Mobility Shift Assay (EMSA) or reporter construct 
assays at individual genes. From this information, consensus binding sequences were derived 
and then, as whole genome sequences became known, the locations of these sequences 
across whole genomes were derived computationally. More accurate methods of deriving 
motifs utilise a position weight matrix (PWM), or position-specific scoring matrix (PSSM), using 
an algorithm that constructs a matrix of weights that can distinguish between true binding 
sites and other non-functional sites with similar sequences (Stormo, Schneider et al. 1982). 
However, it has become clear that not all computationally predicted binding locations are 
necessarily real binding sites or they may not be utilised in all cell types. Recently,  large-scale 
studies of the genome-wide binding of transcription factors using ChIP-chip (Ren, Robert et al. 
2000) and more recently, ChIP-seq (Johnson, Mortazavi et al. 2007)  were undertaken in many 
different cell types to gain more accurate transcription factor binding site information 
(Gerstein, Kundaje et al. 2012). This information, combined with consensus binding sequences 
or position-specific scoring matrix information can be used to derive accurate, cell type specific 
locations of transcription factor binding motifs. 
 
In this study, a set of positions in the genome where REST binds to DNA were derived by 
matching the 17 bp  consensus binding motif NTYAGMTCCNNRGMSAG (Bruce, Donaldson et 
al. 2004) from the hg19 human genome autosomal .fasta files, with transcription factor 
binding ChiP-seq data from the ENCODE project (Gerstein, Kundaje et al. 2012). These Chip-seq 
data were derived from multiple cell lines (See Chapter 2 section 2.5.2). This provided a set of 
precise co-ordinates at the centre of each consensus NRSF/RE1 binding sequence at which it 
has been shown by ChiP-seq that REST binds in multiple cell types. The derived set of 871 REST 
binding elements used in this thesis herein are referred to as RE1 sites.  
5.3 Detection of sub-nucleosomal particles at RE1 sites in iPS cells. 
Genome-wide, cell-type specific changes in patterns of chromatin structure surrounding RE1 
sites during neural cell development were analysed. The average cumulative frequency 
distributions of all three chromatin particle size classes (sub-nucleosomal, nucleosomal and 
super-nucleosomal) derived in this study were plotted at and surrounding RE1 sites. Fig 5.2A 
shows the average cumulative frequency distribution of the sub-nucleosomal (112-137 bp) 
chromatin particle size class at and surrounding RE1 sites. This analysis shows that there is a 
large peak in the frequency of these chromatin particles centred on the RE1 site in iPS cells. 
This peak is absent in NPC cells. 
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 It has been shown in mouse ES cells that REST protein levels are high in ES cells and then 
decrease during the early stages of neuronal differentiation (Ballas, Grunseich et al. 2005; 
Singh, Kagalwala et al. 2008). This downregulation of REST may be mediated through 
degradation of REST through the ubiquitination pathway (Huang, Wu et al. 2011). Hence, the 
DNA binding protein detected at RE1 sites in induced human pluripotent cells in this study has 
the characteristics of REST or the REST complex.    
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Figure 5.2 Chromatin remodelling occurs at RE1 sites during differentiation from pluripotent to 
neuronal precursor cells. 
Normalised  average cumulative frequency distributions of chromatin particle size classes A. 112-137 bp 
(sub-nucleosomes), B. 138-161 bp (representing nucleosomes) and C. 162-188 bp (super-nucleosomes)  
show the chromatin structure at and surrounding (+/-2000 bp) RE1 elements in both iPS and NPC cells 
(n=871). 
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5.4 Nucleosomes are positioned surrounding RE1 sites in both iPS and 
NPC cells. 
Next, the average cumulative frequency distribution of nucleosomal (138-161 bp) and super- 
nucleosomal (162-188 bp) chromatin particle size classes at and surrounding RE1 sites was 
determined. The chromatin particle frequency distributions shown in Fig 5.2 B and C show that 
there are six distinct peaks on either side of the RE1 site in both cell types. This suggests that 
an array of six positioned nucleosomes flanks the RE1 site in both iPS and NPC cells. 
A peak in the frequency of super-nucleosomal chromatin particles at the RE1 site itself was not 
detected in either cell type. However, a small peak, representing a high frequency of 
chromatin particles in the nucleosomal size class (138-161 bp) was found centred on the RE1 
site in iPS cells. This peak is smaller than that shown at the RE1 site in the sub-nucleosomal 
(112-137 bp) chromatin particle size class, hence, the dominant peak at the RE1 site, likely 
representing the REST complex in pluripotent cells, is in the sub-nucleosomal size class. 
It might be expected that REST binds to the RE1 site, recruits its co-repressors which have 
chromatin re-modelling activity and then nucleosomes become organised surrounding the RE1 
site as a result of REST binding. These results are in agreement with this possibility in iPS cells. 
However, this result shows that nucleosomes remain positioned at RE1 sites during 
differentiation from iPS to NPC cells when the peak in the sub-nucleosomal (112-137 bp) 
chromatin particle size class is absent in NPC cells. This suggests that nucleosomes can remain 
positioned at RE1 sites in the absence of the sub-nucleosomal chromatin particle positioned at 
RE1 sites in NPC cells. 
In order to validate the chromatin structure surrounding RE1 sites shown in this study, the 
chromatin structure surrounding RE1 sites in both K562 and GM12878 cells was investigated 
using the nucleosome maps derived by Kundaje et al (Kundaje, Kyriazopoulou-
Panagiotopoulou et al. 2012) that were re-processed for comparison purposes. The core 
nucleosome data (138-161 bp) from iPS and NPC cells in this study is most comparable with 
the published K562 and GM12878 nucleosome maps since, in these published maps, the 
predominant fragment length is the size of a mono-nucleosome. 
Comparisons of the average cumulative frequency distributions of the (138-161 bp) chromatin 
particle size class in iPS versus K562 cells and iPS versus GM12978 cells are shown in Fig 5.3 A 
and C respectively.  These results show that a similar number of positioned nucleosomes 
(approximately 6)  flank the RE1 site in all three genomes, but the peak that is centred on the 
RE1 site in iPS cells, which is likely to be the REST complex, is absent in both  K562 and 
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GM12978 cells. A comparison of the average cumulative frequency distributions of the 
nucleosomal (138-161 bp) chromatin particle size class in NPC versus K562 cells and NPC 
versus GM12978 cells is shown in Fig 5.3 B and D. These results show that a similar number 
(approximately 6) of positioned nucleosomes flank the RE1 site in all three genomes.  
Taken together, the comparison of the analysis of patterns of chromatin particle positioning in 
NPC cells shown here and the results of the analysis of published chromatin maps from two 
other cell types, these results suggest that positioned nucleosomes flank RE1 sites in 
differentiated cells, independently of the presence of the sub-nucleosomal chromatin particle 
positioned at the RE1 site.  
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Figure 5.3 The pattern of positioned nucleosomes flanking RE1 sites is similar in several differentiated 
cell types. 
Comparison of the positions of chromatin particles at and surrounding the RE1 site in the nucleosomal 
(138-161  bp) chromatin particle size range mapped in iPS and NPC cells by MNase-seq with those 
mapped in K562 and GM12878 cells. The data from the nucleosome maps generated for the K562 and 
GM12878 cell lines (Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012) was converted from bedgraph 
to sgr format and the data was re-binned into 10 bp bins, calculating a 3bin moving average. The K562 
and GM12878 maps were constructed by sequencing DNA purified from chromatin in the mono-
nucleosome (approx. 150 bp) size range after MNase digestion. These data were compared with the iPS 
and NPC chromatin particle maps generated in the 138-161 bp size range since this is most similar to the 
size range of the chromatin particles in the K562 and GM12878 maps. An average cumulative frequency 
distribution of the chromatin particle distribution at and surrounding (+/- 2000 bp) each RE1 site was 
constructed and a  comparison of the average cumulative frequency distribution of the chromatin 
particle distribution are shown in   A. iPS and K562,  B. NPC and K562, C. iPS and GM12878, D. NPC and 
GM12878. 
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5.5 A subset of RE1 sites are flanked by strongly positioned nucleosomes. 
The average cumulative frequency distributions of chromatin particles at and surrounding a set 
of genomic feature positions represent an average chromatin structure at and surrounding the 
chosen genomic feature positions.  Hence, it is possible that the pattern of chromatin particle 
positioning observed in Fig 5.2 was derived from a subset of RE1 sites.  
In order to investigate the patterns of positioned chromatin particles in the nucleosomal 
chromatin particle size class in iPS cells further, the chromatin particle data in this size class 
surrounding RE1 sites within a window of +/-300 bp was clustered into eight groups. Cluster 
analysis of these data was undertaken as described previously. For each cluster, the pattern of 
chromatin structure surrounding RE1 sites was plotted as a heat map and an average 
cumulative frequency distribution. Fig 5.4 shows that approximately 50% (411) of the RE1 sites 
(clusters C2, C5 and C7) in the iPS genome possess positioned nucleosomal chromatin particles 
surrounding them. These sites were grouped together to form a subset of RE1 sites in shown in 
Fig 5.5 as ‘Structured’. The average cumulative frequency distribution of positioned sub-
nucleosomal particles (Fig 5.5 C) and super-nucleosomal particles (Fig 5.5D), was determined 
surrounding this subset of RE1 sites in iPS cells. These results show that where there was well-
positioned core nucleosomes surrounding RE1 sites in iPS cells, there tended to be, on 
average, positioned sub-nucleosomal particles at the RE1 site and strongly positioned super-
nucleosomal particles surrounding the site. The remaining RE1 sites (n=460) shown in clusters 
C8, C6, C3, C4 and C1 (Fig 5.4) which have fewer well-positioned nucleosomal particles, were 
grouped together and are labelled “Less structured” in Fig 5.5. The average cumulative 
frequency distribution of positioned sub-nucleosomal particles and super-nucleosomal 
particles was determined surrounding this second subset of RE1 sites, shown in Fig 5.5 F and G 
respectively. Where there were fewer positioned core nucleosomes surrounding RE1 sites in 
iPS cells shown by the graph in Fig 5.5 E, this correlates with fewer positioned sub-nucleosomal  
particles at the RE1 site (Fig 5.5 F) and the presence  of less strongly positioned super-
nucleosomal particles surrounding the site (Fig 5.5 G). From this analysis, strong sub-
nucleosomal chromatin particle positioning occurs centred on a subset (64%) of RE1 sites in iPS 
cells. The presence of this sub-nucleosomal chromatin particle positioning correlates with the 
presence of precise nucleosome positioning flanking RE1 sites, both in the nucleosomal and 
super-nucleosomal chromatin particle size classes. On average, the remaining RE1 sites in iPS 
cells possess weakly positioned nucleosomes surrounding them (Fig 5.5 E and G). This 
correlates with weaker positioning of the sub-nucleosomal chromatin particle at the RE1 sites. 
This suggests that when the REST complex is present at a subset of RE1 sites in pluripotent 
cells, nucleosomes are organised surrounding the RE1 site.  
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Fig 5.4 See next page for legend. 
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 Figure 5.4 Cluster analysis reveals that chromatin is organised surrounding approximately half of the 
RE1 sites in iPS cells. 
Data representing the positions of chromatin particles in the nucleosomal (162-188 bp) particle size 
class at and surrounding all 871 RE1 sites (+/- 300 bp) were clustered (k-means; Canberra distance) into 
eight groups (C1-C8). Each group is shown as a heat map with x-axis =distance relative to the RE1 site 
(bp) and y-axis =log2 of the locally-normalized dyad frequency values for every bin position. For each 
group, the mean chromatin particle frequency values centred on and surrounding the RE1 sites were 
plotted for the nucleosomal size class data and these are shown in the graphs on the right-hand side in 
each group, x-axis =distance relative to site ( bp), y axis = mean mid-point frequency. The groups of RE1 
sites that possess organised chromatin at RE1 sites were C2, C5 and C7, totalling 47% of the RE1sites. 
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Fig 5.5 See next page for legend. 
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Figure 5.5 The presence of positioned nucleosomes flanking RE1 sites in iPS cells correlates with sub-
nucleosomal chromatin particle binding (REST). 
The presence of organised nucleosomes flanking RE1 sites in iPS cells correlates with the presence of a 
high frequency of chromatin particles in the sub-nucleosomal chromatin particle size class (REST) 
positioned at the RE1 site. Approximately half (n=411) of the RE1 sites possess flanking positioned 
nucleosomes in iPS cells, shown in the top half of the combined heat map (A), with x-axis =distance 
relative to the RE1 site (+/- 300  bp) and y-axis =log2 of the locally-normalized dyad frequency values for 
every bin position. Average cumulative frequency distributions of the chromatin particle distribution in 
the nucleosomal (B), sub-nucleosomal (C) and super-nucleosomal particle (D) size-classes at and 
surrounding (+/- 600 bp) this subset (“Structured”) of RE1 sites was plotted with x-axis =distance relative 
to site ( bp), y axis = mean mid-point frequency.  Similar average cumulative frequency distributions 
were plotted for the remaining RE1 sites (“Less structured”, n=460), shown in E, F and G. This group of 
sites had reduced nucleosome positioning surrounding RE1 sites that correlated with a reduction in the 
frequency of chromatin particles in the sub-nucleosomal chromatin particle size class (REST) positioned 
at the RE1 site 
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5.6 Strongly positioned nucleosomes can remain positioned at RE1 sites 
during neural cell development. 
In order to investigate the changes in chromatin structure that occur at RE1 sites during 
differentiation to NPC cells, the subset of “structured” RE1 sites (Fig 5.6 Class 1 sites ) with a 
high frequency of positioned sub-nucleosomal particles, was investigated in NPC cells. Average 
cumulative frequency distributions were plotted at and surrounding the class 1 RE1 sites in 
NPC cells for all three chromatin particle size classes (Fig 5.6 D, E, F). These results  suggest  
that class1 RE1 sites tend to retain positioned nucleosomes at RE1 sites during differentiation 
to NPC cells, since well-positioned nucleosomes and super-nucleosomes flank the RE1 site (Fig 
5.6 D and F), despite the absence of the sub-nucleosomal chromatin particle at the RE1 site in 
NPC cells (Fig 5.6 E). 
These results suggest that the sub-nucleosomal MNase-resistant particle that is positioned at 
RE1 sites in iPS cells represents REST or the REST complex and that chromatin is organised 
around RE1 sites when REST or the REST complex is bound in iPS cells. When iPS cells 
differentiate to NPC cells, the class1 RE1 sites that have positioned nucleosomes in iPS cells 
retain this chromatin organisation, despite the fact that the positioned sub-nucleosomal 
particle at the RE1 site is not detected in NPC cells. It has been shown in mouse cells that REST 
is still present after differentiation to NPC cells but at a much lower level than that in ES cells 
(Ballas, Grunseich et al. 2005). If there were similar reduction in REST levels in human cells 
after differentiation to NPC, this might result in a reduction in occupancy at RE1 sites by REST 
or the REST complex. Nevertheless, the occupancy at RE1 sites in NPC cells has clearly changed 
without a change in the flanking chromatin structure. 
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Fig 5.6 See next page for legend. 
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Figure 5.6 Organised chromatin is maintained surrounding RE1 sites during differentiation from iPS to 
NPC cells. 
Average cumulative frequency distributions were plotted at and surrounding (+/- 600 bp) the 
“structured, class 1” subset of RE1 sites (n=411) with x-axis =distance relative to the RE1 site (bp), y axis 
= mean mid-point frequency in iPS and NPC cells for the nucleosomal (A and D), sub-nucleosomal (B and 
E) and super-nucleosomal particle (C and F) size-classes. The subset of RE1 sites that had a high 
frequency of chromatin particles in the sub-nucleosomal chromatin particle size class (REST) at the RE1 
site in iPS cells (B) maintain strongly positioned nucleosomes flanking these sites in NPC cells (D and F) 
despite the loss of chromatin particles in the sub-nucleosomal chromatin particle size class (REST) at the 
RE1 site in NPC cells (E).  
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The subset of RE1 sites that had less organised flanking chromatin also had a reduced 
frequency of chromatin particles in the sub-nucleosomal chromatin particle size class at the 
RE1 site (Fig 5.5 E and F) in iPS cells. This subset of RE1 sites, henceforth referred to Class 2 RE1 
sites, was further investigated to determine the chromatin structure at and surrounding these 
sites in NPC. Fig 5.7 shows average cumulative frequency distributions plotted at and 
surrounding the Class 2 subset of RE1 sites in NPC cells for the nucleosomal (D), sub-
nucleosomal (E) and super-nucleosomal particle (F) size-classes. This group of RE1 sites had 
reduced nucleosome positioning surrounding RE1 sites in iPS cells. This pattern correlated with 
a reduction in the frequency of chromatin particles in the sub-nucleosomal chromatin particle 
size class (REST) positioned at the RE1 site in iPS cells. This less organised chromatin structure 
is maintained during differentiation to NPC cells, this is shown by comparing Fig 5.7 A with D 
and C with F. Therefore, at this class of RE1 sites, there is some degree of nucleosome 
positioning and this chromatin structure does not change during differentiation from iPS to 
NPC.  
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Fig 5.7 See next page for legend. 
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Figure 5.7 In the absence of REST, dis-organised chromatin is maintained at RE1 sites during 
differentiation from iPS to NPC cells. 
The subset of RE1 sites (“Less structured, class 2” ) that had a reduced frequency of chromatin particles 
in the sub-nucleosomal chromatin particle size class (REST) at the RE1 site show little change in 
nucleosome organisation flanking these sites in NPC cells. Average cumulative frequency distributions 
were plotted at and surrounding (+/- 600 bp) this subset of RE1 sites (n=460) with x-axis =distance 
relative to the RE1 site (bp), y axis = mean mid-point frequency, in NPC cells for the nucleosomal (D), 
sub-nucleosomal (E) and super-nucleosomal particle (F) size-classes. This group of sites had reduced 
nucleosome positioning surrounding RE1 sites in iPS cells, this correlated with a reduction in the 
frequency of chromatin particles in the sub-nucleosomal chromatin particle size class (REST) positioned 
at the RE1 site in iPS cells. This less organised chromatin structure is maintained during differentiation to 
NPC cells. This is shown by comparing A with D and C with F. 
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5.7 Determination of the frequency of RE1 sites that possess positioned 
sub-nucleosomal particles. 
The previous analysis in this chapter suggested that there was a correlation in iPS cells 
between the presence of positioned chromatin particles in the sub-nucleosomal size range, 
which might represent the REST complex and the presence of organised chromatin flanking the 
RE1 sites, in the size range of nucleosomes. The cumulative frequency distributions of paired-
read midpoint positions at and surrounding a set of genomic feature positions represents an 
average chromatin structure surrounding the chosen genomic feature positions. Therefore, it 
is possible that the pattern of chromatin particle positioning observed in the sub-nucleosomal 
size class in Fig 5.2 was derived from a subset of RE1 sites. Some of the RE1 sites that had been 
shown to have organised nucleosomal chromatin flanking the RE1 sites might not have had a 
positioned sub-nucleosomal chromatin particle positioned at the RE1 site itself. Therefore, to 
derive a precise set of RE1 sites that possessed both a positioned sub-nucleosomal chromatin 
particle at the RE1 site and positioned nucleosomal chromatin particles flanking the RE1 sites, I 
decided to analyse the sub-nucleosomal chromatin particle data at RE1 sites in iPS cells 
further. Chromatin particle data representing the positions of chromatin particles in the sub-
nucleosomal particle size class at and surrounding all 871 RE1 sites (+/- 300 bp) was clustered 
(k-means; Canberra distance) into eight groups (clusters C1-8). Each group is shown as a heat 
map (Fig 5.8). For each group of RE1 sites, the mean chromatin particle frequency values 
centred on and surrounding the RE1 sites were plotted for the sub-nucleosomal size class data 
and these are shown in the graphs on the right-hand side. The groups of RE1 sites that possess 
positioned sub-nucleosomal chromatin particles at RE1 sites were designated C1, C2, C5, C6 
and C7, totalling 64% of the RE1 sites. 
The final number and location of RE1 sites that possess both a positioned sub-nucleosomal 
chromatin particle and positioned nucleosomal chromatin particles flanking it was determined 
by obtaining the overlap in the locations of RE1 sites from each group. Thus, a final list of 309 
RE1 sites was obtained for use in further analysis. 
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Fig 5.8 See next page for legend. 
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Figure 5.8 64% of the RE1 sites in iPS cells possess positioned sub-nucleosomal chromatin particles. 
Data representing the positions of chromatin particles in the sub-nucleosomal particle size class at and 
surrounding all 871 RE1 sites (+/- 300 bp) were clustered (k-means; Canberra distance) into eight groups 
(C1-C8). Each group is shown as a heat map with x-axis =distance relative to the RE1 site (bp) and y-axis 
=log2 of the locally-normalized dyad frequency values for every bin position. For each group the mean 
chromatin particle frequency values centred on and surrounding the RE1 sites were plotted for the sub-
nucleosomal size class data and these are shown in the graphs on the right-hand side in each group, x-
axis =distance relative to site ( bp), y axis = mean mid-point frequency. The groups of RE1 sites that 
possess positioned sub-nucleosomal chromatin particles at RE1 sites were C1 ,C2, C5, C6 and C7, 
totalling 64% of the RE1 sites. 
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5.8 Identification of genes targeted by REST during neural cell 
development.  
To identify the genes whose RE1 sites possess positioned nucleosomes during neural cell 
development, the co-ordinates of the RE1 sites utilised in this study were matched to their 
respective genes using the Gencode annotation file: gencode.v18.annotation.gtf (Harrow, 
Frankish et al. 2012). Thus, a list of REST target genes for the RE1 sites used in this study was 
obtained. The subset (n= 309) of genes with RE1 sites that possessed both positioned sub-
nucleosomal chromatin particles and flanking nucleosomal chromatin particles in iPS cells that 
was obtained section 5.7 was matched with a list of 64 known REST target genes, derived from 
the literature that had been validated experimentally (Appendix table A.2).This information 
was used to determine that 504 of the RE1 sites used in this study are within Gencode 
annotated genes and of these, 33 are known to be REST target genes. 18 of the known REST 
target genes used in this study have RE1 sites that possess strongly positioned sub-
nucleosomal and nucleosomal chromatin particles in iPS cells and strongly positioned 
nucleosomal chromatin particles in NPC cells. The remaining 15 known REST target genes used 
in this study have weaker chromatin particle positioning. 
Chromatin particle positioning was visualised by plotting histograms for all three chromatin 
particle size classes (sub-nucleosomal, nucleosomal and super-nucleosomal) in both iPS and 
NPC cells surrounding the RE1 site (+/-1 kb) in two of the known REST target genes, CACNA1A 
(Johnson, Gamblin et al. 2006) and BDNF (Schoenherr and Anderson 1995) (Fig 5.9.A and B 
respectively). CACNA1A encodes a voltage-gated Calcium channel subunit and it is regulated 
by REST in human cells. This gene has four binding sites for REST, only two of which bind REST 
with high affinity in vivo (Johnson, Gamblin et al. 2006). The RE1 site at chr19: 113,552,886 in 
intron 3 of the CACNA1A gene is shown in Fig 5.9.A. This is the position at which Johnson et al 
defined a high affinity REST binding site in HeLa cells (Johnson, Gamblin et al. 2006). This 
provides evidence that this site is a bona fide RE1 site. Hence this is an example of a previously 
characterised RE1 site that retains its nucleosome organisation during neural development.   
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Figure 5.9 Visualisation of chromatin particle positioning at RE1 sites in iPS and NPC cells at REST 
target genes. 
Paired-read midpoint position frequency data in 10 bp bins was extracted from .sgr files at and 
surrounding selected RE1 sites (+/- 1kb) that were within known REST target genes (See table A.2.) A. 
CACNA1A and B. BDNF. Histograms of paired-read midpoint position frequency data were plotted in R, x 
axis =chromosome co-ordinate (hg19), y axis = paired-read midpoint position frequency, for all three 
chromatin particle size classes (sub-nucleosomal, nucleosomal and super-nucleosomal) in both iPS and 
NPC cells. RE1 sites are shown by the grey vertical line. Sub-nucleosomal chromatin particles are 
positioned at RE1 sites in iPS cells (indicated by *), but not in NPC cells. Nucleosomal and super-
nucleosomal particles (indicated by *), are positioned flanking RE1 sites in both iPS and NPC cells in both 
the BDNF and CACNA1A genes. These genes retain positioned nucleosomes flanking their RE1 sites 
during differentiation to NPC, despite the loss of the positioned sub-nucleosomal particles at the RE1 
site (REST) in iPS cells. 
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The BDNF gene encodes brain-derived neurotrophic factor (BDNF) which is a member of the 
neurotrophin family of growth factors that are found in the brain (Barde, Edgar et al. 1982). 
This factor is important in the growth, development and maintenance of nerve cells. BDNF 
transcription is repressed by REST binding to the RE1 site in intron two of the BDNF gene, and 
this repression is inhibited by the wild type huntingtin protein (Zuccato, Tartari et al. 2003) 
which when mutated, causes Huntington’s disease (THDCRG 1993). Thus BDNF is an important 
factor in neuronal gene regulation and the mis-regulation of its expression through the 
opposing effects of REST and huntingtin can have catastrophic effects.  
Two genes that possess RE1 sites and are likely to be REST target genes in humans, but have 
not been as well studied in terms of their relationship to REST are CHD5 and KCNAB2. These 
genes have strongly positioned sub-nucleosomal and nucleosomal size chromatin particles at 
the RE1 sites in iPS cells. This chromatin structure is retained when the cells differentiate to 
NPC (Fig 5.10). The KCNAB2 gene encodes a subunit of a voltage gated potassium channel and 
it has been shown that deletion of this gene in mice causes defects in memory and in 
associative learning (Perkowski and Murphy 2011). Studies in human Huntington’s disease 
cortex samples have shown that KCNAB2 is one of the REST target genes that has significantly 
higher REST occupancy and downregulated expression in disease samples (Zuccato, Belyaev et 
al. 2007).  CHD5 is a chromatin re-modeller that is important in spermiogenesis  (Li, Wu et al. 
2014) but it is also preferentially expressed in the nervous system  (Thompson, Gotoh et al. 
2003) and it is required for terminal neuronal differentiation (Egan, Nyman et al. 2013). It is a 
strong candidate tumour suppressor gene that is deleted in neuroblastoma (Fujita, Igarashi et 
al. 2008). It has been shown that CHD5 has a significant role in the regulation of neuronal 
genes, including polycomb (Egan, Nyman et al. 2013) and it is expressed at high levels in adult 
mouse brain (Vestin and Mills 2013). Hence, CHD5 could be another ‘master regulator’ of 
neural genes though its chromatin remodelling activity. The relationship between CHD5 and 
REST is not clear, but the data presented here suggest that CHD5 might be regulated by REST 
and warrants further investigation, but this is beyond the scope of this thesis. 
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Figure 5.10 Visualisation of chromatin particle positioning at class one RE1 sites in iPS and NPC cells at 
putative novel REST target genes. 
Paired-read midpoint position frequency data in 10 bp bins was extracted from .sgr files at and 
surrounding selected RE1 sites (+/- 1kb) that were within A. CHD5 and B. KCNAB2. Histograms of paired-
read midpoint position frequency data were plotted in R, x axis =chromosome co-ordinate (hg19), y axis 
= paired-read midpoint position frequency, for all three chromatin particle size classes (sub-
nucleosomal, nucleosomal and super-nucleosomal) in both iPS and NPC cells. RE1 sites are shown by the 
grey vertical line. Sub-nucleosomal chromatin particles are positioned at RE1 sites in iPS cells (indicated 
by *), but not in NPC cells. Nucleosomal and super-nucleosomal particles (indicated by *), are positioned 
flanking RE1 sites in both iPS and NPC cells in both the CHD5 and KCNAB2 genes. These genes retain 
positioned nucleosomes flanking their RE1 sites during differentiation to NPC, despite the loss of the 
positioned sub-nucleosomal particles at the RE1 site (REST) in iPS cells. 
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Chromatin particle positioning also was visualised at the RE1 site within the RLTPR gene 
(Matsuzaka, Okamoto et al. 2004). This gene is a representative example from the class of 
genes from this study whose RE1 sites do not possess positioned chromatin particles in iPS 
cells or NPC cells. This gene encodes a lymphoid cell-specific protein that is essential in T cell 
development (Liang, Cucchetti et al. 2013), thus it would not be expected to be involved in 
neural cell differentiation.  
At some RE1 sites weaker nucleosome positioning was detected that correlates with weaker 
sub-nucleosomal chromatin particle positioning at the RE1 site (Class2 sites). The RE1 sites 
utilised in this study were derived from ChIP data from a mixture of cell types.  Hence, it is 
possible that the class 2 RE1 sites characterised by their chromatin structure in this study, are 
not utilised in iPS cells. Alternatively, the characteristics and dynamics of RE1 sites may vary at 
different genes and at different developmental stages. In the mouse genome, it has been 
suggested that there are different levels of REST binding at different stages of development 
and at different genes (Sun, Greenway et al. 2005). If this were true in the human genome, it 
might be reflected in the chromatin dynamics at RE1 sites. 
Taken together, the results in this chapter suggest that there is a specific set of RE1 sites in iPS 
cells that possess sub-nucleosomal chromatin particles positioned at the RE1 site.  These RE1 
sites tend to have positioned nucleosomal chromatin particles flanking them in iPS and NPC 
cells, suggesting that nucleosomes, once positioned at RE1 sites in pluripotent cells, remain 
positioned during early neural differentiation. 
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Figure 5.11 Some RE1 sites are devoid of any positioned chromatin particles 
Visualisation of chromatin particle positioning at a class two RE1 site in iPS and NPC cells. . Paired-read 
midpoint position frequency data in 10 bp bins was extracted from .sgr files at and surrounding a class2 
RE1 site (+/- 1kb) in the RLTPR gene. Histograms of paired-read midpoint position frequency data were 
plotted in R, x axis =chromosome co-ordinate (hg19), y axis = paired-read midpoint position frequency, 
for all three chromatin particle size classes (sub-nucleosomal, nucleosomal and super-nucleosomal) in 
both iPS and NPC cells. RE1 sites are shown by the grey vertical line. This illustrates that not all of the 
putative RE1 sites in this study possess positioned chromatin particles.  This absence of chromatin 
organisation suggests that the RE1 site in the RLTPR gene may not be utilised as a transcription factor 
binding site in iPS and NPC cells. 
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5.9 Discussion 
The work presented in this chapter has shown that it is possible to detect positioned 
nucleosomal chromatin particles flanking the binding motif of a master regulator of neural 
genes, in both iPS cells and NPC cells. This is in agreement with recent work in the human 
genome that has shown that regulatory sites tend to have high nucleosome occupancy in 
human cells (Tillo, Kaplan et al. 2010) and that well positioned nucleosomes are found flanking 
repressor sites (Nie, Cheng et al. 2014). Sub-nucleosomal chromatin particles were positioned 
at the RE1 site iPS cells, but they were not detected at the RE1 site in NPC cells. It has been 
shown in mouse ES cells that the levels of REST protein are high (Ballas, Grunseich et al. 2005). 
If this were true in human iPS cells then the data presented here suggests that the sub-
nucleosomal chromatin particles positioned at the RE1 site in iPS cells detected here, using 
MNase-seq, might be REST or the REST complex. This could be tested using ChIP-seq. 
In this study, a comparison of the nucleosomal chromatin particle positioning at RE1 sites in 
both iPS and NPC cells investigated whether there were changes in nucleosomal chromatin 
structure during neural cell differentiation.  It was shown that nucleosomal chromatin particles 
remain positioned flanking RE1 sites during differentiation from iPS to NPC cells in 
approximately 50% of the RE1 sites investigated. The patterns of strongly positioned 
nucleosomes at RE1 sites in pluripotent cells correlate with the presence of sub-nucleosomal 
chromatin particles at the RE1 site. However, sub-nucleosomal chromatin particles were not 
detected at RE1 sites in NPC cells. In mouse, REST is still present after differentiation to NPC 
cells but at a much lower level than in ES cells (Ballas, Grunseich et al. 2005). It is possible that 
this is true in human cells, but that this low level of REST is not detected using the MNase-seq 
technology used in this study. However, the results presented here suggest that in human 
cells, well organised chromatin structure, once established, tends to be maintained at a subset 
of RE1 sites during the early stages of neuronal differentiation and that this is independent of 
the presence of the positioned sub-nucleosomal chromatin particles at the RE1 site. The 
findings in this chapter are summarised in Fig 5.12. 
The results presented here show that the chromatin structure at RE1 sites in iPS cells is 
maintained in NPC cells, hence further epigenetic changes affecting REST binding or REST 
target gene regulation would be most likely through  post-translational modifications of 
chromatin or DNA rather than through changes in the position of nucleosomes at this stage of 
development. The positioned nucleosomes might mark these RE1 sites and allow REST to 
rebind to some or all of the same binding motifs in NPC cells, or in later development to 
regulate a specific set of target genes. There is evidence that there are different types of RE1 
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sites, having different binding characteristics that can be utilised in different ways in 
development. Bruce et al 2009 (Bruce, Lopez-Contreras et al. 2009) showed that RE1 sites in 
human cells have a binding affinity hierarchy and that the degree of binding is sequence 
specific. Sites at which there is strong REST binding, with canonical binding site sequences, 
tend to be utilised in all cell types, whereas and sites at which there is weak REST binding, with 
divergent binding site sequences, are utilised in a cell type specific manner. 
There is evidence that REST levels are high in cell types other than pluripotent cells. Although 
REST levels are low in NPC cells and cortical neurons, it is expressed at high levels in the adult 
hippocampal granule and pyramidal neurons (Palm, Belluardo et al. 1998). In addition, REST 
expression increases in rat brain after kainate induced seizures (Palm, Belluardo et al. 1998) 
and after global ischemic attacks. Calderone et al showed that increased REST expression after 
global ischemic attacks leads to the suppression of the GluR2 promoter, affecting AMPA 
receptor function and resulting in the death of hippocampal CA1 neurons (Calderone, Jover et 
al. 2003). Hence, although REST levels are low in NPC cells, REST levels can increase in later 
development or in response to cellular stress. Recent work by McClelland et al (McClelland, 
Dube et al. 2011; McClelland, Flynn et al. 2011) has shown that after seizures, REST levels 
increase, but this increase does not affect genes that bind REST with high or low affinity, 
rather, the increase REST levels seemed to affect a subset of genes with ‘mid-range’ affinity 
binding RE1 sites, suggesting that these sites are poised to respond to changes in REST levels. 
This subset of genes is critical for neuronal function. 
Patterns of nucleosome positioning may define different types of REST sites, the degree of 
REST binding and whether and how REST sites are used at different times in development or in 
response to cellular stress. 
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Figure 5.12 Summary of Chromatin structure at RE1 sites during early neuronal differentiation 
A. In pluripotent cells, REST binds to the RE1 site and recruits co-repressor complexes. Nucleosomes are 
positioned flanking the RE1 site. B. In neural progenitor cells, REST is not bound to the RE1 site but 
nucleosomes remain positioned flanking the RE1 site.  
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Chapter 6: Chromatin at CTCF binding motifs during neural cell 
differentiation. 
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6.1 Introduction 
CTCF has a dominant role in chromatin architecture but the relationship between CTCF 
binding, chromatin architecture and genome regulation is not clear. At the local level of 
chromatin structure, it is known that CTCF binding motifs have positioned nucleosomes 
flanking them (Fu, Sinha et al. 2008; Teif, Vainshtein et al. 2012). The aim of this chapter was to 
investigate whether changes occur in nucleosome positioning at CTCF binding motifs during 
early neural cell differentiation in human cells. This would generate information about the role 
of CTCF in early neural cell differentiation and provide insight into the mechanisms involved in 
changes in chromatin architecture that lead to changes in the regulation of cell type specific 
genes. The roles of CTCF were discussed in Chapter1, section 1.15.1 and they are summarised 
in Fig 6.1. 
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Figure 6.1 The roles of the insulator protein CTCF 
CTCF can act as a barrier between areas of active and inactive chromatin and it is involved in the 
formation of chromatin loops.  A. Cartoon of a linear section of an active chromatin domain in the 
human genome flanked at its edges by CTCF sites which act as barriers to flanking heterochromatin. The 
cartoon depicts an actively transcribed gene, an inactive gene and an enhancer with interspersed CTCF 
binding motifs. CTCF binding motifs have directionality (shown by arrows in the motif), affecting the 
direction in which chromatin loops form. B. After CTCF has bound to its motif; cohesin and the co-
activator Mediator are recruited, leading to the formation of chromatin loops or topologically active 
domains (TADs). Looping may bring together a gene promoter and an enhancer, resulting in an active 
gene, shown in the left-hand loop. Alternatively looping might block the interaction of a gene promoter 
with an enhancer, preventing gene activation, shown in the right hand loop. 
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6.2 Derivation of CTCF binding motifs. 
In this this study, a human core CTCF consensus binding motif was mapped to ChIP-seq data to 
derive a set of CTCF binding motifs to be, as near as possible, specific to human pluripotent 
cells. The 12 bp human core consensus CTCF binding motif, 
[C][C][A|G][C|G][C|T][A][G][G|A][T|G][G][G][C|T], encompassing modules 2 and 3 of the total 
52 bp motif was used (Ong and Corces 2014). This motif was derived in HeLa cells using ChIP-
exo (chromatin immunoprecipitation combined with lambda exonuclease digestion). This 12 
bp motif was shown to be utilised by half of the locations bound by CTCF in HeLa cells, with 
intermediate levels of occupancy (Rhee and Pugh 2011) and it is similar to the motif derived by 
Nakahashi et al (Nakahashi, Kwon et al. 2013).  As publicly available CTCF ChIP data from iPS 
cells was not available, it was decided to use CTCF ChIP data derived from human embryonic 
stem cells (H1-hESC) from the ENCODE project  (Gerstein, Kundaje et al. 2012). The extent to 
which the characteristics of iPS cells are the same as those of ESC cells has been a topic of 
debate for some time (Chin, Mason et al. 2009; Hu, Weick et al. 2010). However, recent 
studies have shown, in several cell lines tested, that iPS cells and ESC have similar patterns of 
gene expression and chromatin marks (Guenther, Frampton et al. 2010; Mallon, Chenoweth et 
al. 2013). Specifically, Mallon et al have studied gene expression in the male H1-hESC line and 
in both differentiated NPC cells and undifferentiated iPS cells derived from them. This work 
showed that the undifferentiated isogenic cell populations did not show significant differences 
in gene expression (Mallon, Hamilton et al. 2014).  
In this study, the positions of the centre of the 12 bp core CTCF consensus binding motif 
described above was extracted from the hg19 human genome autosomal fasta files. The 
positions of these sites were mapped to the H1-hESC cell CTCF ChiP-seq data from the Broad 
institute (for methods see Chapter 2 section 2.5.2).This provided a set of precise co-ordinates 
at the centre of each consensus CTCF binding sequence at which it has been shown by ChiP-
seq that CTCF binds in H1-hESC cells The derived set of 9,516 CTCF binding elements used in 
this thesis herein are referred to as CTCF sites. To study genome-wide, cell-type specific 
changes in patterns in chromatin structure surrounding CTCF sites during neural cell 
development, the average cumulative frequency distributions of all three chromatin particle 
size classes (sub-nucleosomal, nucleosomal and super-nucleosomal) used in this study were 
plotted at and surrounding the derived set of CTCF sites. 
181 
 
6.3 Detection of sub-nucleosomal MNase-protected chromatin particles 
at CTCF sites during differentiation. 
The average cumulative frequency distribution of the sub-nucleosomal (112-137 bp) chromatin 
particle size class at and surrounding CTCF sites shows that there is a large peak in the 
chromatin particle mid-point frequency  centred on the CTCF site in iPS cells (Fig 6.2 A). This 
suggests that, on average, protection from MNase digestion by sub-nucleosomal chromatin 
particles at this derived set of CTCF sites in iPS cells can be detected. 
In NPC cells the peak in the sub-nucleosomal chromatin particle positioned at the CTCF binding 
site is reduced to approximately 30% of that found in iPS cells. This result could be explained 
by two scenarios: i) on average, protection from MNase digestion by sub-nucleosomal 
chromatin particles is reduced after differentiation from iPS to NPC cells. This suggests that 
CTCF binding is reduced at this set of CTCF sites in NPC cells or ii) CTCF occupancy is reduced 
across the CTCF sites in the genomes of the NPC cell population, i.e. CTCF does not bind at the 
same place in every cell in the population (Fig 6.3).   
6.4 Nucleosomal and super-nucleosomal chromatin particles are 
positioned surrounding CTCF sites in both iPS and NPC cells. 
Next, the average cumulative frequency distribution of the nucleosomal (138-168 bp) and 
super- nucleosomal (162-188 bp) chromatin particle size classes at and surrounding CTCF sites 
was determined. The peaks in the average cumulative frequency distribution suggest that in 
both chromatin particle classes, there is an array of seven positioned particles on each side of 
the CTCF site in both iPS and NPC cells (Fig 6.2B and C). In contrast, there are few positioned 
chromatin particles in these size classes at the CTCF site itself. This result suggests that the 
nucleosomal chromatin structure flanking CTCF sites is, on average, retained during 
differentiation from pluripotent cells to NPC cells. However, there is a peak representing a high 
frequency of positioned chromatin particles in the nucleosomal size class (138-161 bp) centred 
on the CTCF site in iPS cells. This peak is smaller than that shown at the CTCF site in the sub-
nucleosomal (112-137 bp) chromatin particle size class. Hence, the dominant peak at the CTCF 
site, most likely representing CTCF in a complex with other proteins, is in the sub-nucleosomal 
size class. 
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Figure 6.2  Chromatin remodelling occurs at CTCF sites during differentiation from pluripotent to 
neuronal precursor cells. 
Normalised average cumulative frequency distributions of chromatin particle size classes A. 112-137 bp 
(sub-nucleosomes), B. 138-161 bp (representing nucleosomes) and C. 162-188 bp (super-nucleosomes)  
show the chromatin structure at and surrounding (+/-2000 bp) CTCF elements (n=9516) in both iPS and 
NPC cells.  
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Figure 6.3 Model of CTCF occupancy. 
A. In a population of cells, transcription factors that bind to their motif in the same place in the genome 
from one cell to the next in all cells have high occupancy. B. Transcription factors that do not bind to 
their binding motif in the same place in every cell have low occupancy. 
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In order to validate the chromatin structure surrounding  CTCF sites shown in this study, the 
chromatin structure surrounding CTCF sites in both  K562 and GM12878 cells was investigated 
using the nucleosome maps derived by Kundaje et al (Kundaje, Kyriazopoulou-
Panagiotopoulou et al. 2012) that were  re-processed for comparison purposes as described in 
Chapter 3. Comparisons of the average cumulative frequency distributions in the nucleosomal 
(138-161 bp) chromatin particle size class in iPS versus K562 cells and iPS versus GM12878 cells 
are shown in Fig 6.4 A and C respectively.  These results show that a similar number of 
positioned nucleosomes flank both sides of the CTCF site in all three genomes, but the peak 
that is centred on the CTCF site in iPS cells, is completely absent in K562 and GM12978 cells. 
This suggests that the peak that is centred on the CTCF site in iPS cells is specific to pluripotent 
cells. Comparisons of the average cumulative frequency distributions in the (138-161 bp) 
chromatin particle size class in NPC versus K562 cells and NPC versus GM12978 cells are shown 
in Fig 6.4 B and D respectively. Again, these results show that a similar number of positioned 
nucleosomes flank the CTCF site in all three genomes. 
Taken together, these results confirm the finding from NPC cells shown here, that positioned 
nucleosomal chromatin particles flank CTCF sites in differentiated cells. In addition, these 
results suggest that positioned nucleosomal particles flank the CTCF binding motif even when 
sub-nucleosomal chromatin particle positioning at the CTCF site is reduced, as in NPC cells.  
 
  
185 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fi
g 
6
.4
 S
e
e
 n
e
xt
 p
ag
e
 f
o
r 
le
ge
n
d
. 
186 
 
Figure 6.4 The pattern of positioned nucleosomes flanking CTCF sites is similar in differentiated cell 
types 
Comparison of the positions of chromatin particles at and surrounding the CTCF site in the nucleosomal 
(138-161 bp) chromatin particle size range mapped in iPS and NPC cells by MNase-seq with those 
mapped in K562 and GM12878 cells. The data from the nucleosome maps generated for the K562 and 
GM12878 cell lines (Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012) was converted from bedgraph 
to sgr format and the data was re-binned into 10 bp bins, calculating a 3bin moving average. The K562 
and GM12878 maps were constructed by sequencing DNA purified from chromatin in the mono-
nucleosome (approx. 150 bp) size range after MNase digestion. These data were compared with the iPS 
and NPC chromatin particle maps generated in the 138-161 bp size range since this is most similar to the 
size range of the chromatin particles in the K562 and GM12878 maps. A comparison of the average 
cumulative frequency distributions of the chromatin particles in different cell types at and surrounding 
(+/- 2000 bp) CTCF sites are shown A. iPS and K562,  B. NPC and K562, C. iPS and GM12878, D. NPC and 
GM12878. 
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6.5 CTCF sites possess positioned sub-nucleosomal particles in iPS cells. 
The cumulative frequency distributions of chromatin particles at and surrounding a set of 
genomic feature positions represented an average chromatin structure at and surrounding the 
chosen genomic feature positions. Hence, it was possible that the pattern of chromatin 
particle positioning observed in Fig 6.2 was derived from a subset of CTCF sites. So it was 
decided to investigate the patterns of positioned chromatin particles in the sub-nucleosomal 
chromatin particle size class in iPS cells further. This would determine whether sub-
nucleosomal chromatin particles were positioned at all of the CTCF sites, or whether the 
pattern observed in Fig 6.2A was derived from a subset of CTCF sites. The chromatin particle 
data in the sub-nucleosomal size class surrounding CTCF sites within a window of +/-300 bp 
was clustered into six groups. For each cluster, the pattern of chromatin structure surrounding 
CTCF sites was plotted as a heat map and an average cumulative frequency distribution. 
Fig 6.5 shows that sub-nucleosomal chromatin particles are positioned at all of the CTCF sites 
in iPS cells used in this study (n=9516), but the level of signal, indicating the level of protection 
from MNase digestion at CTCF sites by sub nucleosomal particles is variable. For example, 
cluster C5 has a signal intensity that is more than two fold greater than that in cluster C3. This 
suggests that all of the CTCF sites defined in this study are bound by CTCF and its co-binding 
proteins in iPS cells. 
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Figure 6.5 All of the CTCF sites possess positioned sub-nucleosomal particles in iPS cells 
Data representing the positions of sub-nucleosomal chromatin particles at and surrounding all 9516 
CTCF sites (+/- 300 bp) were clustered (k-means; Canberra distance) into six groups (clusters C1-6). Each 
group is shown as a heat map with x-axis =distance relative to the CTCF site (bp) and y-axis =log2 of the 
locally-normalized dyad frequency values for every bin position. For each group, the mean chromatin 
particle frequency values centred on and surrounding the CTCF sites was plotted for the sub-
nucleosomal size class data and these are shown in the graphs on the right-hand side in each group: x 
axis = distance relative to CTCF site ( bp), y axis = mean mid-point frequency. All of the groups of CTCF 
sites possess positioned sub-nucleosomal chromatin particles at the CTCF site.  
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6.6 Sub-nucleosomal particles are positioned at all CTCF sites after 
differentiation to NPC cells. 
Next, the positioning of sub-nucleosomal particles at CTCF sites after differentiation of iPS to 
NPC cells was investigated. The clusters of CTCF sites generated in the analysis of sub-
nucleosomal particle positioning at CTCF sites  in iPS cells was assembled into a master list of 
sites in order of the signal intensity obtained (i.e. cluster C5>C4>C1>C2>C6>C3).  This ordered 
list of all CTCF sites was used to extract the corresponding data, in the same order,  
representing the positions of sub-nucleosomal chromatin particles at and surrounding all 9516 
CTCF sites (+/- 300 bp) in NPC  cells. A heat map was constructed from these data (Fig 6.6).  
This analysis suggests that sub-nucleosomal particles are positioned in NPC cells at all of the 
CTCF sites tested in this study. This result is similar to the result found in iPS cells, however in 
NPC cells there is generally a much lower signal intensity at CTCF sites in NPC cells (compare 
Fig 6.6 A and B). This suggests weaker positioning of sub-nucleosomal particles at all of the 
CTCF sites in NPC cells. To investigate this further and to establish whether there might be a 
sub population of CTCF sites in NPC cells at which positioning of sub-nucleosomal particles is 
completely absent, the chromatin particle data in this size class surrounding CTCF sites within a 
window of +/-300 bp was clustered into six groups.  For each cluster, the pattern of chromatin 
structure surrounding CTCF sites was plotted as a heat map and an average cumulative 
frequency distribution (Fig 6.7). This result suggests that, although it is possible to cluster these 
data into groups with slightly different patterns of chromatin particle positioning, sub-
nucleosomal particles are weakly positioned at all CTCF sites in NPC cells.  
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Figure 6.6 Sub-nucleosomal chromatin particles are positioned at all of the CTCF sites in NPC cells 
The clusters of CTCF sites generated in the analysis of sub-nucleosomal particle positioning in iPS cells 
(shown in Fig 6.5) were assembled into an ordered master list of sites , according to the absolute 
particle position mid-point frequency (from high to low, i.e. clusters C5>C4>C1>C2>C6>C3). The 
corresponding data representing the positions of sub-nucleosomal chromatin particles at and 
surrounding all 9516 CTCF sites (+/- 300 bp) in iPS cells was extracted in the same order as the master 
site list. These data are represented as a heat map (A) with x-axis =distance relative to the CTCF site (bp) 
and y-axis =log2 of the locally-normalized dyad frequency values for every bin position. The 
corresponding data representing the positions of sub-nucleosomal chromatin particles at and 
surrounding all 9516 CTCF sites (+/- 300 bp) in NPC was extracted in the same way and it is represented 
as a heat map (B). 
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Figure 6.7 All of the CTCF sites possess positioned sub-nucleosomal particles in NPC cells 
Data representing the frequency of mid-point positions of sub-nucleosomal chromatin particles at and 
surrounding all 9,516 CTCF sites (+/- 300 bp) were clustered (k-means; Canberra distance) into six 
groups (clusters C1-6). Each group is shown as a heat map with x-axis =distance relative to the CTCF site 
(bp) and y-axis =log2 of the locally-normalized dyad frequency values for every bin position. For each 
group, the mean chromatin particle frequency values centred on and surrounding the CTCF sites were 
plotted for the sub-nucleosomal size class data. These are shown in the graphs on the right-hand side in 
each group: x axis = distance relative to CTCF site (bp), y axis = mean mid-point frequency. All of the 
groups of CTCF sites possess positioned sub-nucleosomal chromatin particles at the CTCF site.  
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6.7 Nucleosomal chromatin particles flank CTCF sites during 
differentiation from iPS to NPC.  
The positioning of nucleosomal particles surrounding CTCF sites in both iPS and NPC cells was 
investigated using the ordered list of CTCF sites generated according to the signal intensity 
obtained in the iPS sub-nucleosomal particle size class. The ordered list of CTCF sites was used 
to extract the corresponding chromatin particle midpoint position frequency data for the 
nucleosomal (168-161 bp) chromatin particle size class for both iPS and NPC. These data were 
plotted as heat maps, shown in Fig 6.8. This result shows that positioned nucleosomal 
chromatin particles can be detected flanking all CTCF sites in both iPS and NPC cells. 
Interestingly, the signal strength shown in the heat map for positioned nucleosomal chromatin 
particles in NPC cells is weaker than that in iPS cells. This suggests that nucleosomal chromatin 
particle positioning at CTCF sites is weaker in NPC cells than that in iPS cells. 
6.8 Super-nucleosomal chromatin particles flank CTCF sites during 
differentiation from iPS to NPC. 
The positioning of super-nucleosomal particles surrounding CTCF sites in both iPS and NPC 
cells was investigated using the ordered list of CTCF sites generated according to the signal 
intensity obtained in the iPS sub-nucleosomal particle size class. The ordered list of CTCF sites 
was used to extract the corresponding chromatin particle midpoint position frequency data for 
the super-nucleosomal chromatin particle size class in both iPS and NPC cells. These data were 
plotted as heat maps, shown in Fig 6.9. This result shows that positioned super-nucleosomal 
chromatin particles can be detected flanking all CTCF sites in both iPS and NPC cells. The signal 
strength shown in the heat map for positioned super-nucleosomal chromatin particles in NPC 
cells appears to be slightly weaker than that in iPS cells. This suggests that super-nucleosomal 
chromatin particle positioning at CTCF sites is weaker in NPC cells than that in iPS cells. 
  
193 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8 Nucleosomal chromatin particles remain positioned flanking CTCF sites during 
differentiation from iPS to NPC. 
The clusters of CTCF sites generated in the analysis of sub-nucleosomal particle positioning in iPS cells 
(shown in Fig 6.5) was assembled into an ordered master list of sites, according to the absolute particle 
position mid-point frequency (from high to low, i.e. clusters  C5>C4>C1>C2>C6>C3 represented by  the 
black triangle). The corresponding chromatin particle midpoint position frequency data for the 
nucleosomal chromatin particles at and surrounding all 9,516 CTCF sites (+/- 300 bp) in iPS cells was 
extracted in the same order as the master site list. These data are represented as a heat map (A) with x-
axis = distance relative to the CTCF site (bp) and y-axis =log2 of the locally-normalized dyad frequency 
values for every bin position. The corresponding data representing the positions of nucleosomal 
chromatin particles at and surrounding all 9516 CTCF sites (+/- 300 bp) in NPC was extracted in the same 
way and represented as a heat map (B). 
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Figure 6.9 Super-nucleosomal chromatin particles remain positioned flanking CTCF sites during 
differentiation from iPS to NPC. 
The clusters of CTCF sites generated in the analysis of sub-nucleosomal particle positioning in iPS cells 
(shown in Fig 6.5) was assembled into an ordered master list of sites , according to the absolute particle 
position mid-point frequency (from high to low, i.e. clusters  C5>C4>C1>C2>C6>C3 represented by  the 
black triangle). The corresponding chromatin particle midpoint position frequency data for the super-
nucleosomal chromatin particle size class at and surrounding all 9,516 CTCF sites (+/- 300 bp) in iPS cells 
was extracted in the same order as the master site list. These data are represented as a heat map (A) 
with x-axis =distance relative to the CTCF site (bp) and y-axis =log2 of the locally-normalized dyad 
frequency values for every bin position. The corresponding chromatin particle midpoint position 
frequency data for the super-nucleosomal chromatin particle size class at and surrounding all 9,516 
CTCF sites (+/- 300 bp) in NPC was extracted in the same way and represented as a heat map (B). 
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6.9 Super-nucleosomal chromatin particles are re-positioned flanking 
CTCF sites during differentiation from iPS to NPC.  
The average cumulative frequency distributions of the chromatin particle size classes shown in 
figure 6.2 were examined further. Fig 6.10A shows an expanded version of the average 
cumulative frequency distributions in the super-nucleosomal chromatin particle size class 
surrounding CTCF sites in both iPS and NPC cells derived from figure 6.2C. Closer examination 
of the chromatin particle positioning data in the super-nucleosomal size classes revealed that 
the positioning of the nucleosomes flanking CTCF sites differs in iPS and NPC cells. Fig 6.10A 
shows that the super-nucleosomal chromatin particles both upstream and downstream of the 
CTCF site in NPC were positioned nearer to the CTCF site than the counterpart super-
nucleosomal chromatin particle in iPS cells. The extent of the difference in positioning 
between iPS and NPC cells in this chromatin particle size class was investigated further. The 
positions of the peak maxima from the average cumulative frequency distributions shown in 
Fig 6.10A in both iPS and NPC cells were plotted as a bar chart. The bar chart shown in Fig 
6.10B shows the positions of the peak maxima on the x axis relative to the CTCF site (x=0) and 
y was given an arbitrary constant value. Fig 6.10B illustrates that super-nucleosomal chromatin 
particles flanking CTCF sites are repositioned during differentiation from iPS to NPC. The first 
three super-nucleosomal chromatin particles both upstream and downstream of the CTCF site 
were positioned 10 bp nearer to the CTCF site than their counterpart iPS nucleosomes. The 
fourth flanking super-nucleosomal chromatin particle both upstream and downstream of the 
CTCF site was repositioned by approximately 20 bp in NPC cells relative to the position of the 
same super-nucleosomal chromatin particle in iPS cells. 
These results suggest that re-positioning of nucleosomes flanking CTCF sites occurs during the 
early stages of neural cell differentiation. This re-positioning of nucleosomes flanking CTCF 
sites correlated with a reduction in the positioning of sub-nucleosomal particles at the CTCF 
site in NPC cells.  
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Figure 6.10 Super-nucleosomal chromatin particles flanking CTCF sites are repositioned, or 
remodelled, during differentiation from iPS to NPC 
A. Normalised  average cumulative frequency distributions of the super-nucleosomal (162-188 bp) 
chromatin particle size class show the chromatin structure at and surrounding (+/-2000 bp) CTCF sites in 
both iPS and NPC cells (n=9516). B. The positions of the peak maxima (x axis) relative to the CTCF site 
(x=0) were derived from each of the average cumulative frequency distributions in A. The positions of 
the peak maxima values were plotted for both iPS and NPC cells as a bar chart, with y as an arbitrary 
constant value. The first three nucleosomes both upstream and downstream of the CTCF site were 
positioned 10 bp nearer to the CTCF site than their counterpart iPS nucleosomes. The fourth flanking 
both upstream and downstream of the CTCF site was repositioned by approximately 20 bp in NPC cells 
relative to the position of the same nucleosome in iPS cells. 
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6.10 Discussion. 
The work presented in this chapter has shown that nucleosomal chromatin particles are 
positioned flanking the CTCF binding motif in both human iPS and NPC cells. This is in 
agreement with previous studies of nucleosome positioning at CTCF sites in both the human 
lymphocytes (Fu, Sinha et al. 2008; Valouev, Johnson et al. 2011) and the mouse genomes 
(Teif, Vainshtein et al. 2012). In addition, a dominant peak in the sub-nucleosomal chromatin 
particle mid-point frequency was shown to occur at all of the CTCF sites in iPS cells. The peak in 
the chromatin particle mid-point frequency representing sub-nucleosomal chromatin particles 
positioned at the CTCF site also was present in NPC cells, but at only approximately 30% of the 
level seen in iPS cells. This suggested that there may be sub-groups of CTCF sites in NPC cells, 
some having strongly positioned sub-nucleosomal chromatin particles and others where sub-
nucleosomal chromatin particle positioning does not occur. Cluster analysis showed that this 
was not the case; rather, all of the CTCF sites in NPC cells appeared to possess sub-
nucleosomal chromatin particle positioning, albeit weak. This suggests that the change that 
occurs during differentiation from iPS to NPC cells is not simply that sub-nucleosomal particles 
are ‘on’ or ‘off’ a CTCF site. This suggests that CTCF does not bind to its binding motif in the 
same place in every cell in the NPC population; therefore CTCF sites have low occupancy in 
NPC cells (Fig 6.3).   
The presence of the peak in the average cumulative frequency distribution of the sub-
nucleosomal chromatin particles positioned at CTCF sites could be explained by direct 
protection of DNA from MNase cleavage by CTCF and other binding partners at CTCF sites in 
pluripotent cells. It  has been shown in CD4+ cells, by DNase foot-printing analysis, that CTCF 
protects 50-72 bp of DNA (Fu, Sinha et al. 2008). It  is known that CTCF binds a number of 
other proteins, for example, cohesin (Rubio, Reiss et al. 2008; Lee and Iyer 2012), TAF3 (Liu, 
Scannell et al. 2011), SIN3A (Lutz, Burke et al. 2000) and several other proteins such as YY1 and 
RNA polymerase II  (Zlatanova and Caiafa 2009). Also, CTCF footprints can be cell type specific 
(Boyle, Song et al. 2011). As the CTCF sites used in this study were derived using ChIP data 
derived from H1-hESCs, it would be expected that these sites would be bound by CTCF and its 
binding partners in hiPS cells. However, there are other possibilities that cannot be excluded. 
For example, it is possible that the positioned sub-nucleosomal chromatin particle at CTCF 
sites represents a non-standard nucleosome. At its simplest this could be an ’unwrapped’ 
nucleosome that is more susceptible to MNase cleavage (Li, Levitus et al. 2005; Henikoff, 
Belsky et al. 2011). Alternatively, sub-nucleosomal chromatin particles could be constructed 
from two nucleosomes that lose the H2A and H2B histones, then the remaining two histone 
(H3/H4)2 dimers slide together to form an octamer. Weak protection from MNase at the ends 
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of the octamer would mean that 10 bp of DNA is trimmed from each end of the particle, 
leaving 125 bp of DNA (Read and Crane-Robinson 1985). More recently, precise nucleosome 
mapping in S. cerevisiae has suggested that half nucleosomes comprising one copy of each 
histone exist in dynamic regions of chromatin (Rhee, Bataille et al. 2014).  The existence of any 
of these proposed half-nucleosome structures is possible at CTCF sites. However, it has been 
shown that nucleosomes flanking CTCF sites tend to be enriched for H2AZ  (Fu, Sinha et al. 
2008) and that human H2A.Z nucleosomes protect approximately 120 bp of DNA (Tolstorukov, 
Kharchenko et al. 2009).  Hence, it is possible that the positioned sub-nucleosomal chromatin 
particle at the CTCF is an H2A.Z -containing nucleosome.  
Arrays of approximately seven strongly positioned nucleosomes were detected flanking each 
side of all CTCF sites in both iPS and NPC, despite the weaker positioning of the sub-
nucleosomal chromatin particle in NPC cells. However, it was shown here that nucleosomes 
are re-positioned flanking CTCF sites in human NPC cells. Nucleosomes both upstream and 
downstream of the CTCF site in NPC were positioned nearer to the CTCF site than the 
counterpart nucleosome in iPS cells. As a single turn of  DNA is approximately 10.5 bp (Wang 
1979), a 10 bp change in the position of the nucleosomes flanking CTCF sites in NPC cells would 
not affect the rotational position. It has been shown in vitro that ATP-dependent remodellers 
can move nucleosomes in 10 bp steps (Schwanbeck, Xiao et al. 2004). Therefore, this change in 
positioning  of the nucleosomes flanking CTCF sites in NPC cells, relative to that seen in iPS 
cells, could be brought about by the action of the ATP-dependent remodellers that slide 
nucleosomes, such as the ISWI remodellers  (Deindl, Hwang et al. 2013) or by CHD1 (Stockdale, 
Flaus et al. 2006), which is a member of the CHD remodellers. It has been shown in S 
.cerevisiae that the chromatin remodeller Isw2 moves nucleosomes into nucleosome free 
regions which might act to occlude transcription factor binding sites and repress transcription 
(Whitehouse and Tsukiyama 2006). One candidate remodeller in this case in human cells is the 
NURF complex from the ISWI group of remodellers as it has been shown to be enriched in the 
brain and is involved in bringing about neurite outgrowth (Barak, Lazzaro et al. 2003). 
Alternatively, positioning of the sub-nucleosomal particle at the CTCF site in iPS cells might act 
as a barrier, resulting in statistical positioning of the flanking nucleosomes (Mavrich, Ioshikhes 
et al. 2008). Alternatively, the re-positioning of nucleosomes could be due to a change in the 
size of the nucleosomes. This could occur through the binding of a small protein to one side of 
each nucleosome. Therefore the amount of DNA protected from MNase digestion would 
increase, resulting in a small change in the mid-point position of MNase-protection for these 
nucleosomes. However, it seems most likely that this re-positioning is brought about by the 
action of ATP-dependent chromatin re-modelling enzymes.  
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The work in this chapter is summarised in Fig 6.11. This work has shown that all of the CTCF 
sites in iPS cells possess positioned sub-nucleosomal particles and flanking nucleosomal 
particles. Broadly, this pattern of chromatin organisation is retained at all CTCF sites in NPC 
cells, but significantly, the nucleosomes flanking the CTCF site are re-positioned (Fig 6.10).This 
suggests that nucleosome positioning at CTCF sites is important during early neural cell 
differentiation, perhaps affecting higher order chromatin architecture to regulate neural 
specific genes. 
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Figure 6.11 Model of nucleosome positioning surrounding CTCF sites during neural cell differentiation 
CTCF binds to its motif in iPS cells and recruits cohesin and mediator. Super-nucleosomal chromatin 
particles are positioned flanking the CTCF binding motif. After differentiation to NPC cells, CTCF and its 
co-binding proteins are lost from the CTCF motif and the flanking nucleosomes are re-positioned 
towards the CTCF motif, suggesting that chromatin remodelling occurs at CTCF sites in the early stages 
of neural cell differentiation. 
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Chapter 7: General Discussion 
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7.1 Project aims 
The aim of this project was to study changes in genome-wide chromatin particle positioning in 
the human genome during the earliest stages of neural cell development to answer the 
following questions: 
1. Are nucleosomes randomly distributed or strategically placed in the human genome? 
2. Does chromatin structure change during neural development? 
3. Does chromatin structure change at regulatory sites during neural development? 
4. Can I identify genes that are targeted for regulation during neural development? 
ATP-dependent chromatin remodelling complexes regulate nucleosome positioning and 
occupancy in chromatin. It has been shown that mutations in genes that encode chromatin 
remodellers are highly associated with genetic risk (De Rubeis, He et al. 2014). Prevalent 
among these are genes whose mis-regulation occurs in neurodevelopmental disorders such as 
Rett’s, Kleefstra’s, and CHARGE syndromes (Amir, Van den Veyver et al. 1999; Vissers, van 
Ravenswaaij et al. 2004; Kleefstra, van Zelst-Stams et al. 2009). Hence, mis-regulation of 
chromatin structure is implicated in a range of childhood neuro-developmental syndromes and 
mental health disorders. Chromatin dynamics appears to have a pivotal role in gene regulation 
and its mis-regulation is implicated neuro-psychiatric disorders. This raises the questions of 
how and why does the control of nucleosome positioning increase the risk of neuropsychiatric 
disorders. By studying the dynamic changes in chromatin structure that occur during human 
neuro-development, the work in this thesis has revealed fundamental information about 
nucleosome positioning that is required to begin to answer this question.  
7.2 Bioinformatics Methods. 
In order to determine the changes in patterns of chromatin structure that occur during 
differentiation from induced pluripotent cells to neural progenitor cells, high resolution 
genome-wide chromatin maps from both cell types were  constructed and compared.  As the 
human genome is large (approximately 3x109 base pairs) this study involved developing a work 
flow for processing ‘big data’ using high performance computing. To analyse these maps, I 
used both previously published methods, such as ‘SiteWriter’ (Kent, Adams et al. 2011) and 
methods that I developed during the course of this work. The ‘SiteWriter’ tool generates 
average genome-wide pattern of chromatin particle positioning at specific genomic sites 
normalised to the mean particle position per bin value in the window surrounding the site. 
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To investigate the patterns of positioned nucleosomes at regulatory sites in more detail, I used 
two other methods of analysis. Firstly, I optimised the methodology for cluster analysis in R to 
apply to chromatin particle positioning at regulatory sites in the human genome. Secondly, in 
order to locate individual positioned chromatin particles genome-wide and to align them to 
regulatory regions of the human genome, I developed a computational method for locating 
the positions of Gaussian peaks derived from the cumulative read count in each of three 
consecutive 10 bp bins genome-wide. The resulting tool, PeakFinder, was a simple heuristic 
peak marker. The parameters used to define this peak were set stringently to detect high 
numbers of reads in the central bin of the peak, so as to detect well positioned chromatin 
particles. Hence, this tool detects only very strongly positioned chromatin particles. This means 
that the estimates of the total numbers of positioned particles might be low, since chromatin 
particles that are positioned, albeit weakly would not have been detected using this tool. 
However, the total of numbers of positioned chromatin particles obtained was in a similar 
range to those found by others using different cell types and different methods of peak 
detection (Gaffney, McVicker et al. 2012). The major way in which this tool was used in this 
thesis was to locate well-positioned chromatin particles in the maps from undifferentiated iPS 
cells and the same cells developed to NPC. These three complementary methods provided 
information about both the global patterns of nucleosome positioning across the genomes of 
both iPS and NPC cells and local patterns at specific regulatory regions of the genome.  
7.3 Key findings 
7.3.1 Global patterns of chromatin particle positioning in the human genome 
The genome-wide analysis of the chromatin particle positioning maps in both iPS and NPC cells 
in this thesis showed that it was possible to detect individual positioned chromatin particles. 
These were divided into in three size classes: sub-nucleosomal, nucleosomal and super-
nucleosomal. The work presented in this thesis shows that broadly, well positioned chromatin 
particles in the human genome are not positioned at high density across the genome; they are 
usually distributed singly or in groups on two or three. This result is in contrast to the 
nucleosome organisation in the S. cerevisiae genome in which 85% of the genome possesses 
positioned nucleosomes and they tend to be organised in arrays (Mavrich, Ioshikhes et al. 
2008; Kent, Adams et al. 2011). This contrast in chromatin organisation between the human 
and yeast genomes may not be as surprising as it seems, as the structure and complexity of the 
human genome is very different from that in S. cerevisiae, in overall size, gene density and 
gene organisation. A human cell has 20 Mb of DNA per µm3 whereas yeast has 4Mb of DNA per 
µm3. In addition, the S. cerevisiae genome is approximately 12 MB in size and possesses 
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approximately 6,000 genes (Goffeau, Barrell et al. 1996), hence is gene-dense. The human 
genome is 240 times larger (3GB of DNA) with approximately 20,000 protein coding genes 
(Lander, Linton et al. 2001). It has been shown that the  S. cerevisiae genome has  67,517 
positioned nucleosomes  (Brogaard, Xi et al. 2012). Hence in S. cerevisiae, on average, for 
every kilo-base of DNA there are 5 positioned nucleosomes, leaving only 200 bp of nucleosome 
free DNA. Using the peak finding tool that I developed to detect well positioned nucleosomes 
(PeakFinder), the work presented here makes a conservative estimate that human NPC cells 
possess approximately 1x106 well-positioned nucleosomes. This means that, on average, there 
is only one nucleosome for every 3kb of DNA in NPC cells. This low density of well positioned 
nucleosomes in the human genome has been shown in other human cell types, suggesting that 
this may occur generally across human cell types (Valouev, Johnson et al. 2011; Gaffney, 
McVicker et al. 2012) . The human genome possesses only fifteen fold more positioned 
chromatin particles than the S. cerevisiae genome. This difference in number of positioned 
chromatin particles is not in proportion to the difference in size of these two genomes, 
illustrating that the density of strongly positioned nucleosomes across the genome is much 
lower in human cells than in S. cerevisiae.  
The presence of a nucleosome free region (NFR) in expressed genes determined from micro-
array data in human cells suggests that there might be a similar local regulatory function of 
nucleosome positioning at gene promoters in the human genome to that in S. cerevisiae 
(Ozsolak, Song et al. 2007; Tirosh and Barkai 2008). However, global chromatin structure may 
differ in humans from that in S. cerevisiae because of differences in the overall organisation of 
the regulatory components of the genome. This suggests that that the mechanisms of genome 
regulation that occur as a result of nucleosome positioning might differ between the human 
and the S. cerevisiae  genomes; individual nucleosomes appear to be strategically placed rather 
than being randomly distributed in the human genome. This work provides the answer to 
question 1. 
7.3.2 Patterns of nucleosome positioning at regulatory regions of the human genome 
Having examined the general patterns of well -positioned chromatin particles across the 
human genome, I examined the patterns of chromatin particle positioning at specific 
regulatory sites: selected transcription factor binding sites, TSS, CTCF and RE1 sites. This work 
showed that it is possible to detect positioned nucleosomes at TSS, CTCF and RE1 binding sites 
across the genome but not at the other selected transcription factor binding sites tested in the 
work of this thesis.  
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Examination of the global patterns of chromatin particle positioning at TSS of protein coding 
genes in both undifferentiated and differentiated cells did not show a canonical pattern of 
chromatin particle positioning. This is in contrast to the canonical patterns of nucleosome 
positioning found at TSS in the S. cerevisiae genome, which have a nucleosome free region 
flanked by arrays of well-positioned nucleosomes with weaker positioning upstream than 
downstream of the TSS (Mavrich, Ioshikhes et al. 2008; Jiang and Pugh 2009). This could be 
explained if the patterns of chromatin particle positioning are variable at TSS across the human 
genome. In this case, any patterns of chromatin particle positioning would be masked by 
plotting the average chromatin particle frequency distribution.  In addition, the size and 
complexity of the human genome should be taken into account. There are approximately 
198,000 annotated transcripts in the human genome, of which approximately 80,000 are 
protein coding transcripts. As there are only approximately 20,000 protein coding genes in 
total in the human genome this means that each one generates multiple transcripts (GENCODE 
Release (version 22) www.gencodegenes.org). In addition, it has been shown using cluster 
analysis, that there are different patterns of chromatin structure at TSS in human cells 
(Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012). Taken together, this means that the 
number and complexity of the TSS in the human genome makes global analysis of patterns of 
chromatin particle positioning at TSS challenging.  Hence, in this study it was decided to use 
the peak finding method developed in this thesis. This was used firstly to locate strongly 
positioned chromatin particles at TSS in both iPS and NPC cells and secondly to determine how 
many and which of these positioned chromatin particles were exclusive or in common 
between the two cell types. This led to the finding that it was possible to detect loss and gain 
of individual positioned nucleosomes at TSS during differentiation from iPS to NPC cells. These 
changes were detected at the TSS of genes involved in both the maintenance of pluripotency 
(e.g. Nanog) and at the TSS of neural -specific genes (e.g. GRIA1 which encodes an AMPA 
receptor subunit). At the TSS of selected genes involved in the maintenance of pluripotency 
and at neural-specific genes it was shown that the loss and gain of nucleosomes occurring 
during differentiation from iPS to NPC cells, correlated with changes in gene expression. In 
addition, it was shown that extent of the increase in number of positioned nucleosomal size 
chromatin particles at TSS that occurred during differentiation from iPS to NPC cells broadly 
reflected the global increase in the number of positioned nucleosomal chromatin particles at 
TSS during differentiation from iPS to NPC.  
I have shown from global analysis of positioned chromatin particles, that the additional 
nucleosomal chromatin particles in NPC cells are most likely positioned de novo. This suggests 
that independent de novo positioning of chromatin particles may occur at the TSS of neural 
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specific genes during neural cell differentiation, rather than through the inter-conversion of 
existing particles of another size class. However, it cannot be excluded that the pattern of 
chromatin particle positioning at TSS may differ from the global pattern described here. It has 
been shown in S. cerevisiae that nucleosomes at gene promoters can be partially unwrapped 
(Floer, Wang et al. 2010), that they can be more accessible to MNase cleavage (Weiner, 
Hughes et al. 2010) and that smaller, approximately 100 bp chromatin particles are located 
upstream of the TSS of highly expressed protein coding genes (Kent, Adams et al. 2011). Hence 
it is possible that larger nucleosomal chromatin particles might convert to sub-nucleosomal 
chromatin particles at TSS in human cells and this might account for the small overlap in the 
positions of chromatin particles shown in this study. 
Patterns of positioned nucleosomes have been shown to occur flanking CTCF sites and RE1 
sites  (Fu, Sinha et al. 2008; Valouev, Johnson et al. 2011; Teif, Vainshtein et al. 2012; Nie, 
Cheng et al. 2014), but this the first time that the changes in chromatin particle positioning at 
these sites have been investigated in detail in human cells during early neural development. It 
was shown here that MNase-seq can be used to detect sub-nucleosomal chromatin particles at 
both RE1 and CTCF sites. These sub-nucleosomal chromatin particles most likely represent 
transcription factor complexes at their binding sites, but could represent smaller/remodelled 
nucleosomes.  Arrays of positioned nucleosomes were detected flanking both RE1 sites and 
CTCF sites in iPS cells. In both cases this correlated with the presence of a sub-nucleosomal 
particle at these sites. After differentiation to NPC cells changes in chromatin particle 
positioning were detected both at RE1 and CTCF sites. However, the types of changes in 
nucleosome positioning occurring during neural cell differentiation were specific to each 
transcription factor.  CTCF appears to remain bound to its site in NPC cells and nucleosomes 
remain positioned flanking it. This suggested that nucleosome positioning at CTCF sites in both 
cell types might be dependent upon CTCF binding. Initially it appeared that there was little 
change in CTCF binding or nucleosome positioning at the set of CTCF sites utilised here during 
differentiation from iPS to NPC. A possible explanation for this would have been that the set of 
CTCF sites used in this study, derived from H1-ESC cells, was specific to pluripotent cells and 
therefore a completely different set of sites might be utilised in NPC cells to regulate neural 
specific genes.  It has been shown in mouse cells that CTCF site utilisation might be cell type 
specific during early neural differentiation (Teif, Vainshtein et al. 2012), so it would be 
interesting to investigate this possibility in human cells.  However, closer examination of the 
chromatin particle positioning at CTCF sites in NPC cells revealed that the levels of CTCF 
binding might be lower in NPC cells. Interestingly, loss of occupancy at CTCF sites also has been 
shown during differentiation of mouse ESC cells to embryonic fibroblasts (MEFs) (Teif, 
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Beshnova et al. 2014). In addition to a loss of CTCF occupancy, it was shown here that 
nucleosomes are re-positioned towards the CTCF site in NPC cells. This suggests that 
chromatin remodelling occurs during neural cell development at the H1-ESC cell derived set of 
CTCF sites analysed here, but does not rule out the possibility that other CTCF sites might be 
used to activate neural-specific genes. CTCF might bind to specific CTCF sites in iPS cells and 
recruit remodelling complexes to position nucleosomes flanking them. During differentiation, 
loss of CTCF at these sites might result in the removal of  a ‘barrier’ and allow the flanking 
nucleosomes to redistribute , encroaching on the CTCF site, perhaps blocking the activity of 
transcription factors that activate genes involved in the maintenance of pluripotency.  This 
nucleosome re-positioning might be brought about remodellers that slide nucleosomes, for 
example, the NURF complex.  Kagey et al have shown that the formation of DNA loops 
between enhancers and promoters in mouse ESC’s brings about cell type specific gene 
expression (Kagey, Newman et al. 2010). In addition, Zhang et al have shown that in order to 
reprogram human somatic cells to iPSC, intra-chromosomal looping is required to re-activate 
pluripotency genes (Zhang, Jiao et al. 2013). These studies emphasise the importance of higher 
order chromatin structure in the regulation of pluripotency and thus in development. 
In contrast to CTCF binding, occupancy at RE1 sites, perhaps by REST or the REST complex, was 
not detected during differentiation to NPC cells in this study. In Chapter 5, a large peak in the 
frequency of sub-nucleosomal chromatin particles (112-137 bp) was detected centred on RE1 
sites in iPS cells but this peak was not detected at RE1 sites in NPC cells. Nevertheless, 
nucleosomal chromatin particles remained strongly positioned flanking approximately 50% of 
the RE1 sites derived in this study, during differentiation from iPS to NPC cells. This suggested 
that nucleosome positioning at RE1 sites is independent of the binding of REST or the REST 
complex and that nucleosomes remain positioned at this subset of RE1 sites during neural cell 
development. This analysis led to the identification specific groups of REST target genes which 
retain chromatin structure flanking RE1 sites during neural cell differentiation. This suggests 
that subsets of REST target genes are targeted during differentiation from iPS to NPC cells, 
thus answering question four. 
It was shown here that there are some similarities in the chromatin structure flanking RE1 and 
CTCF sites in iPS cells. The presence of arrays of positioned nucleosomes flanking RE1 and CTCF 
sites correlates with the presence of a sub-nucleosomal chromatin particle in iPS cells. This is 
likely to be the transcription factor or a transcription factor complex.  In both cases in iPS cells, 
these transcription factors might bind and recruit chromatin remodelling complexes that 
position nucleosomes flanking their binding sites. However after differentiation to NPC cells, 
the patterns of nucleosome positioning flanking RE1 and CTCF sites differ, suggesting that 
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there might be different mechanisms of regulation at these two important transcription factor 
binding sites. Nucleosomes that remain positioned at transcription factor binding sites after 
early differentiation, might act as an ‘epigenetic memory’ so that the transcription factor can 
rebind to the site, affecting gene regulation at a later time in development, for example in the 
case of REST.  Movement of nucleosomes towards the transcription factor site might occlude 
the site, restricting transcription factor access. In the case of CTCF, restricting access to its 
binding site might prevent the recruitment of cohesin, resulting in an inability to form 
chromatin loops. This might result in the repression of pluripotent genes. 
The work in this thesis has shown that chromatin structure does change at regulatory sites in 
human cells during neural cell development, thus answering question 3. The local changes in 
nucleosome positioning at regulatory sites during early development shown here might be 
fundamental in affecting the balance of activation and repression of genes involved in the 
specification of cell fate in neural development. 
7.3.3 Changes in chromatin particle positioning during neural development. 
I have shown that chromatin particle positioning changes both locally and globally during 
neural cell development. Local changes in nucleosome positioning were shown to occur at 
regulatory sites during early neural cell differentiation. This was shown in Chapters 5 and 6. 
Evidence for global changes in the numbers of positioned chromatin particles was shown in 
Chapter 3.  The number of positioned chromatin particles increased during differentiation 
from iPS to NPC cells. In addition I have shown that similar high numbers of positioned 
chromatin particles are found in the published chromatin maps from K562 and GM12878 cells 
(Kundaje, Kyriazopoulou-Panagiotopoulou et al. 2012). Interestingly, recent work by West et al  
has shown in both mouse and human cells that nucleosome occupancy increases during 
differentiation from iPS to fibroblast cells (West, Cook et al. 2014). Taken together, these 
results suggest that chromatin is more organised in differentiated cells than in pluripotent cells 
and that the presence of high numbers of strongly positioned nucleosomes is a characteristic 
of differentiated cells.  
Observations suggesting that in pluripotent cells, chromatin organisation is both accessible and 
dynamic, whereas in differentiated cells chromatin is more compact, were discussed in 
Chapter 1. These observations led to the idea that pluripotent cell chromatin architecture is 
‘open’ and ‘fluid’ allowing the access of cell machinery to regulatory regions of the genome 
that are important in specifying cell fate. The evidence presented in this thesis supports these 
observations and answers question two. 
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The increase in the number of positioned chromatin particles shown in Chapter 3 was most 
marked in the nucleosomal chromatin particle size class, suggesting that this class of chromatin 
particle is the most dynamic during neural cell development. In the human genome histone H1 
containing nucleosomes, known as chromatosomes, might be represented by the super-
nucleosomal chromatin particle size class. The H1 depleted or core nucleosomes might be 
represented by the nucleosomal chromatin particle size class. This strong positioning of core 
nucleosomes in NPC cells suggested a high degree of genome regulation in these cells by this 
chromatin particle size class. This fits with previous observations discussed in Chapter 1, 
section 1.3, that histone H1 containing nucleosomes are depleted in active chromatin and that 
H1 containing nucleosomes increase chromatin compaction, leading to transcriptional 
repression. 
As I have shown in Chapter 3 (Fig 3.8), that the chromatin particle size classes described in this 
study are largely discrete, it would be interesting to know whether these nucleosomal particles 
are enriched regions of active chromatin in NPC cells. This could be tested by ChIP-seq using 
antibodies against active chromatin marks, such as H3K9ac and H3K27ac or against the histone 
variant H3.3. 
7.4 Future work 
7.4.1 A targeted approach to chromatin particle positioning analysis. 
The size of the human genome means that it is very expensive to undertake sequencing it in its 
entirety multiple times to make comparisons between cells types. Now that I have constructed 
and characterised a basic chromatin map from both a pluripotent and a differentiated cell 
type, it would be possible to take a targeted enrichment approach to studying specific areas of 
interest in the genome. It might be possible to do this using an approach that combines ChiP 
with MNase-seq, selecting the regions of the genome of interest using an antibody, then 
characterising the chromatin structure in that region. Alternatively regions of interest in the 
genome could be selected after MNase digestion by DNA hybridisation with the region of 
interest (Yigit, Zhang et al. 2013). 
7.4.2 The relationship between changes in nucleosome positioning and human 
neuro-psychiatric disorders. 
Mutations in the genes that encode ATP-dependent chromatin remodelling proteins are highly 
associated with genetic risk. Specifically, approximately half of the CHD group of chromatin 
remodellers that can move and evict nucleosomes, (CHD2, 5, 7 and 8) have neuro-psychiatric 
disease associations in humans. Now it is possible to begin to examine how the regulation of 
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nucleosome positioning is involved in genetic risk of neuropsychiatric disorders. This could be 
carried out by integrating maps of human mutations (SNPs and small indels) with the 
nucleosome positioning data presented in this thesis. This would correlate genome-wide 
changes in chromatin structure with common genetic variants associated with neuro-
psychiatric diseases. This analysis would reveal the regulatory regions of the genome that are 
targeted by chromatin remodelling proteins. 
In relation to the work presented here on the analysis of chromatin structure at RE1 sites, it 
would be interesting to examine changes in chromatin structure at later stages of neural 
development by developing human NPC cells to a later stage of differentiation in culture. Also 
it would be interesting to examine chromatin structure at RE1 sites after seizures. In the latter 
case, this would involve developing MNase seq methods from cells derived from rat models, 
for example after kainate-induced seizures (Hellier and Dudek 1999). This would show how 
chromatin structure relates to specific sets of neuronal genes and further determine the 
relationship between the regulation of REST and chromatin structure in human disease. These 
approaches would lead to insight into the mechanisms of regulation of the neural cell genome 
and ultimately to deciphering the causes human neuro-psychiatric disorders. 
7.4.3 Further global analysis of the locations of the positioned chromatin particles. 
It is clear that a large amount of information is contained in these chromatin particle 
positioning maps, hence further analysis will likely reveal answers to some of the additional 
questions raised during this work. For example, in this work I have made a conservative 
estimate of the numbers of well positioned chromatin particles in differentiated cells and 
located their “geographical” locations in the genome. I have mapped these positioned 
chromatin particles to known regulatory regions in the genome; some positioned chromatin 
particles are located at TSS and some are in arrays flanking RE1 sites and CTCF sites. The 
number of positioned chromatin particles surrounding RE1 sites and CTCF sites genome-wide 
was obtained by multiplying the number of peaks obtained in the average cumulative 
frequency distributions by the number of sites analysed in the genome in each case. This gives 
an approximate number of nucleosomes surrounding these binding sites in the genome. As 
this number was obtained using the results from the average cumulative frequency 
distributions, it is likely to be an overestimate. However, this does not alter the conclusion that 
most of the positioned super-nucleosomal chromatin particles in differentiated cells that are 
accounted for in this study are at CTCF sites and fewer are at RE1 sites and at TSS. This leaves 
approximately 75% of the positioned super-nucleosomal chromatin particles for which 
genomic positions have been obtained in this study, not yet accounted for (Fig 7.1). Therefore, 
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it would be interesting to map the remaining unaccounted for positioned chromatin particles 
to determine whether they are located at other known genomic features, or at so far 
undiscovered ones.  
7.6 Concluding remarks. 
I have characterised changes that occur in chromatin particle positioning during neural cell 
development. This has provided insight into the role of chromatin structure in the regulation of 
the human genome both in pluripotent and differentiated cells. In both cell types, only a small 
proportion of the genome possesses strongly positioned nucleosomes, but in the work of this 
thesis I have shown that it is possible to detect regulatory  regions of the genome where 
dynamic changes in chromatin structure occur and regions where chromatin structure remain 
stable during neural cell differentiation. As these regulatory regions of the genome with 
positioned nucleosomes are small, this information could be used to develop methods of 
correlating changes in chromatin structure with genetic variants associated with human 
diseases. Developing epi-genome-wide association studies (EWAS) to correlate genome-wide 
changes in chromatin structure with common genetic variants associated with neuro-
psychiatric diseases will provide a route to understanding the pathways connecting the mis-
regulation of chromatin structure and disease risk.  
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Figure  7.1 The number of super-nucleosomes mapped to the regulatory regions in the human genome 
in NPC cells. 
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Fig  A.1. The nucleosome repeat length of bulk human chromatin. The nucleosome repeat length of 
bulk chromatin was determined  by plotting a calibration curve of the log of the molecular size in base 
pairs against the distance migrated by the DNA in the gel and then determining the size of the furthest 
migrating band in the MNase ladder ( the lane labelled ‘total’). 
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Table A.1 Sequence reads derived from MNase resistant DNA in iPS cell and NPC cultures show 
broadly similar counts for each chromosome.  
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A 
     
Fig A.2 The number and size of the aligned paired-end sequencing reads for individual chromosomes 
was determined single base pair resolution. Frequency distributions for chromosomes 1-6 are shown 
for both iPS (blue) and NPC (orange) cells. 
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B
 
Fig A.2 The number and size of the aligned paired-end sequencing reads for individual chromosomes 
was determined single base pair resolution. Frequency distributions for chromosomes 7-12 are shown 
for both iPS (blue) and NPC (orange) cells. 
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C 
 
 
Fig  A.2  The number and size of the aligned paired-end sequencing reads for individual chromosomes 
was determined single base pair resolution. Frequency distributions for chromosomes 13-18 are shown 
for both iPS (blue) and NPC (orange) cells. 
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D 
 
Fig  A.2. The number and size of the aligned paired-end sequencing reads for individual chromosomes 
was determined single base pair resolution. Frequency distributions for chromosomes 19-Y are shown 
for both iPS (blue) and NPC (orange) cells. 
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Figure A.3 A comparison of the positions of chromatin particles mapped by MNase-seq in the 
nucleosomal chromatin particle size class from three differentiated cell types NPC, K562 and 
GM12878. Chromatin particles, defined as peaks in the genomic distribution of MNase-seq sequence 
read mid-points, were given explicit genome positions using the heuristic peak-finding algorithm 
(PeakFinder). The Venn diagram shows the number of particle positions determined for the nucleosomal 
size class (138-161 bp) of sequence read in NPC cells   and the frequency of the overlap of the positions 
within +/- 10 bp for K562 and GM12878 cells. 
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GENE 
NAME REFERENCE 
ACTA1 (Schoenherr, Paquette et al. 1996) 
ADAM23 
(Sun, Greenway et al. 2005) (Otto, 
McCorkle et al. 2007) 
APBA2 (Sun, Greenway et al. 2005) 
ARC (Sun, Greenway et al. 2005) 
ASIC2 (Sun, Greenway et al. 2005) 
ATP2B2 (Sun, Greenway et al. 2005) 
BDNF (Schoenherr and Anderson 1995) 
BRINP1 (Toshiyuki and Ichiro 2004) 
BSX (Park, Kim et al. 2007) 
CACNA1A (Johnson, Gamblin et al. 2006) 
CACNA2D3 (Sun, Greenway et al. 2005) 
CACNG2 (Bruce, Donaldson et al. 2004) 
CALB1 (Ballas, Grunseich et al. 2005) 
CDH4 (Sun, Greenway et al. 2005) 
CDK5R2 
(Sun, Greenway et al. 2005; Martin, 
Allagnat et al. 2012) 
CHRNB2 (Bessis, Salmon et al. 1995) 
CREBBP (Sun, Greenway et al. 2005) 
CRH (Bruce, Donaldson et al. 2004) 
CTNND2 (Sun, Cooper et al. 2008) 
CYP11B1 (Schoenherr, Paquette et al. 1996) 
DDR2 (Sun, Greenway et al. 2005) 
EXTL3 (Sun, Greenway et al. 2005) 
GABRG2 (Mu and Burt 1999) 
GJD2 (Martin, Allagnat et al. 2012) 
GLRA1 (Schoenherr, Paquette et al. 1996) 
GRIA2 (Brene, Messer et al. 2000) 
GRIN1 (Schoenherr, Paquette et al. 1996) 
GRIN2A (Bruce, Donaldson et al. 2004) 
HTR1A (Lemonde, Rogaeva et al. 2004) 
KCNH1 (Sun, Greenway et al. 2005) 
KIRREL3 (Sun, Greenway et al. 2005) 
L1CAM (Kallunki, Edelman et al. 1997) 
LHX3 (Bruce, Donaldson et al. 2004) 
LSAMP (Zhang, Pazin et al. 2008) 
MAPK8IP1 (Martin, Allagnat et al. 2012) 
MBP (Sun, Greenway et al. 2005) 
NEFH (Bruce, Donaldson et al. 2004) 
NEFM  (Schoenherr, Paquette et al. 1996) 
NPAS4 (Bersten, Wright et al. 2014) 
NPPA (Schoenherr, Paquette et al. 1996) 
NPTXR (Bruce, Donaldson et al. 2004) 
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NRXN3 (Bruce, Donaldson et al. 2004) 
NTRK3 (Bruce, Donaldson et al. 2004) 
OPRM1 (Kim, Hwang et al. 2004) 
PDGFRA (Sun, Greenway et al. 2005) 
PPP2R2C (Sun, Greenway et al. 2005) 
PRLHR  (Kemp, Lin et al. 2002) 
PTPRN (Martin, Allagnat et al. 2012) 
RAB4A (Sun, Greenway et al. 2005) 
RESP18 (Sun, Greenway et al. 2005) 
RGS7 (Bruce, Donaldson et al. 2004) 
SCN3A (Zhang, Pazin et al. 2008) 
SF1  (Sun, Greenway et al. 2005) 
SHANK2 (Sun, Greenway et al. 2005) 
SNAP25 (Bruce, Donaldson et al. 2004) 
STMN2  (Schoenherr and Anderson 1995) 
SYN1 (Schoenherr and Anderson 1995) 
SYP (Schoenherr, Paquette et al. 1996) 
SYT2 (Sun, Greenway et al. 2005) 
SYT7 (Sun, Greenway et al. 2005) 
TUBB3 (Zhang, Pazin et al. 2008) 
UNC5D (Sun, Greenway et al. 2005) 
VRK3 (Sun, Greenway et al. 2005) 
ZFM1 (Sun, Greenway et al. 2005) 
 
Table A.2 Genes that are known to be regulated by REST.  
Experimentally validated genes that are targeted by REST were derived from the literature. The 
bibliography is shown on the next page. 
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